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Post-corrosive Late Complications in Esophagus and 
Stomach – Role of the Esophageal Rest
Andon Chibisev
University Clinic for Toxicology, Clinical Centre, Skopje, Republic of Macedonia
Acute corrosive poisonings cause severe chemical injuries of the upper gastrointestinal tract, the most common location being the esophagus and the stomach. There are different opinions concerning the ques-
tion of taking food and liquids by mouth immediately after caustic ingestion. 
This prospective study comprised 146 patients aged between 14 and 75 years 
divided in two groups. In the examined group prevailed those with esopha-
gitis gr.IIb ( n=36; 54,54 %), esophagitis gr.III ( n=30; 45,45 %), gastritis gr. 
IIb  (n=42, 63,63 %) and gastritis III (n=24;36,36%). In the controlled group 
prevailed those with esophagitis gr III ( n= 52; 65 %) and esophagitis gr IIb (n= 
28; 35 %), gastritis gr. IIb( n= 55; 68,75 %)and gastritis gr III (n= 25; 31,25 %). 
Analysis of the results has shown a high percentage of esophageal stenosis in 
both groups 25 days after poisoning (31.82% v.s 43.75%), three and six months 
after poisoning (36.36% v.s. 52.50%) and also gastric injuries 25 days after the 
poisoning ( 37,88 % v.s. 46,25 %), three and six months after the poisoning 
(40,91% v.s 53,75%) In spite of the not significant difference, the results of 
our investigation have shown that the group with “esophageal rest” (NPO) 
had a smaller percentage of post-corrosive complications than the patients 
who were given food or liquids immediately after poisoning. Key words: 
caustic poisonings, caustic injuries, esophageal rest, post-corrosive stenosis
Corresponding author: Andon Chibisev, MD, PhD. University Clinic for Toxicology, Clinical Centre, Vodnjanska 
17, 1000 Skopje, Republic of Macedonia, Tel: +389 2 3211 072, +389 2 3237 504, +389 2 3147 635, +389 70 
387 040, +389 75 223 223, E-mail: toksikourgentna@gmail.com
1. INTRODUCTION
Acute corrosive poisonings appear 
as a result of ingestion of acids, bases, 
oxidants, heavy metal salts and other 
chemical substances. They cause chem-
ical injuries of the upper gastrointesti-
nal track, the most common location 
being the esophagus and the stomach. 
The patients present with a serious clin-
ical picture; clinical examinations are 
difficult to be conducted and therapy 
and final outcome are often uncertain 
(1,2). The most serious lesions occur in 
the esophagus and the stomach since 
the poison remains there a long time 
due to the specific anatomic structure 
of these organs. If the patient survives 
the acute phase of the poisoning, regen-
erative response may result in esoph-
ageal and/or gastric stenosis and in-
creased risk for esophageal and gastric 
cancer (3,4).
In establishing the diagnosis and 
therapeutic approach of corrosive poi-
sonings, the severity of the post-corro-
sive endoscopic changes of the esopha-
gus, stomach and duodenum is of major 
importance. It is detected with esoph-
agogastroduodenoscopy, which is con-
ducted 12-24 hours after ingestion of 
the corrosive agent (5,6).
We usually use the classification of 
endoscopic post-corrosive injuries in 
the upper GIT suggested by Kikendall:
 • First grade: erythema and edema 
of the mucosa;
 • Second (A) grade: erosions, blis-
ters, superficial
 • ulcers (transversal and linear), ex-
udation, hemorrhage;
 • Second (B) grade: circumferen-
tial lesions;
 • Third grade: multiple deep brown-
ish-black or grey ulcerations and 
necrosis;
 • Fourth grade: perforation (7).
Severity of the lesions depends on 
the nature, quantity and concentration 
of the corrosive substance, and the du-
ration of exposure . The damaged mu-
cosa, submucosa and muscle layer re-
generate with great difficulty because of 
the surrounding inflammation, necro-
sis and secondary complications. Tis-
sue fibrosis, adhesions or circular ste-
nosis appear, which greatly disturb the 
normal functioning (impeded peristal-
tic, impeded passage). All these compli-
cate the entire general condition of the 
patient, including inadequate normal 
food intake, loss of body weight, pros-
tration, cachexia (8).
There are different opinions con-
cerning the question of taking food 
and liquids by mouth immediately after 
caustic ingestion. Many authors recom-
mend NPO (nill per os) or the so-called 
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“esophageal rest” until the first endo-
scopic control (10 – 15 days). During 
the “rest”, the patient is fed completely 
parenterally by peripheral or central 
vein, or enterally by nasogastric or na-
soenteral tube, gastrostoma or jejunos-
toma (9).
There is another group of authors 
that recommend taking liquids 48 
hours after ingestion if the patient can 
swallow his/her saliva (10).
The aim of this paper was to pres-
ent the influence of the esophageal rest 
i.e. NPO in development of post-corro-
sive stenosis in the upper gastrointes-
tinal tract.
2. MATERIAL AND METHODS
This prospective study included a 
group of 146 patients, at the age be-
tween 14 and 75 years, hospitalized 
and treated at the University Clinic 
of Toxicology in Skopje in the period 
2007-2009. The patients were divided 
in two groups:
Group 1: consisted of 66 patients, 
with mean age in the interval 42.9 ± 
16.5 years, who were fed enterally (na-
sojejunal tube or feeding enterostoma) 
and were not given food by mouth in 
the first 10-15 days (NPO or esopha-
geal rest). This was the examined group.
G r o u p  2 :  c o n s i s t e d  o f  8 0 
patients,with mean age in the interval 
32.9 ± 15.6 years, who were given liq-
uid food by mouth in addition to par-
enteral nutritional support in the first 
48 hours after admission to the hospi-
tal. This was the control group.
Fol low-up period lasted for 6 
months.
In all patients diagnostic esophago-
gastroduodenoscopy was done in the 
first 12-14 hours after caustic ingestion, 
control esophagogastroduodenoscopy 
15-25 days, three or six months after 
caustic ingestion. During urgent esoph-
agogastroduodenoscopy in patients of 
group 1 with II B grade of injury naso-
jejunal tube was inserted under endo-
scopic control for post-pyloric nutrition. 
In patients with III grade of injury, af-
ter consulting an abdominal surgeon, 
a feeding enterostoma was implanted 
laparoscopically in the first 96 hours 
for artificial post-pyloric nutrition. Pa-
tients were analyzed according to their 
clinical findings, gender, way of poison-
ing (suicidal and accidental), chemical 
structure of the corrosive agent (acids, 
alkalis, other caustic substances).
The following statistical methods 
have been applied:
 • Chi-square test (X2 test) was used 
to determine the significance of 
difference in the onset of steno-
sis in the examined and control 
groups (post-corrosive esophagi-
tis gr. IIb and III and post-corro-
sive gastritis gr. IIb and III);
 • Relative risk (RR) was used to de-
termine the risk for onset of ste-
nosis in the examined and control 
groups (post-corrosive esophagi-
tis gr. IIb and III and post-corro-
sive gastritis gr. IIb and III).
3. RESULTS
The examined group consisted of 
66 patients, of whom 15 (22.72%) were 
males and 51 (77.27%) females; the 
youngest patients being 18 years old and 
the oldest 71 years old (± 95.000 Con-
fid. Interval from 37.3 to 48.4 years.).
Days when patients received no food 
by mouth (NPO) varied in the interval 
10.39±1.49 days, minimum 8 days and 
maximum 14 days.
The control group consisted of 80 
patients, of whom 16 (20%) were males 
and 64 (80%) females. The youngest pa-
tients were 14 years old and the oldest 
75 years old (± 95.000 Confid. interval 
from 29.4 to 36.3 years).
These patients were given liquid 
food by mouth 48 hours after esoph-
ageal rest.
The largest number of the exam-
ined group of patients – 43 (65.15%) 
ingested HCl, 15 (22.72%) used NaOH 
and 8 (12.12%) CH3COOH.
The majority of patients – 61 
(92.42%) had suicidal intent and 5 
(7.57%) ingested caustic agent acci-
dentally.
In the control group of patients, 
prevailed those who ingested hydro-
chloric acid – 51 (63.75%), 13 (16.25%) 
used acetic acid, 9 (11.25%) ingested so-
dium hydroxide whereas 7 (8.75%) sul-
phuric acid.
Analysis of the results in both 
groups of patients showed a high per-
centage of esophageal stenosis 25 days 
Category Admission
15 days after 
ingestion
25-30 days 3 months 6 months
E.R.
(n)(%)
L.D.
(n)(%)
E.R.
(n)(%)
L.D.
(n)(%)
E.R.
(n)(%)
L.D.
(n)(%)
E.R.
(n)(%)
L.D.
(n)(%)
E.R.
(n)(%)
L.D.
(n)(%)
Esophagitis / /
51
(77,27)
69
(87,25)
3
(4,55)
4
(5,0)
/ / / /
Esophagitis 
gr.II b
30
(45.45)
42
(52,50)
5
(7,58)
7
(8,75)
1
(1,52)
9
(11,25)
/ / / /
Esophagitis 
gr.III
36
(54.55)
38
(47,50)
8
(12,12)
4
(5,0)
1
(1,52)
2
(2,5)
/ / / /
Stenosis / /
1
(1,52)
/
21
(31,82)
35
(43,75)
24
(36,36)
41
(51,25)
24
(36,36)
42
(52,50)
Normal 
finding / /
1
(1,52)
/
40
(60,61)
30
(37,50)
42
(63,64)
39
(48,75)
42
(63,64)
38
(47,50)
Total 66(100) 80(100) 66(100) 80(100) 66(100) 80(100) 66(100) 80(100) 66(100) 80(100)
Table 1. Endoscopy/esophagus (esophageal rest v.s. liquid diet) E.R.- esophageal rest L.D.- liquid diet
Category Admission
15 days after
Ingestion
25-30 days 3 months 6 months
E.R.
(n)(%)
L.D.
(n)(%)
E.R.
(n)(%)
L.D.
(n)(%)
E.R.
(n)(%)
L.D.
(n)(%)
E.R.
(n)(%)
L.D.
(n)(%)
E.R.
(n)(%)
L.D.
(n)(%)
Gastritis / / 51
(77,27)
60
(75,0)
4
(6,06)
3
(3,75)
1
(1,52)
/
1
(1,52)
/
Gastritis
gr.II b
42
(63,64)
46
(57,50)
10
(15,15)
11
(13,75)
1
(1,52)
2
(2,5)
/ / / /
Gastritis 
gr.III
24
(36,36)
38
(47,50)
3
(4,55)
9
(11,25)
/ / / / / /
Stenosis 
antri
/ / / /
4
(6,06)
9
(11,25)
5
(7,58)
8
(10,0)
4
(6,06)
10
(12,5)
Stenosis 
antropylori
/ /
1
(1,52)
/
10
(15,15)
13
(16,25)
11
(16,67)
16
(20)
12
(18,18)
16
(20)
Stenosis 
pylori
/ / / /
11
(16,67)
15
(18,75)
11
(16,67)
17
(21,25)
11
(16,67)
17
(16,67)
Normal 
finding
/ /
1
(1,52)
/
36
(54,54)
38
(47,50)
38
(57,58)
39
(48,75)
38
(57,58)
37
(46,25)
Total 66(100) 80(100) 66(100) 80(100) 66(100) 80(100) 66(100) 80(100) 66(100) 80(100)
Table 2. Endoscopy/gaster (esophageal rest v.s.liquid diet) E.R.- esophageal rest L.D.- liquid diet
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after poisoning (31.82% vs 43.75%) and 
three and six months after poisoning 
(36.36% vs 52.50%) (Table 1 ).
Analysis of the results in both 
groups of patients has shown a large 
percentage of post-corrosive gastric 
injuries 25 days after caustic ingestion 
(37.88% vs 46.25%) and three and six 
months after caustic ingestion (40.91% 
vs 53.75%) (Table 2 ).
Table 1a. shows the results of the 
risk for onset of post-corrosive inju-
ries (esophagitis IIB and III) in the ex-
amined and control groups of patients.
Fifteen days after initiation of ther-
apy, for chi-square=1.22 and p >0.05 
(p=0.27), there was no significant dif-
ference in the distribution of the re-
sults between the examined and con-
trol group.
After administration of therapy for 
25-30 days, the chance for occurence 
of stenosis in patients fed by tubes was 
0.73 times smaller / RR=0,73 (95%CI 
0.47-1.12)/, in comparison with patients 
given liquid diet, although the differ-
ence was not significant.
Three months after treatment, the 
chance for occurence of stenosis in 
patients feb by tubes was 0.71 times 
smaller / RR=0,71 (95%CI 0.49-1.04)/, 
in comparison with patients given liq-
uid diet, although the difference was 
not significant.
After 6 months, the chance for oc-
curence of stenosis in patients feb by 
tubes was 0.69 times smaller / RR=0,69 
(95%CI 0.47-1.01), in comparison with 
patients given liquid diet, although the 
difference was not significant.
Table 2a. presents the results of the 
risk for onset of stenosis in patients with 
post-corrosive injuries of the stomach 
(gastritis IIB and III) in the examined 
and control groups of patients.
Fifteen days after initiation of the 
therapy, for chi-square=1.22 and p >0.05 
(p=0.27), there was no significant dif-
ference in the distribution of the re-
sults between the examined and con-
trol group.
After administration of therapy for 
25-30 days, the chance for occurence 
of stenosis in patients fed by tubes was 
0.86 times smaller / RR=0,86 (95%CI 
0.59-1.28)/, in comparison with patients 
given liquid diet, although the diffe-
rence was not significant.
Three months after treatment, the 
chance for occurence of stenosis in 
patients feb by tubes was 0.80 times 
smaller / RR=0,80 (95%CI 0.56-1.14)/, 
in comparison with patients given liq-
uid diet, although the difference was 
not significant.
After 6 months, the chance for oc-
curence of stenosis in patients feb by 
tubes was 0.76 times smaller / RR=0,76 
(95%CI 0.53-1.08), in comparison with 
patients given liquid diet, although the 
difference was not significant.
4. DISCUSSION
Corrosive agents cause tissue de-
struction due to coagulation or lique-
faction necrosis, which intensity de-
pends on the type and concentration of 
the corrosive agent, duration of expo-
sure, quantity of the ingested agent, etc. 
(11). A retrospective study conducted in 
239 patients who ingested sodium hy-
droxide (NaOH) detected post-corro-
sive esophagitis in 89.3% of the patients 
and esophageal or gastric stenosis in 
72.6%. One percentage of the patients 
died in the acute phase of poisoning (in 
the first 24 h) and 1.4% in the chronic 
phase of the poisoning. It is interest-
ing to emphasize that the incidence of 
stenosis in female patients was 80.8% 
and in male patients 62.5%. Percentage 
of stenosis in patients who ingested a 
larger amount of corrosive agent (two 
or several spoonfuls) was 93.6%; post-
corrosive carcinoma of the upper GIT 
was found in 1.8% of the patients, fis-
tulas in 9.9% and perforation in 4.6% of 
the patients (12).
Tabela 1a. Determination of risk for occurence of stenosis in patients with post-corrosive injuries 
(esophagitis IIA and III) in the examined and control group
Tabela 2a. Determination of risk for occurence of stenosis in patients with post-corrosive injuries 
(gastritis IIA and III) in the examined and control group
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Intensity and mucous damage of the 
upper GIT in caustic poisonings are of 
huge importance in decision making 
on the therapeutic approach. The ma-
jority of authors think that hyperali-
mentation (enteral or parenteral) and 
antibiotic therapy have the biggest ef-
fect in successful healing. In contrast 
to post-corrosive injuries of grade I and 
II A that usually do not develop post-
corrosive complications, 50-70% of pa-
tients with II B grade of injury develop 
stenosis in the first 6 months after in-
gestion and all (100%) of patients with 
III grade of injury (13).
Extensive damage of the upper gas-
trointestinal tract of grades II A and III 
hinder physiological nutrition in these 
patients and, within a short period of 
time, they fell into a severe general con-
dition due to hypercatabolic state and 
negative alkali balance. Artificial nu-
trition is life-maintaining therapy in 
patients who cannot take food and are 
disposed to a risk of malnutrition. The 
type of the artificial nutrition depends 
on the degree of esophageal or gastric 
damage (14).
In many studies, patients with II 
B and III grades of injury are recom-
mended the so-called esophageal rest. It 
may be possible only if the patient does 
not take food by mouth (NPO or nill 
per os). During the “rest”, the patient is 
fed enterally by nasogastric or nasoen-
teral tube, gastrostoma or jejunostoma 
and parenterally by peripheral or cen-
tral vein. The positive effect of not tak-
ing food by mouth for a certain period 
of time is explained by the fact that food 
particles do not enter granulocytes of 
the esophageal wall and do not exac-
erbate the inflammation which is in a 
positive correlation with late post-cor-
rosive complications (15,16).
One study which examined 522 pa-
tients demonstrated positive effects of 
the esophageal rest in the first 10 days 
after caustic ingestion regarding the 
percentage of the severe late post-cor-
rosive complications (17).
Another study performed on 118 
patients examined the relation of the 
esophageal rest with the percentage of 
late post-corrosive complications and 
revealed a positive relation between 
not taking food by mouth (NPO) and 
number of patients who had stenosis 
of the upper GIT as a final outcome of 
the poisoning (18).
Many authors recommend avoiding 
food intake by mouth (NPO) until the 
10th day after ingestion and some other 
authors recommend it until the 15th 
day, that is, until the first endoscopic 
control (19).
There is a group of authors who ad-
vocate taking liquids 48 hours after cor-
rosive ingestion if the patient can swal-
low his/her saliva. These authors also 
think that 48 hours after corrosive in-
gestion the patients can take food by 
mouth (20).
Deskin R. (21) supports the so-called 
esophageal rest in patients with acute 
corrosive poisonings. This rest is pos-
sible if the patient does not take food 
by mouth (NPO or nill per os). During 
the rest, the patient is fed by nasoen-
teral tube, gastrostoma or jejunostoma. 
This author explains that taking food 
by mouth exacerbates the infection of 
GIT post-corrosive burns and thus, de-
lays and complicates the healing of the 
lesions. If enteral nutrition is impossi-
ble, then he advises TPI.
Kikendal (22) advises the so-called 
esophageal rest of minimum 10 days 
since the endoscopic diagnosis of the 
poisoning and permanent control of 
the nutritional status of the patient for 
maintenance of the good general con-
dition.
Eric Kardon (23) does not recom-
mend taking food by mouth (NPO) in 
acute corrosive poisonings until the 
first endoscopic control (between 15 
and 20 days).
Katzka A. David (24) thinks that in 
all corrosive poisonings of II B and III 
grades of injury of upper GIT, it is nec-
essary to implant feeding tube (jeju-
nostoma) for nutritional support and 
to avoid food intake by mouth (NPO) 
for 15 days.
One study examined 118 children 
with severe post-corrosive esophageal 
and gastric burns who, in addition to 
the usual therapy, received nothing by 
mouth for 7 days in order to prevent 
colonization of bacteria on the necrotic 
parts and to reduce the possibility of in-
fection. Seventeen percentages of them 
developed post-corrosive stenosis. Since 
physiological nutrition was not possi-
ble, feeding gastrojejunostoma was in-
stalled until the adequate surgical treat-
ment (25).
5. CONCLUSION
Acute corrosive poisonings are a se-
rious clinical, socio-economic and di-
agnostic-therapeutic problem, which, 
in spite of the modern sophisticated 
diagnostics and treatment, cause a se-
rious invalidity in patients. These poi-
sonings are most common in subjects 
who are in their most creative period 
of life; they burden the social commu-
nity because of the expensive diagnos-
tic and therapeutic programs and pro-
longed hospital stay.
In spite of the not significant dif-
ference of the results obtained in our 
study, it was shown that the group of 
patients with “esophageal rest” (NPO) 
had a smaller percentage of post-cor-
rosive complications than the patients 
who were given food or liquids imme-
diately after caustic ingestion. This 
might be a result of avoiding additional 
injuries during NPO status as well as 
of less frequent infections that would 
compromise the healing of post-cor-
rosive injuries.
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Aim: To evaluate and compare the clinical efficacy of intravenous omeprazole versus intravenous ranitidine therapy for the treatment of non-variceal upper gastrointestinal (UGI) bleeding after endoscopic 
therapy. Methods: 108 patients (72 males and 36 females) admitted with non-
variceal UGI bleeding in the Intensive Care Unit of the University Hospital 
of Durres, Albania, from 2004 to 2008, were included in the study. Patients 
with gastro-duodenal malignancy and those who were previously receiving 
anti-secretory drugs were excluded. All patients were treated endoscopically 
by injecting epinephrine (diluted 1:10.000) followed by ethanol and subse-
quently were randomized to receive either intravenous omeprazole (with an 
initial dose of 80 mg, followed by 8 mg/h infusion [n = 54]), or intravenous 
ranitidine (100 mg bolus, followed by 100 mg boluses every 6 hours for the 
next 72 hours [n = 54]). Results: The re-bleeding rate 72 hours after endo-
scopic treatment was lower in the omeprazole group than in the ranitidine 
group (6 vs. 14 patients, respectively; OR=3.4; 95% CI =1.1 –7.2; P<0.01). 
Less volume of blood transfusion was needed for the omeprazole group 
than for the ranitidine one (1.1 ± 1.8 units vs. 2.3 ± 2.9 units, P=0.03). The 
hospitalization period was shorter among patients treated with omeprazole 
than among those treated with ranitidine (5.4 ± 2.6 days vs. 6.8 ± 3.3 days, 
respectively; P=0.04). The need for surgery and the mortality rate were not 
statistically different between the two groups. Conclusion: After endoscopic 
treatment of non-variceal UGI bleeding, intravenous omeprazole reduced 
the risk of recurrent bleeding, decreased the need for blood transfusion and 
shortened the period of hospitalization. Intravenous omeprazole should be 
used in patients with non-variceal UGI bleeding after effective endoscopic 
treatment. Key words: bleeding, omeprazole, peptic ulcer, ranitidine.
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1. INTRODUCTION
Non-variceal upper gastrointestinal 
(UGI) bleeding remains a major reason 
for hospitalization and mortality. Its 
overall incidence is approximately 150 
hospital admissions per 100.000 inhab-
itants per year and the most common 
cause of UGI hemorrhage is peptic ulcer 
(1, 2). Most ulcers stop bleeding sponta-
neously as a result of intrinsic haemo-
static mechanisms, but in one fifth of 
cases these mechanisms may fail, and 
the bleeding continues (2).
Endoscopic therapy for bleeding 
peptic ulcer is an important modal-
ity of treatment. A meta-analysis has 
shown that endoscopic treatment in 
such cases reduces the rates of recur-
rent bleeding, surgery and mortality 
(3). However bleeding recurs within 72 
hours after endoscopic therapy in ap-
proximately 20% of patients and over-
all mortality of UGI bleeding remains 
around 10% (4, 5).
Pharmacological treatment is an 
attractive adjuvant to endoscopy ther-
apy in UGI bleeding. The major goal of 
the medical therapy is the inhibition of 
gastric acid secretion. The studies have 
shown that a high intragastric pH could 
facilitate platelet aggregation and re-
moval of proteolitic influence of pepsin 
on thrombus (2, 6, 7). The intragastric 
pH above 6.0 for a minimum period of 
72 hours is necessarily for clot stability 
at the ulcer site (8).
The intravenous use of Histamine 
H2-receptor antagonists (H2RA) or 
Proton Pump Inhibitors (PPI) inhib-
its the gastric secretion but the intra-
venous infusion of PPI maintains in-
326 MED ARH 2010; 64(6) • ORIGINAL PAPER 
Role of Intravenous Omeprazole on Non-variceal Upper Gastrointestinal Bleeding After Endoscopic Treatment: a Comparative Study 
tragastric pH above 6.0, showing bet-
ter effect than H2RA administration 
(6, 9). Thus, the intravenous use of PPI 
is theoretically superior in preventing 
recurrent bleeding.
Several studies have evaluated the 
effect of PPI on the non-variceal UGI 
bleeding (10-13). Unfortunately in some 
of them the results are not very clear be-
cause of including a heterogenic group 
of patients (10, 11), or not performing 
any endoscopic treatment (12, 13).
2. GOAL
The aim of our study was to evalu-
ate the clinical effectivity of intravenous 
PPI therapy compared with intravenous 
H2RA for the treatment of non-variceal 
UGI bleeding after endoscopic therapy.
3. METHODS
Study population
Between June 2004 and August 
2008, 173 patients with upper GI bleed-
ing were admitted at the Intensive 
Care Unit of the University Hospital of 
Durres, Albania. All of them were di-
agnosed and eventually treated endo-
scopically. We included in our study the 
patients with non-variceal UGI bleed-
ing older than 16 years in whom hae-
mostatic endoscopy had been success-
ful. We excluded patients with gastro-
duodenal malignancy and those previ-
ously treated with antisecretory drugs 
(H2RA or PPI).
Endoscopic therapy
Endoscopic examinations were per-
formed using a video-endoscope (FU-
JINON 2200) within the first 24 hours 
of admission. Patients were treated en-
doscopically by injecting 10–25 cm3 of 
adrenaline (epinephrine) (diluted 1:10 
000) around the ulcer crater and abso-
lute alcohol on the ulcer bed to stop the 
bleeding. Haemostasis was considered 
as established if bleeding had stopped 
and bleeding vessels were flattened or 
cavitated. In patients with non-bleeding 
visible vessels, haemostasis was consid-
ered as established when the vessel dis-
appeared.
Data collection
After endoscopic treatment, pa-
tients were randomized to receive in-
travenous infusions of omeprazole or 
ranitidine for a period of 72 hours. They 
were divided into two groups according 
to the medical therapy: group I had re-
ceived 80 mg intravenous omeprazole 
bolus, followed by an 8 mg/h infusion 
for 72 hours, and group II had received 
intravenous ranitidine 100 mg bolus, 
followed by 100 mg boluses every 6 
hours for a period of 72 hours.
The following data were recorded 
on every patient: age, sex, location 
of the ulcer (stomach or duodenum), 
bleeding stigmata (visible vessel, ooz-
ing hemorrhage, spurting or clot), pres-
ence of shock, hemoglobin and hema-
tocrit level, previous ulcer bleeding or 
ulcer disease, non-steroid anti-inflam-
matory drugs or aspirin use, and co-
morbid conditions. The Rockall scoring 
system was used to assess the severity 
of bleeding in both groups (14).
The primary end-point was 72-hours 
re-bleeding rate. Re-bleeding was de-
fined as new hematemesis, melaena, 
or hypotension (< 100 mm Hg systolic 
blood pressure) associated with a drop 
in hemoglobin and/or endoscopic evi-
dence of fresh re-bleeding. Volume of 
blood transfusion, hospital stay, need 
for surgery and mortality were consid-
ered as secondary end-points.
Statistical analysis
Data were entered into a personal 
computer and analyzed using the Sta-
tistical Package for the Social Sciences, 
version 12.0 (SPSS Inc., Chicago, IL, 
USA). Continuous variables were pre-
sented as means (± standard devia-
tions). The results of the two treatment 
groups were compared by chi square 
(χ2) test (categorical variables), and Stu-
dent’s t test (numerical variables). To 
test the association between outcomes 
and clinical co-variables, we estimated 
risk ratios and 95% confidence inter-
vals (95%CI). In all analyses, statistical 
significance was considered at P ≤ 0.05.
4. RESULTS
During the study period, a total of 
173 patients with upper GI bleeding 
were admitted to our Unit. We excluded 
Variable Omeprazole Group (N=54) Ranitidine Group (N=54)
Sex (no. of patients)
Male
Female
35
19
37
17
Age (in years) 55.4 ± 17.3† 55.8 ± 16.9
Hemoglobin (g/dl) 8.24 ± 1.4 8.29 ± 1.5
Hematocrit level (%) 27.7 ± 4.2 27.5 ± 3.7
Shock at presentation (no. of patients)‡ 7 6
Location of ulcer (no. of patients)
Stomach
Duodenum
15
39
16
38
Endoscopic signs of bleeding (no. of 
patients)
Visible vessel
Oozing hemorrhage
Spurting hemorrhage
Clot with underlying vessel
16
20
4
15
12
19
3
19
Size of ulcer (in cm.) 1.06 ± 0.8 1.12 ± 1.0
Previous ulcer disease (no. of patients) 11 12
Previous ulcer bleeding (no. of patients) 5 4
Risk factors for bleeding ulcer (no. of 
patients)
Use of NSAID
Use of aspirin
10
18
11
26
Rockall score 5.2 ± 1.8 5.1 ± 1.7
Coexisting illnesses (no. of patients)
Ischemic heart diseases
Cerebral stroke
Diabetes mellitus
Hypertension
Other diseases
8
3
3
4
2
10
2
2
5
4
Table 1. Base-line characteristics of the 108 patients. There was no statistically significant difference 
between the two groups. † Means ± standard deviations. ‡ Shock was defined as a systolic blood 
pressure of 90 mm Hg or less, or a pulse rate of 110 beats per minute or more.
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from the study 28 patients with other 
gastro duodenal lesions who were not 
treated endoscopically or underwent 
surgery because of profuse bleeding, 
23 patients with esophageal varices, 6 
patients with gastric tumors, and 8 pa-
tients who had previously received anti-
secretory drugs, H2RA or PPI. Only 
108 patients fulfilled the criteria to be 
included in our study. The mean age of 
the patients was 55.6 years (range: 17 – 
85 years). We had 54 patients in group 
I (taking intravenous omeprazole) and 
54 patients in group II (taking intrave-
nous ranitidine).
There were no statistically signifi-
cant differences between the two study 
groups on regard of age, the severity of 
bleeding at presentation, the location 
of ulcer, endoscopic signs of bleeding, 
risk factors for ulcers, and coexisting 
illnesses (table 1).
Table 2 shows the clinical outcomes 
of this study. The re-bleeding rate after 
72 hours of endoscopic treatment was 
lower in the omeprazole group than in 
the ranitidine group (6 vs. 14 patients, 
respectively; OR=3.4; 95% CI =1.1 –7.2; 
P=0.003). The mean (±SD) number of 
units of blood transfused after endos-
copy and medical treatment was signifi-
cantly smaller in the omeprazole group 
than in the ranitidine group (1.1 ± 1.8 
vs. 2.3 ± 2.9 units, P=0.03). The differ-
ence was probably related to treatment, 
since the mean number of units trans-
fused before endoscopic treatment was 
similar in the two groups (0.9 ± 1.2 and 
1.0 ± 1.4 units, respectively; P=0.45). 
The hospitalization period was shorter 
among patients treated with intrave-
nous omeprazole than those treated 
with intravenous ranitidine (5.4 ± 2.6 
days vs. 6.8 ± 3.3 days, respectively; 
P=0.04). Twenty patients (6 in the 
omeprazole group and 14 in the raniti-
dine group) who had recurrent bleed-
ing underwent a second endoscopy. 
The endoscopic retreatment stopped 
the bleeding in 67% of the patients in 
omeprazole group (4/6), and in 64% of 
the patients in ranitidine group (9/14). 
The need for surgery was lower in the 
omeprazole group (two vs. five), but the 
difference was not significant (P=0.17). 
Also, the mortality rate was not statis-
tically different between the two groups 
of the study. One patient (1.8%) died in 
the omeprazole group compared with 
2 (3.7%) in ranitidine group (P=0.14). 
All the patients died because of coex-
isting illnesses.
5. DISCUSSION
The main findings of our study in-
dicate that aggressive acid suppression 
with intravenous omeprazole signif-
icantly reduces the rate of recurrent 
bleeding, if compared with intravenous 
ranitidine in patients with non-variceal 
UGI bleeding after endoscopic schlero-
therapy. Patients who were treated with 
intravenous omeprazole required fewer 
blood transfusions and had signifi-
cantly shorter period of hospital stay. 
The need for surgery and the mortal-
ity rate were also lower in the omepra-
zole group, but these differences were 
not significant.
Several studies have evaluated the 
use of PPI in patients with non-vari-
ceal UGI bleeding. These studies have 
shown that patients who received intra-
venous PPI had significantly lower rate 
of recurrent bleeding than those who 
received H2RA or placebo (10, 15, 16). 
PPI also decreases the need for blood 
transfusions, the need for surgery, the 
mortality rate, and shortens the time of 
hospitalization (9, 17).
In second reports, the use of intra-
venous omeprazole is shown ineffective 
in patients with upper gastrointestinal 
haemorrhage either with (18) or with-
out endoscopic therapy (12). The study 
of Daneshmend et al. included patients 
with variceal bleeding, tumours, and 
peptic ulcers, but in these two studies, 
the authors used an 80 mg intravenous 
bolus of omeprazole followed by 40 mg 
every 8 hours. Two other studies found 
that intravenous omeprazole reduced 
the need for surgery if it was accompa-
nied with endoscopic therapy, but they 
did not show if it reduced the rate of re-
current bleeding or mortality (19, 20)
In our study, we enrolled patients 
with gastro-duodenal bleeding ulcers. 
All the patients were treated with endo-
scopic epinephrine and ethanol injec-
tion within the first 24 hours of admis-
sion. Adrenaline in doses of 20 ml so-
lution 1: 10 000 leads to about 85-90% 
suppression of non-variceal UGI bleed-
ing (21, 22).
After endoscopic therapy we used 
80 mg intravenous omeprazole bolus, 
followed by an 8 mg/h infusion for the 
next 72 hours. PPI are continuously be-
ing generated, and the half-life of ome-
prazole in the circulation is short (50 
minutes), therefore it needs to be given 
more frequently (e.g. every 3 hours) or 
continuously (23). Recommended dose 
of PPI for prevention of non-variceal 
bleeding recurrences is 80 mg in bo-
lus and subsequently through next 72 
hours dosage of 8mg/hour (7, 8). We 
used intravenous omeprazole because 
oral omeprazole may suppress acid pro-
duction to a similar degree, but it may 
take several days before the pH is con-
sistently above 6.0.
Omeprazole acts on K+-H+-ATPases 
pump situated in parietal cells and out-
side gastric sites, in renal and vascular 
smooth muscles (23, 25). This can result 
in decreased renal function and vaso-
constriction in blood vessels. In our pa-
tients the mortality rate was not signif-
icant between the two groups and the 
deaths were caused only by co-morbid 
conditions.
Our study had some limitations. 
We did not measure intra-gastric pH 
in our patients because the high dose 
of omeprazole, like the one we used, 
can maintain intra-gastric pH above 6.0 
(6). Our patients were not examined for 
Helicobacter pylori presence. The prev-
alence of H. Pylori in Albanian popula-
tion is very high (26, 27) and therefore 
Variables
Omeprazole 
Group (N=54)
Ranitidine Group
(N=54)
Relative Risk 
(95% CI)
P value
Recurrent bleeding (%) 6 (11.1) 14 (25.9) 3.4 (1.1-7.2) <0.05
Volume of blood transfusion 
(units)
1.1 ± 1.8* 2.3 ± 2.9 ___ <0.05
Hospital stay (days) 5.4 ± 2.6* 6.8 ± 3.3 ___ <0.05
Surgery (%) 2 5 0.5 (0.09-2.8) NS†
Death (%) 1 2 1.9 (1.5-2.3) NS
Table 2. Clinical outcomes after endoscopic therapy and medical treatment * Means ± standard 
deviations.† Not statistically significant (P>0.05).
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we did not examine for this bacteria in 
this group of peptic ulcer patients.
6. CONCLUSION
We found that intravenous omepra-
zole reduce the risk of recurrent bleed-
ing, decreased the need for blood trans-
fusion and shortened the hospital stay 
in patients with non-variceal UGI 
bleeding after endoscopic epinephrine 
injection. It should be used in these pa-
tients after effective endoscopic treat-
ment.
REFERENCES
1. Gilbert DA. Epidemiology of upper gas-
trointestinal bleeding. Gastrointest En-
dosc, 1990;36:S813.
2. Laine L, Peterson WL. Bleeding peptic ul-
cer. N Eng J Med, 1994;331:717-27.
3. Cook DJ, Gujatt GH, Salena BJ, laine 
LA. Endoscopic therapy for acute non-
variceal upper gastrointestinal hemor-
rhage: a meta-analysis. Gastroenterol-
ogy, 1992;102:139-42.
4. Van Leerdam ME, Vreeburg EM, Rauws 
EA, Geraedts AA, Tijssen JG, Reitsma JB, 
Tytgat GN. Acute upper GI bleeding: did 
anything change? Time trend analysis of 
incidence and outcome of acute upper GI 
bleeding between, 1993/1994 and 2000. 
Am J Gastroenterol, 2003;98:1.494-9.
5. Higham J, Kang JY, Majeed A. Recent 
trends in admissions and mortality due 
to peptic ulcer in England: increasing 
frequency of haemorrhage among older 
subject. Gut, 2002;50:460-4.
6. Netzer P, Gaia C, Sandoz M, et al. Effect 
of repeated injection and continuous in-
fusion of omeprazole and ranitidine on 
intragastric pH over 72 hours. Am J Gas-
troenterol, 1999;94:351-7.
7. British Society of Gastroenterology En-
doscopy Committee. Non-variceal upper 
gastrointestinal hemorrhage: guidelines. 
Gut, 2001; 51(Suppl. 4): IV1-IV6.
8. Barkun A, Bardou M, Marshall JK. Con-
sensus recommendation for managing 
patients with non-variceal upper gas-
trointestianl bleeding. Ann Intern Med, 
2003;1399(10): 843-57.
9. Martin JE, Macaulay SS, Zarnke KB, et 
al. Proton Pump Inhibitors versus H2 an-
tagonists or placebo for upper gastroin-
testinal bleeding with or without endo-
scopic hemostasis: a meta-analysis. Gas-
troenterology, 2003; 124 (Suppl.1):A625.
10. Khuroo MS, Farahat KL, Kagevi IE. 
Treatment with proton pump inhibitors 
in acute non-variceal upper gastrointes-
tinal bleeding: a meta-analysis. J Gas-
troentrol Hepatol, 2005;20(1):11-25.
11. Gisbert JP, Gonzalez L, Calvet X, Roque 
M, Gabriel R, Pajares JM. Proton pump 
inhibitors versus H2-antagonists: a 
meta analysis of their efficacy in treating 
bleeding peptic ulcer. Aliment Pharma-
col Ther, 2001;15(7):917-26.
12. Daneshmend TK, Hawkey CJ, Langman 
MJS, Logan RFA, Long RG, Walt RP. 
Omeprazole versus placebo for acute 
upper gastrointestinal bleeding: ran-
domised double blind controlled trial. 
BMJ, 1992;304:143-7.
13. Khuroo MS, Yattoo GN, Javid G, et al. A 
comparison of omeprazole and placebo 
for bleeding peptic ulcer. N Engl J Med, 
1997;336:1054-8.
14. Rockall TA, Logan RFA, Devlin HB, 
Northfield TC and the steering commit-
tee and members of Natl Audit of acute 
upper gastrointestinal haemorrhage. 
Risk assessment following acute up-
per gastrointestinal haemorrhage. Gut, 
1996; 38:316-21.
15. Bardou M, Toubouti YM, Benhaberou-
Brun D et al. High dose intravenous pro-
ton pump inhibitors decrease both re-
bleeding and mortality in high-risk pa-
tients with acute peptic ulcer bleeding: 
a series of meta-analyses. Gastroenter-
ology, 2003;124(Suppl 1):A625.
16. Andriulli A, Annese V, Caruso N et al. 
Proton-pump inhibitors and outcome of 
endoscopic hemostasis in bleeding pep-
tic ulcers: a series of metaanalyses. Am J 
Gastroentrol, 2005;100:207-19.
17. Leontiadis GI, Sharma VK, Howden CW. 
Systematic review and meta-analysis: 
proton-pump inhibitor treatment for ul-
cer bleeding reduces transfusion require-
ments and hospital stay-results from the 
Cochrane Collaboration. Aliment Phar-
macol Ther, 2005;22:169-74.
18. Villanueva C, Balanzo´ J, Torras X, et 
al. Omeprazole versus ranitidine as ad-
junct therapy to endoscopic injection 
in actively bleeding ulcers: a prospec-
tive and randomized study. Endoscopy, 
1995; 27:308-12.
19. Schaffalitzky de Muckadell OB, Havelund 
T, Harling H, et al. Effect of omeprazole 
on the outcome of endoscopically treated 
bleeding peptic ulcers: randomized dou-
ble-blind placebo-controlled multicen-
tre study. Scand J Gastroenterol, 1997; 
32:320-7.
20. Hasselgren G, Lind T, Lundell L, et al. 
Continuous intravenous infusion of 
omeprazole in elderly patients with pep-
tic ulcer bleeding: results of a placebo- 
controlled multicenter study. Scand J 
Gastroenterol, 1997;32:328-33.
21. Calvet X, Vergara M, Brullet E, Gisbert 
JP, Campo R. Addition of a second endo-
scopic treatment following epinephrine 
injection improves outcome in high-risk 
bleeding ulcers. Gastroenterology, 2004; 
126:441-50.
22. Lin HJ, Hsieh YH, Tseng GY, Perng CL, 
Chang FY, Lee SD. A prospective, ran-
domized trial of large–versus small–vol-
ume endoscopic injection of epinephrine 
for peptic ulcer bleeding. Gastrointest 
Endosc, 2002;55:615-9.
23. Brunner G, Luna P, Thiesemann C. Drugs 
for pH control in upper gastrointestinal 
bleeding. Aliment Pharmacol Ther, 1995; 
9(Suppl 1):47-50.
24. McCabe RD, Young DB. Evidence of a K+-
H+-ATPases in vascular smooth muscle 
cells. Am J Physiol, 1992;262:H19558.
25. Christensen PB, Albertsen KEP, Jensen 
P. Renal failure after omeprazole. Lan-
cet, 1993;341:55.
26. Megroud F, Bouchard S, Brugmann D, et 
al. Seroprevalence of Helicobacter pylori 
infection in six countries of Eastern Eu-
rope using a common methodology. Gut, 
1995;1(39):A283.
27. Resuli B, Agimi F, Hoxha L, Bega B, Kraja 
B. The prevalence of Helicobacter pylori 
infection in Albanian children. Helico-
bacter, 2004;9:515.
329MED ARH 2010; 64(6) • ORIGINAL PAPER
Evaluation of Medical and Surgical Management of Critical Extremity Ischemia Caused by Atherothrombosis
ORIGINAL PAPER
Evaluation of Medical and Surgical Management of Critical 
Extremity Ischemia Caused by Atherothrombosis
Nedzad Rustempasic1, Emir Solakovic1, Medzida Rustempasic2, Izet Masic3
Clinic for Vascular Surgery, Clinical Center of University of Sarajevo, Bosnia and Herzegovina1
Clinic for Pulmonary Diseases and Tuberculosis, Clinical center of University of Sarajevo, Bosnia and Herzegovina2
Academy of Medicial Sciences, Sarajevo, Bosnia and Herzegovina3
Aim: To assess efficacy of surgical and medical (conservative) treatment of acute exacerbation of chronic extremity ischemia by evaluating their early therapeutic outcomes in terms of mortality, extremity 
amputation and reamputation rate, limb salvage rate and length of hospi-
talization period. Patients and methods: Patients were divided into two 
groups based on method used for the treatment of critical ischemia. Group 
A consisted of 40 patients that were subjected to surgical treatment of critical 
extremity ischemia during period 2004-2009. All patients were subjected to 
thrombectomy in local anesthesia ( 2% lidocaine ) as initial step of treatment 
protocol. Urgent Seldinger angiography was performed for all patients that 
have undergone thrombectomy regardless of successfulness of thrombec-
tomy. Based on angiography findings decision was made about further de-
finitive treatment. It consisted of either using antiaggregating drugs (acetyl 
salicylic acid; 150 mg/day ) if no significant postthrombectomy stenotic 
lesion was found or subjecting patients to further surgical revascularization 
in the form of bypass were significant stenosis or occlusion was identified. 
Group B consisted of 40 patients; all of them received conventional heparin 
anticoagulation therapy supplemented with vasoactive infusion treatment 
(Pentoxyohylline 300 mg/day) during period 1998-2004. On the third 
day of hospitalization oral anticoagulation (Sintrom) was included in the 
therapy protocol using dosage 2-8mg/day in order to achieve INR 2-4, once 
therapeutic INR was obtained heparin was withdrawn. Study was clinical, 
designed as retrospective prospective and was conducted at the Clinic for 
vascular surgery in Sarajevo. Results: Mean age in group A was 66,5 years 
and in group B it was 65,78 years. Lenght of hospital stay in group A was 
13,78 days while in group B it was 34,25 days ( P value <0,001). Limb salvage 
rate was 70% in group A and 17,5% in group B ( P value < 0,001). In group 
A , nine amputations were performed (22,5%) while in group B we had to 
perform 38 amputations ( 95%), P value <0,001. Only one reamputation was 
performed in group A ( 2,5% of patients) while in group B ten reamputations 
were performed (25% of patients ). Mortality rate between groups was not 
statistically significant (P value <0,077). Conclusion: Surgical thrombectomy 
as introduction to definitive treatment of critical limb ischemia caused by 
atherothrombosis gives statistically superior results in comparison to con-
servative treatment. Key words:
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1. INTRODUCTION
Acute exacerbation of chronic ex-
tremity ischemia is caused by thrombus 
formation in the artery on its athero-
sclerotic plaque, the process also known 
as atherothrombosis. In 60% of cases it 
is responsible for acute limb ischemia. 
Clinically this phenomenon is recog-
nizable as preterminal ischemia or crit-
ical limb ischemia which has been de-
fined as degree of ischemia that would 
in the absence of timely provision of 
adequate revascularization lead to am-
putation of limb1.Besides atherothrom-
bosis, thromboembolism may also lead 
to acute limb ischemia and it is consid-
ered to be responsible factor in 30% of 
cases. Other causes of acute ischemia 
are trauma, thrombosis of arterial an-
eurysm, dissection of aorta etc. When 
thrombus occludes artery affected by 
atherosclerosis, vascular segment that 
is located distally from the site of arte-
rial occlusion undergoes spasm, reac-
tion that is deemed to have protective 
role in terms of prevention of throm-
bus propagation into distal arterial 
tree2. There is also retrograde deposi-
tion of thrombus in the artery with re-
sultant complete covering or masking 
of potential culprit stenosis in the ath-
erothrombosed artery. Distal arterial 
spasm persists about 8 hours and then it 
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is followed by relaxation of arterial wall 
with consequent deposition of throm-
bus in arterial segment located distally 
from the site of occlusion that in turn 
leads to occlusion of collateral vessels 
with exacerbation of ischemia2.Skel-
etal muscles and nerves tolerate isch-
emia for about 8 hours without irre-
versible damage. Skin marmorization 
due to appearance of reticular cyano-
sis takes place. Skin can tolerate isch-
emia for about 24 hours. When period 
of ischemia tolerance is used up, irre-
versible phase of ischemia sets in3. Pri-
mary aim of treatment is prevention 
of mortality and limb loss. Five year 
mortality in patients with critical limb 
ischemia reaches up to 70%. Desirable 
outcome is survival without limb loss4. 
Treatment options are aimed at removal 
of thrombus by surgical or pharmaco-
logical means. Then angiographic map-
ping of affected artery and radiological 
insight into position, extent and de-
gree of stenotic atherosclerotic lesion 
is done with subsequent planning of 
reconstructive procedure. The aim of 
this study was to assess efficacy of sur-
gical and medical (conservative) treat-
ment of acute exacerbation of chronic 
extremity ischemia by evaluating their 
early therapeutic outcomes on basis of 
following parameters:
 • Length of hospitalization period
 • Efficacy of limb salvage between 
analyzed groups
 • Number of amputation proce-
dures
 • Number of reamputation proce-
dures
 • Mortality rate.
In addition primary, patency of re-
vascularization procedure will be de-
termined.
Current management of this con-
dition is based on urgent thrombolytic 
treatment followed by additional endo-
vascular or surgical revascularisation of 
arterial stenotic lesion. In our setting, 
instead of active thrombolysis we at-
tempted to remove thrombus with Fog-
arty catheter and then based on angio-
graphic findings we decided about fur-
ther definitive treatment.
2. PATIENTS AND METHODS
Patients were divided into two 
groups based on method used for the 
treatment of critical ischemia. Inclu-
sion criteria were: rest pain, confirmed 
positive history of previous intermit-
tent claudication, positive risk factors 
for atherosclerosis. Exclusion criteria 
were: absolute arrhythmia, extremity 
rest pain after myocardial infarction, 
thromboangitis obliterans and throm-
bosis of arterial aneurysm.
Group A consisted of 40 patients 
that were subjected to surgical treat-
ment of critical extremity ischemia dur-
ing period 2004-2009. After confirm-
ing diagnosis of atherothrombosis, pa-
tients were subjected to urgent throm-
bectomy of affected artery. Thrombec-
tomy was made in local anesthesia (2% 
lidocaine). Approach to occluded arte-
rial segment was made via arteritomy 
on common femoral artery in case of 
lower extremity isch-
emia or through arteri-
otomy made on brachial 
or cubital artery in case 
of ischemia of upper ex-
tremity. Fogarty embo-
lectomy catheters Ch 4 
or 6 (depending on the 
size of artery) were used 
for extraction of throm-
bus from the artery ex-
ploiting technique of an-
terograde or retrograde 
Fogarty thrombectomy. 
Urgent Seldinger angi-
ography was performed 
for all patients that have 
undergone thrombectomy regardless of 
successfulness of thrombectomy. Based 
on angiography findings that might 
have revealed the cause of atherothrom-
bosis decision was made about defini-
tive treatment. It consisted of further 
therapy using antiaggregating drugs 
(acetyl salicylic acid 150 mg/day ) or 
subjecting patients to further surgical 
revascularization in the form of bypass.
Group B consisted of 
40 patients; all of them 
received conventional 
heparin anticoagulation 
therapy supplemented 
with vasoactive infusion 
treatment (Pentoxyohyl-
line 300 mg/day) during 
period 1998-2004. Hep-
arin was used as part of 
a standard protocol for 
treatment of extremity atherothrom-
bosis at our Clinic until year 2004. On 
admission, patient received heparin so-
lution intravenously during 6 hour pe-
riod (20000 IU in 500 ml of Normal 
Saline) and then every 6 hours bolus 
intravenous heparin supplementation 
was administered depending on APTT 
value according to the following scheme 
(see table 1).
On the third day of hospitalization 
oral anticoagulation ( Sintrom ) was in-
cluded in the therapy protocol and once 
value of INR 2-4 was achieved, heparin 
was withdrawn. In case of favorable re-
sponse patients continued to receive 
Sintrom, maintaining INR in therapeu-
tical range (for maximum of 6 months 
when they would replace Sintrom with 
Aspirin-100 mg /day indefinitely). Con-
comitantly with heparin, pentoxyphil-
line infusion was administered to pa-
tients with favorable clinical response 
for 10 days in total. After that period pa-
tients would receive pentoxiphylline per 
os ( 400 mg, tid ). Discrepancies in anti-
coagulation response are based on indi-
vidual differences in heparin clearance 
as well as to the value of APTT on ad-
ministered quantity of heparin.5 Study 
Table 1 Bolus dosage according to APTT
Table 2. Age difference between analyzed groups ( in years ) and 
statistical significance
Table 3. Length of hospital stay between analyzed groups (in days) and 
statistical significance
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was clinical, designed as retrospective 
prospective and was conducted at the 
Clinic for vascular surgery in Sarajevo.
3. RESULTS
Mean age in group A was 66,5 years 
and in group B it was 65,78 years. ( Ta-
ble 2 ). Lenght of hospital stay in group 
A was 13,78 days while in group B it 
was 34,25 days, P value <0,001, ( Ta-
ble 3, Figure 1 ). Limb salvage rate in 
group A was 70% and in group B it was 
17,5%, P value <0,001.( Table 4, Figure 
2). In group A , nine amputations were 
performed (22,5%) while in group B we 
had to perform 38 amputations ( 95% 
), 33 major amputations and 5 minor 
amputations; major amputation stands 
for amputation performed above ankle 
joint and minor for amputations at the 
level of foot-below ankle joint. (Table 
5 and Figure 3). Only one reamputa-
tion was performed in group A ( 2,5% 
of patients). In group B, 10 reamputa-
tions were performed (25% of patients 
), difference in reamputation rate was 
statistically significant (Table 6, Fig-
ure 4). Mortality rate between groups 
was not statistically significant , P value 
<0,077, though in group 
A we had three cases 
with death outcome. In 
group B mortality rate 
was zero. ( Table 7)
4. DISCUSSION
Mean age for group 
A was 66.65 years while 
for the group B it was 
65.78. Difference was not 
statistically significant 
and it was similar to the 
mean age in other rele-
vant studies6. Age is im-
portant determinant of 
peripheral arterial dis-
ease (PAD) and with ad-
vancing age prevalence 
of PAD increases.
Length of hospi-
tal stay is expressed in 
days and it varies signifi-
cantly between analyzed 
groups, (group A= 13,78 
days, group B= 34,25; 
p<0,001). Mean patient 
hospital stay in surgi-
cal group is below mean 
hospital stay mentioned 
in Report of National Survey of Great 
Britain and Ireland6. 679 
patients were included 
in that study and 70% 
of them received revas-
cularization treatment; 
mean hospital stay in 
that study was 25 days. 
Length of hospital stay 
of patients in the group 
B was longer due to ob-
viously ineffective ther-
apeutical response in 
terms of failure to im-
prove oxygen delivery 
to limb periphery and 
consequently it required 
higher rate of extremity 
amputation and ream-
putation treatments.
Limb salvage rate in 
group A was success-
ful in 28 out of 40 pa-
tients. In group B it was 
significantly less, it was 
achieved only in case of 
7 out of 40 patients ( 70 
vs. 17,5 %; p<0,001). Al-
though some studies7,8 report certain 
therapuetical effect of pentoxifylline in 
the treatment of chronic critical isch-
emia in our study its effect was obvi-
ously inferior when compared to the re-
sults obtained by surgical intervention. 
Lapentalo et Matzke also noticed sig-
nificant reduction of limb salvage per-
centage in the absence of reconstruc-
tion for the treatment of chronic criti-
cal limb ischemia9.
In the group that received conser-
vative treatment (group B), 33 amputa-
tions were done above ankle joint (ma-
jor amputations), 5 patients had am-
putations of digits and 2 patients did 
not require amputation treatment at 
all. In summary, conservative therapy 
was effective in the case of 7 patients (2 
patients did not required amputation 
treatment at all, while 5 patients after 
minor amputations of digits had suc-
cessful wound healing and their walk-
ing function of foot was undisturbed)
In surgically treated group (group 
A) thrombectomy was successfully 
achieved in 29 out of 40 patients. In 
remaining 11 patients tip of Fogarty 
catheter came across hard intralumi-
nal resistance that could not be tra-
versed without danger of penetrating 
Table 4. Percentage of limb salvage between analyzed groups and 
statistical significance
Table 5. Number of patients with amputations and statistical 
significance
Table 6. Number of patients with reamputations and statistical 
significance
Table 7. Number of lethal outcomes and statistical significance
Figure 1. Lenght of hopsital stay in days
Figure 2. Percentage of limb salvage in analyzed groups
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arterial wall therefore thrombectomy 
procedure was abandoned. After ur-
gent Seldinger angiography was per-
formed, thrombectomy per se proved 
to be sufficient revascularization pro-
cedure in case of 20 patients since no 
haemodynamically significant stenosis 
was found in affected artery. All these 
cases coincided with intraopeartive 
finding of soft plaque and thrombus ex-
traction from the artery with remain-
ing denuded arterial wall that was de-
void of presence of significant steno-
sis. Lifelong acetyl salicylic acid ther-
apy -150 mg/day was administered to 
all those patients. 3 out of remaining 
9 patients after thrombectomy proce-
dure was performed ended up with am-
putation due to progression of irrevers-
ible leg ischemia while other 6 patients 
were subjected to additional revascu-
larization procedure in the form of by-
pass with resulting successful limb sal-
vage. Eleven patients that that did not 
receive successful thrombectomy due 
to hardness of intra-arterial obstruc-
tive lesion were nevertheless subjected 
to Seldinger angiography and they had 
the following outcome: 4 amputations 
(nonexistence of adequate recipient ves-
sel on angiography), 4 
bypass reconstructions 
(2 successful outcomes 
in 30 days follow up pe-
riod while remaining 2 
patients ended up with 
amputations due to pro-
gression of irreversible 
ischemia-insufficient 
outflow to the periphery 
) and 3 death cases.
Amputation rate in 
group B was 95% while 
a mput at ion rate  i n 
group A was 22,5%. Dif-
ference is statistically 
significant; p<0,001. In-
creased need for ampu-
tation treatment should 
be also viewed in the 
light of possible belated 
referral of patients with 
critical ischemia to vas-
cular surgery center as 
well as inadequate con-
trol of atherosclerotic 
risk factors. This prob-
lem is also noticed and 
reported in developed 
countries e.g. Great Britain10. In other 
words, timely referral of these patients 
to appropriate vascular centers will 
contribute to the decrease of num-
ber of amputation treatments11. In Na-
tional Report of Great Britain and Ire-
land amputation percentage for the 
treatment of critical limb ischemia was 
21,5%1. According to this study ampu-
tation treatment was directly related to 
longer intrahospital stay, higher mor-
tality rate and more complex institu-
tional support.
We report need for one reamputa-
tion (2,5%) in group A. On the other 
hand, in the group B due to wound de-
hiscence of amputation stump and as-
cending infection, 10 reamputations 
(25%) were performed. Difference in 
number of reamputation procedures 
between analyzed groups is signifi-
cant; p<0,003.
There were no statistically signif-
icant difference in mortality rate be-
tween analyzed groups (p<0,077), the 
first patient died due to postproce-
dural myocardial infarction, second pa-
tient succumbed to massive pulmonary 
thromboembolism while third patient 
was lost because of aggravation of gen-
eral status following stroke for which 
he was addmitted to the stroke unit 
prior to occurrence and treatment of 
acute atherothrombotic limb ischemia. 
Aune and Trippestad reported 14% op-
erative mortality after 30 days12. Wolf 
and Wyatt reported 26% high mortal-
ity rate after one year of follow up pe-
riod13. In National Survey of Great Brit-
ain and Ireland total mortality rate for 
the treatment of critical limb ischemia 
was 13,5%. Overall score of surgical 
treatment after 30 days of follow up pe-
riod was: 28 successful limb salvages 
(70%), 3 dead cases (7,5% ) and 9 patients 
with major amputations ( 22,5% ). Re-
sults of limb salvage rate in our study 
did not significantly differ from limb 
salvage rate (75%) reported in National 
survey of Great Britain and Ireland re-
garding treatment of critical limb isch-
emia1. According to Baily and Saha af-
ter analyzing 130 patients in their one 
year prospective study, limb salvage 
rate was 61%14. Primary patency of re-
vascularization treatment in the group 
A, after 30 days, was 70%. 50% (n=20) 
of revascularizations were in the form 
of thrombectomy while 20% (n=8) of 
them were bypass reconstructions. In 
British and Irish National survey for the 
treatment of critical limb ischemia, pri-
mary patency of performed revascular-
ization procedures at the time of patient 
discharge from the hospital was 75%1.
5. CONCLUSION
Surgical thrombectomy as intro-
duction to definitive treatment of crit-
ical limb ischemia caused by athero-
thrombosis gives far superior results in 
comparison to conservative treatment 
in terms of higher limb salvage rate as 
well as lower rate of amputations and 
reamputations. Furthermore, patient 
hospital stay is significantly shorter in 
the group that received surgical treat-
ment. Primary patency rate of revascu-
larization procedures performed in this 
study was 70% and it positively corre-
lates with published results of other Eu-
ropean vascular centers.
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The aim of this study was to evaluate the incidence, clinical data and patterns of mediastinal lymph node metastasis (pN2) in non-small-cell lung cancer patients who underwent systematic mediastinal lymph 
node dissection (SMLND). We retrospectively studied 140 consecutive pa-
tients [125 male and 15 female, mean ages 54.61±9.23 years (range, 21-75)], 
underwent SMLND and major lung resections due to non-small lung cancer 
(NSCLC), from January 2005 till December 2009. Preoperative clinical stag-
ing for mediastinal lymph node metastasis was negative (cN0) in all patients. 
SMLND was defined as a complete removal of mediastinal lymph nodes. 
Clinicalpathological data were compared according to the pN stage. Lymph 
node metastasis to the mediastinum was confirmed in 13(9.28%) patients. In 
squamous cell cancer pN2 were in 8(5.71%) cases out of 82 cases with cN0. On 
the other side in the adenocarcinomas pN2 were in 5(3.57%) cases out of 48 
with cN0. Unvaried analysis revealed central tumor site as predictive factor 
for mediastinal lymph node involvement. The upper mediastinal compartment 
was infiltrated in 12(8.57%) cases, middle in 8(5.71%) and lower in 3(2.14%) 
cases. Pneumonectomy was the most performed surgical procedure in pN2 
patients. We concluded that SMLND improves pTNM staging in lung cancer 
patients who underwent major lung resections with central location of the 
tumour. Key words: Mediastinal lymph node metastasis, clinically N0 non-
small-cell lung cancer, undrewent surgical resection
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1. INTRODUCTION
Lung cancer is common cause of 
cancer mortality in the developed 
world. Despite advances in variety of 
therapies, surgery for NSCLC is still the 
most effective method of controlling 
the primary tumor provided it is resect-
able for cure. The treatment of NSCLC 
depends of the TNM stage and medi-
astinal N2 lymph nodes remain a criti-
cal part of staging lung cancer patients. 
For this reason many authors insist on 
the importance of SMLND for accu-
rate staging (1). In this study we aimed 
to assess overall rate of pN2 for patients 
who underwent SMLNS based on our 
experience. We evaluated all consecu-
tive SMLND and lung cancer resections 
performed on our department during 5 
year period.
2. MATERIAL AND METHODS
We retrospectively studied clini-
cal records of 140 consecutive patients 
with mean ages 54.61 ± 9.23 (range 21-
75)] who underwent complete anatom-
ical resection for histological proven 
NSCLC in five years, from January 
2005 till December 2009. Among this 
group, 125 male patients with mean 
age 54.45±10.91 years and 15 female 
patients with mean age 53.16±11.34 
years were enlisted. All patients had 
stage T1-3N0, assessed by preopera-
tive computer tomography (CT) imag-
ing of the chest, brain, abdomen, bone 
scan and abdominal and supraclavicu-
lar ultrasound scanning. Patients with 
proven N2 or N3 lymph node involve-
ment were excluded from study. None 
of the patients in the study received 
preoperative chemotherapy or radio-
therapy. Patients with previous or co-
existent malignant disease were ex-
cluded from the study. Pulmonary and 
circulatory functions were required to 
be eligible for radical resections. Com-
plete resection was defined as removal 
of primary tumor and all accessible hi-
lar and mediastinal lymph nodes with 
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no residual tumor left behind. SMLND 
is defined as a radical and block me-
diastinal lymph node dissection. The 
major lung resections procedures were 
lobectomy and pneumonectomy with 
standard posterolateral thoracotomy. 
The three compartments included up-
per or superior mediastinal node (sta-
tion 1-4), the middle or subcarinal and 
paraesophageal node (station 7-8) and 
lower compartment or pulmonary lig-
ament node (station 9). Metastasis to 
these compartments including either 
to one or multiple node regarded as 
positive. All tissue samples were sent 
to department of pathology. Three ma-
jor types of carcinoma, squamous cell 
carcinoma, adenocarcinoma and large 
cell carcinoma were diagnosed and se-
lected to analyze lymph node pattern.
2.1. Statistical analysis
Statistical analysis was performed 
using χ2 test (or the Fisher’s exact test 
as required). Values were expressed as 
mean ± S.D. (ranges). Univariate anal-
ysis was performed to identify factors 
linked to the status of nodal involve-
ment. P-value ≤ 0.05 was regarded as 
significant.
3. RESULTS  
All patients were treated by lobec-
tomy or pneumonectomy with standard 
posterolateral thoracotomy. There were 
3 postoperative deaths or 2.1%. Atrial 
fibrillation was observed in 12 (8.5%) 
patients. Wound infections, athelec-
tasis, prolonged air leak and thoracic 
empyema were observed in 10 (7.1%), 
8 (5.7%) 3 (2.1%), and 5 (3.6%) patients. 
The extent of resection was lobectomy 
in 89 (63.6%) patients and pneumonec-
tomy in 51 (36.4%). The pathologist re-
vealed 82 (58.5%) squamous cell carci-
noma, 48 (34.3%) adenocarcinoma and 
10 (7.1%) large cell carcinoma. Postop-
erative TNM and histological status is 
shown in Table 1.
Patient’s clinicopathological char-
acteristics according to the N status 
are listed in Table 2. The pattern of 
lymph node status was N0 55 (39.3%), 
N1 72 (51.4%) and N2 13 (9.3%). Men 
were more likely to have lung cancer 
surgery than women (125/15). Lymph 
node metastasis to the mediastinum was 
confirmed in 13 (9.3%) patients. In squa-
mous cell cancer pN2 were in 8 (5.7%) 
cases out of 82 cases with cN0. On the 
other side in the adenocarcinomas pN2 
were in 5 (3.6%) cases out of 48 with cN0. 
Univariate analysis revealed central tu-
mor site as predictive factors for medi-
astinal lymph node involvement. Pneu-
monectomy was performed in 12 (8.5%) 
pN2 patients and lobectomy in 1(0.7%). 
The feature of lymph node metastasis to 
the mediastinal compartment based on 
individual pattern is shown in Table 3.
Single or multiple compartments 
metastasis pattern of N2 involvement 
based on histology of the tumors are 
shown in Table 3. We had no significant 
statistical differences among all groups.
4. DISCUSSION
This study did not reveal an in-
creased morbidity after SMLND in 
patients with NSCLC compared to the 
findings of other reports in this respect 
(2). Our results in general agree with the 
study reported by Izbicky and associates 
(3), which described 2001 patients and 
demonstrated no increase in the rate 
of broncho-pleural fistula due to inter-
ruption of blood supply to the bronchial 
stump, phrenic and recurrent laryngeal 
nerve injury, chylothorax and hemotho-
rax. We reported only relatively high 
incidence of arterial fibrillation (8.5%) 
and athelectasis (5.7%) probably due to 
excess denervation after hilar dissec-
tion and inadequate controlling post-
operative pain. Operative mortality in 
lung resections reported by Allen et 
al. (2) was 2.0% compared with 2.1% in 
current study. Therefore, the fear of in-
creased complications by performing a 
SMLND is unfounded.
The results of our study confirmed 
lymph node metastasis to the mediasti-
num in 13 (9.3%) patients out of 140 pa-
tients with negative preoperative medi-
astinal lymph node staging (cN0). There 
was strong similarity in the percentage of 
patients (11.5%) reported by Sugi et al. (4). 
Sioris et al. (5) also demonstrated that 
SMLND is necessary for accurate pN2 
staging. They found 17% pN2 patients 
who were preoperatively diagnosed as 
cN0. This highly accurate staging after 
SMLND might allow a more precise 
Stage SCC1 AC2 Others3 Total (%)
I 26 18 2 46 (32.9)
II 41 24 6 71 (50.7)
IIIA 15  6 2 23 (16.4)
Total,% 82 (58.6) 48 (34.3) 10 (7.1) 140 (100)
1.Small-cell carcinoma, 2. Adenocarcinoma, 3. Large-cell carcinoma
Table 1. Postoperative TNM and histological status
 N0  N1  N2* Total (%)
 Patients  55  72  13  140(100)
Male  51  63  11  125(89.3)
 p>0.05
Female  4  9  2  15(10.7) 
Squamous cc  27 47  8  82(58.6) 
 p>0.05
Adeno cc  28  15  5  48(34.3)
Central TS  11 31  10  59(42.1)
 p=0.040
Peripheral TS  44 41  3  81(57.8)
Pneumonectomy  7 32  12  51(36.4)
 p=0.021 
Lobectomy  48 40  1  89(63.6)
*group of patients who underwent univariate analysis
Table 2. Clinicopathological characteristics of patients according to the N status
UC (n, %) UMC*(n, %) MC (n, %) MLC*(n, %) LC (n,%)
Total (n,%) 12(92.3) 6(46.1) 8(61.5) 2(15.4) 3(23.1)
Squamous cc1 6 3 4 1 2
 Adeno cc 4 2 3 1 1
 Large cc 2 1 1 0 0
1Cell-cancer; UC, single upper compartment metastasis; UMC*, Upper-middle multiple 
compartment metastasis; MC, single middle compartment metastasis; MLC* multiple middle-
lower compartment metastasis, LC, single lower compartment metastasis;
Table 3. Compartments pattern of N2 metastasis involvement based on tumor pathology
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selection of the patient chemotherapy 
protocols with possible benefit in over-
all survival (6). It also may allow to erad-
icate otherwise undetected micro me-
tastasis which might result in better lo-
cal control and improved overall out-
come of the patients (7).
This study also analyzed clinico-
pathological factors that might be sig-
nificant predictive for lymph nodal 
involvement in patients who under-
went resections of the NSCLC. Uni-
variate analysis revealed central tumor 
site as predictive factor for mediastinal 
lymph node involvement with p=0.04. 
Ketchedijan et al. also showed that cen-
tral tumors have a higher incidence of 
lymph node metastasis (8). In their series 
the incidence for nodal involvement was 
50% for central tumor of any size. The 
major contributors may be intrapulmo-
nary lymphatic route, interlobar lymph 
node so-called lymph sump and tumor 
infiltration capability (9).
Considering our results, a lobec-
tomy is acceptable for patients for N0-1 
patients with peripheral tumor, and 
pneumonectomy for N1-2 patients with 
central tumors. The similar results are 
revealed by Takizawa et al. (10). In this 
study pneumonectomy is high corre-
lated with pN2 involvement in patients 
underwent NSCLC surgery.
The distribution pattern of differ-
ent N2 compartment metastasis was 
assessed. The most involved region of 
mediastinum was upper compartment. 
We have not recorded different lym-
phatic spreading pattern of N2 metasta-
sis involvement according to the differ-
ent histological type of tumor as Wu et 
al. revealed (11). Our results agree with 
those previously reported by Kotoulas 
et al. (12).
5. CONCLUSION
In conclusion, among our group 
of NSCLC patients who underwent 
SMLND, 9.3% of patients with preoper-
ative negative mediastinal lymph node 
metastasis involvement had pN2 dis-
ease. Factors as central location of tu-
mor and upper mediastinal metastasis 
compartment involvement were highly 
correlated with pN2 disease. SMLND 
is safe procedure, and improves pTNM 
staging in NSCLC patients. Results con-
firmed that SMLND should be per-
formed in all patients who underwent 
pneumonectomy with central site of 
the tumor.
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Meteorological Parameters
Merima Kasumovic
Clinic for Plastic and Maxillofacial Surgery, University Clinical Centre Tuzla
Considering hospitalization as an indicator of the severity of acute subglottic laryngitis (ASL), the aim of this study was to determine the correlation between meteorological parameters and the incidence of 
ASL in children from the Tuzla area. The study included fifty-nine boys and 
girls from the Tuzla area, which were referred and hospitalized due to the 
ASL at the Clinic for diseases of ear, nose, throat, cervical and maxillofacial 
Surgery, University Clinical Center in Tuzla, Bosnia and Herzegovina, dur-
ing the period of March 21st 2006 until March 20th 2007. We formed two 
databases: 1. the database on each hospitalized child included data on Body 
Mass Index (BMI), sex and age. 2. Meteorology database which included 
information on humidity, air temperature, wind direction and atmospheric 
pressure, sorted by day, month and season. The results of this study indicate 
that the number of hospitalized boys due to ASL was significantly higher 
than girls (48 boys and 11 girls). Boys with an average BMI of 34.53 kg/m² 
and 6.77 years of age suffered more frequently from the ASL (81.35%) than 
girls (18.64%) with an average BMI of 21.59 kg/m² and the age of 3.8 years. 
The largest number of children with ASL was admitted during the period 
of lowest temperature (Fall-12.27˚C; Winter-0.50˚C), and the largest value 
of relative humidity (fall 77.33 mmHg–winter 82.50 mmHg). Therefore, this 
study indicates that meteorological factors (temperature, humidity, wind di-
rection, atmospheric pressure) increase the risk of ASL with young children, 
primarily boys. Key words: Children, subglotic laryngitis, meteorological 
parameters.
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University Clinical Center Tuzla, Tuzla, Trnovac 1., Bosnia and Herzegovina. E-mail:pluschel@hotmail.com
1. INTRODUCTION
Laryngismus stridulus–spasm clo-
sure of the glottis, which last for few sec-
onds and is followed by a noisy inspira-
tion, it is known under the name pseudo 
croup. Keyword, croup “comes from 
the Anglo-Saxon word CROUP which 
means, to cry out loud” (Cherry, 2004).
Subglottic laryngitis (pseudo croup, 
croup, laryngotracheobronchitis) is 
a form of viral infection of subglot-
tic part of the upper respiratory tract, 
most often of the vocal cords and the 
structure of the larynx below the vocal 
cords, which causes acute inflamma-
tion and edema. Children are mostly 
affected by subglottic laryngitis, but it 
is not excluded also in adults (Bjornson 
and Johnson, 2004).
As a cause of croup were identified 
following the etiologic agents: parain-
fluenza virus type 1 and type 3, adeno-
virus, influenza A virus, parainfluenza 
virus type 2, respiratory syncytial vi-
rus, mycoplasma pneumoniae, staphy-
lococcus, haemophylus influenzae type 
B, Klebs-Löffler bacillus, allergic reac-
tions or insect bite in the area of phar-
ynx or larynx, environmental pollution 
(cigarette smoke, air pollution in high 
concentrations).
Most common clinical manifesta-
tions are: slight fever, abrupt onset (of-
ten at night), distinctive ringing child 
cough, hoarseness, wheezing, island 
structures lining the larynx, contrac-
tion (spasm), the muscle below the vocal 
cords, narrowing of the airway.
Diagnosis: Radiography of the neck, 
blood tests, pulse oximetry, viral cul-
ture or rapid antigen tests, a clinical 
scoring system (Croup test table).
Westley Croup Score
LEVEL OF CONSCIOUSNESS
Normal (including sleep) 0
Disorientation 5
CYANOSIS
Without 0
Cyanosis with anxiety / agitation 4
Cyanosis at rest 5
STRIDOR
None 0
Irritated / disturbed 1
At rest 2
AIRFLOW
Normal 0
Decreased 1
Significantly reduced 2
RETRACTION
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None 0
Moderate (jugulum, epigastria) 1
Medium (jugulum, epigastria, 
sternal) 
2
Severe (jugulum, sternal, 
intracostal, Epig.) 
3
Westley Croup Score (Westley et 
al., 1978)
2. GOAL
The aim of this study was to deter-
mine the correlation between meteoro-
logical parameters and the incidence of 
ASL in children from the area of Tuzla, 
taking hospitalization as an indicator of 
the severity of clinical manifestations of 
acute subglottic laryngitis (ASL).
3. MATERIAL AND 
METHODOLOGY
The study included seventy-four 
children from the area of Tuzla aged 
0-14 years that were referred and hospi-
talized due to ASL at the Clinic for ear, 
nose, throat disease, cervical and max-
illofacial surgery, University Clinical 
Center in Tuzla, Bosnia and Herzegov-
ina, in a period from March 21st 2006 
until March 20th 2007. We formed two 
databases: 1. The database on each hos-
pitalized child included data on Body 
Mass Index (BMI), sex and age. 2 The 
meteorological database which in-
cluded information on humidity, air 
temperature, wind direction and atmo-
spheric pressure, sorted by day, month 
and season in the area of Tuzla.
4. RESULTS
In the period of investigation at the 
Clinic for ear, nose, throat disease, cer-
vical and maxillofacial surgery, Uni-
versity Clinical Centre Tuzla, due to 
acute subglottic laryngitis (ASL) were 
referred 74 patients, of whom 59 were 
hospitalized (79.2%).
Gender and age distribution of chil-
dren hospitalized at the Clinic due to 
ASL in the examined period is shown 
in Table 1.
This study included 48 boys and 11 
girls with mean age of 2.98 ± 0.376 years 
(aged from 2 months to 13 years). From 
the table we can see that in the period 
of investigation at the Clinic due to ASL 
were hospitalized more boys than girls 
(81.35%: 18.64%). The boys were a little 
older than the girls, the mean rate of 3.2 
± 0.3137 years.
In Table 2 shows the values of height 
and weight, and BMI values of hospital-
ized children.
Distribution of children referred 
and hospitalized for ASL by month dur-
ing the same period is shown in Table 3 
(Names of months in the Table marked 
initial letters, in chronological order 
from beginning to the end of the pe-
riod of investigation).
The largest number of children hos-
pitalized because of the ASL was dur-
ing the fall, winter and early spring and 
lowest in summer. Months in which the 
largest number of hospitalizations of 
children due to ASL was: March, May, 
September, October, November, De-
cember, January, and months with the 
lowest number of hospitalized children 
were: July and August.
Majority of children hospitalized for 
ASL had only one episode of the disease 
(42), two episodes of disease had 12 chil-
dren and more than two episodes of the 
disease is found in 5 children.
Table 4 shows the number of chil-
dren hospitalized for ASL by the num-
ber of episodes of disease.
Seasonal distribution of episodes of 
acute subglottic laryngitis showed that 
the majority of cases occur during the 
colder time of year (from November to 
March) with a frequency that is nearly 
doubled compared to the warmer sea-
son (from May to October). Since the 
month of November the frequency of 
the frequency increases and reaches 
its maximum in March. Since March 
the number of children suffering from 
acute subglottic laryngitis gradually 
declines, reaching its minimum in Au-
gust. From the table we can also see that 
the largest number of children hospital-
ized for ASL (with one or two episodes 
of disease) was in the colder seasons 
(winter-spring) and totaled 39 cases, 
and that children which are hospital-
ized more than two episodes of disease 
had no special seasonal representation 
(5 children).
Average monthly values of temper-
ature and humidity during the same 
Sex
No. Of hospitalized 
children
Average age 
(years)
Minimal age 
(years)
Maximum age 
(years)
Male 48 6.77 0.291 13.25
Female 11 3.8 0.5 7.1
Table 1. Sex and age distribution of patients hospitalized due to ASL
Sex
Average weight
(kg)
Average height
(cm)
Average Body Mass 
Index (kg/m2)
Male 12.85 61.50 34.53
Female 12.74 77.00 21.59
Table 2 Body Mass Index of children hospitalized due to ASL by gender
YEAR 2006 2007
Month Mar. Apr. May Jun. Jul. Aug. Sep. Oct. Nov. Dec. Jan. Feb Mar.
Season Spring Summer Autumn Winter
Referred 
children 
(number)
8 2 10 2 1 1 3 3 13 9 8 2 12
Hospitalized 
children
(number)
4 2 9 2 1 1 3 3 9 5 6 2 12
Table 3 Monthly distribution of children referred and hospitalized for ASL
No. Of 
episodes
Season
Autumn Winter F-W Summer Spring S-S
1 5 17 22 3 17 20
2 4 4 8 3 1 4
3 0 0 0 1 1 2
4 0 1 1 0 2 2
Total 9 22 31 7 21 28
Table 4 Seasonal distribution of children hospitalized for ASL by the number of episodes of disease
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period in the municipality of Tuzla are 
shown in Table 5.
This table shows that the average 
monthly air temperature in the area 
of Tuzla in the period of investigation 
was the largest in months: June, July, 
August, September, October, and low-
est in months: November, December, 
January, February, and March. The av-
erage atmospheric pressure of air dur-
ing the same period in the municipality 
of Tuzla was the highest in the month 
of December (10949 kPa) and lowest in 
March 2007 (9607 kPa).
It is evident that the highest val-
ues of humidity for the period studied 
were in March, late April, in May, June, 
July and August 2006. Humidity has 
increased since the beginning of Sep-
tember 2006, and the highest was in 
December 2006 and January and Feb-
ruary 2007. For the studied period were 
not recorded large fluctuations in the 
values of moisture. Minimum value of 
relative humidity was recorded in July 
2006 and amounted to 43 mmHg, and 
the average humidity was 70 mmHg. 
The maximum value of humidity was in 
December 2007 and was 95 mmHg, and 
the average humidity was 84 mmHg.
Figure 2 shows daily fluctuations in 
air temperature during the same period 
in the municipality of Tuzla.
From Figure 2 it is concluded that 
the largest increase in air temperature 
during the day for the research period 
was the beginning of July 2006. The 
maximum temperature in July of 2006 
was 28.7˚C, and the average value of 
air temperature was 21.4˚C. The largest 
drop in the value of air temperature was 
at the beginning of November (2.2˚C) 
and December (-0.2˚C) 2006. Aver-
age air temperature values were also in 
early November (7.0˚C) and December 
(3.2˚C) 2006. Temperature fluctuations 
during the episodes were 
changing to the amount 
of ± 5˚C.
Results of this study 
indicate that there is 
a significant seasonal 
distribution of disease. 
More cases in the au-
tumn and winter (25 
children). From Novem-
ber 2006 to March 2007, 
almost double the num-
ber of cases (44 chil-
dren), than from May to 
October 2006 (27 chil-
dren). Least number of 
cases was in the sum-
mer during the month 
of July and August 2006 
(2 children).
5. DISCUSSION
Acute subglottic lar-
yngitis is a common re-
spiratory disease of chil-
dren, much more seri-
ous than acute laryngitis 
in adults, which appears in the course of 
generalized viral infections of upper re-
spiratory tract. Symptoms include slight 
fever, a rapid onset (often at night), dys-
phonia, cough like a barking dog, in-
spiratory stridor and dyspnea. Typical 
acute subglottic laryngitis in children 
is almost always viral, caused by influ-
enza viruses, parainfluenza, rhinovirus 
and adenovirus.
In the fifth century BC, Hippocrates 
suggested that weather changes can af-
fect physical health (Shutty et al., 1992).
Meteorological factors such as fluc-
tuations in temperature, humidity and 
wind direction affect the incidence of 
respiratory diseases. Colds, asthma and 
croup are the most studied diseases. 
It is interesting that the temperature 
changes in Earth’s crust affect the oc-
currence of colds. It was noted that the 
drop in temperature of 1˚F directly as-
sociated with increased morbidity from 
colds to 1% (Hope, 1958).
A highly significant correlation was 
found with an increased number of pa-
tients with croup and low daily temper-
atures, low absolute humidity and the 
rapid decline in mean monthly temper-
atures (Fielder et al., 1989).
Most authors agree that acute sub-
glottic laryngitis (ASL) usually affect 
children in the second year of life, and 
then is the highest incidence of this 
disease (Denny et al., 1983; Save and 
Branica, 1993, Schwartz et al., 1991). 
Children with ASL are most often aged 
6 months to 3 years (Ramos et al., 1990), 
and 90% of affected children are under 7 
years of age (Save and Branica, 1993). Of 
course, the disease can affect children 
younger than 3 months, and those older 
than 15 years (Thomas and Friedland, 
1998), although ASL is not recorded 
YEAR 2006 2007
Month Mar. Apr. May Jun. Jul. Aug. Sep. Oct. Nov. Dec. Jan. Feb Mar.
Season Spring Summer Autumn Winter
Average air 
temperature 
(˚C)
5.2 11.7 15 18.2 21.4 18.7 16.9 12.9 7 3 5 6 8
Average 
humidity 
(mmHg)
74 73 72 76 70 78 78 77 77 84 75 76 71
Average 
value of 
atmospheric 
pressure 
(kPa)
9760 9796 9816 9843 9838 9772 9830 9833 9847 10949 9848 9788 9697
Table 5 The basic meteorological parameters in the region of Tuzla in the period of investigation
-15.0
-10.0
-5.0
0.0
5.0
10.0
1 31 61 91 121 151 181 211 241 271 301 331 361
Figure 2. The greatest increase and greatest decrease in air 
temperature during the tested period
Figure 1. The greatest increase and greatest decrease in the value of 
moisture throughout the day during the same period
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in the first month of life (Denny et al., 
1983). Analyzing acute respiratory ill-
nesses in children, it can be argued that 
ASL usually affect children in the sec-
ond year of life, while obstructive bron-
chitis usually affect children in the first 
year of life (Schwartz et al., 1991). Our 
findings were correspondent with the 
results of these authors.
The boys are gender group which is 
more often affected by ASL, more than 
girls (Ramos Lizana J et al., 1990), and 
some authors the ratio of male to fe-
male ratio expressing in ratio of 1.43:1 
(Denny et al., 1983) to 2.1:1 (Segal et 
al., 2005). The male to female ratio was 
70:30% in a study conducted in Croatia 
during nineties of the twentieth century 
(Save and Branica, 1993). Our findings 
were correspondent with the results of 
previous researchers.
Most authors who dealt with the 
ASL testing in children came to the 
conclusion that the highest incidence of 
this disease is in the autumn and win-
ter (Cohen and Dunt, 1988, Mars et al., 
1997). If we are talking about months 
in which the highest incidence, it is Oc-
tober, a month with a minimum of ad-
missions is February (Mars et al., 1997) 
and July (Save and Branica, 1993). Our 
findings regarding the seasonal occur-
rence of the ASL show that it occurs 
more often in late autumn and early 
winter. Months with the lowest number 
of hospitalizations were July and August 
2006, while the highest incidence was in 
November 2006 and March 2007. Based 
on these facts, we conclude that our re-
sults are correspondent with the results 
of previous researchers.
Statistical analysis demonstrated 
that there was no significant differ-
ence in BMI and occurrence of ASL 
(Chmielk et al., 1984; Hide and Guyer, 
1985). Our research has shown that 
children with higher BMI are more fre-
quent occurrence of ASL (p &lt; 0.05). 
Thus, our results are correspondent 
with the results of these authors.
6. CONCLUSION
Research conducted during the pe-
riod from March 21st 2006 until March 
20th 2007 at the Clinic for ear, nose, 
throat diseases, cervical and maxillo-
facial surgery, Clinical Center in Tuzla 
has shown that meteorological param-
eters affect the incidence of diseases 
such as acute subglottic laryngitis. The 
results of this research do not always 
prove a statistically significant effect 
of changing weather conditions and 
the incidence of diseases such as acute 
subglottic laryngitis. Therefore, we can 
confirm the assumption that the me-
teorological parameters are one of the 
major causes of morbidity in the patho-
genesis of acute subglottic laryngitis.
Children’s respiratory tract is 
smaller than in adults, so any inflam-
mation leads to a reduction in the diam-
eter of the respiratory tract. The high-
est incidence is between 6 months and 
three years, and the highest frequency 
in the second year of life. Croup was not 
recorded in the first month of life, but 
it is in children above fourteen years of 
age. Boys are more often affected than 
girls, at the percentage ratio of 70%:30%. 
In terms of season, more cases is re-
corded in late autumn and early win-
ter, from November to March, twice 
as many cases than from May to Oc-
tober. The lowest incidence was in the 
summer, in July and August. Minimal 
changes in temperature or humidity 
changes have no impact on the occur-
rence of subglottic laryngitis. However, 
large and sudden changes in tempera-
ture and humidity results in a larger 
number of episodes, which have been 
proven by other researchers (Danielides 
et al., 2002).
Based on the foregoing, we consider 
useful for future researchers to suggest 
that besides the monitoring of meteoro-
logical parameters for the occurrence of 
subglottic laryngitis, research should be 
focused also on a concentration of air 
pollutants monitoring and air quality, 
in order to try correlated them with the 
appearance of subglottic laryngitis in 
children in municipality Tuzla.
REFERENCES
1. Ausejo M, Saenz A, Pham Ba’, Kellner JD, 
Johnson DW, Moher D, Klassen TP. The 
effectivness of glucocorticoids in treat-
ing croup: meta-analysis. BMJ, 1999; 319: 
595-600.
2. Bhende MS. End tidal carbon dioxide mon-
itoring in pediatrics-clinical applications. J 
Postgrad Med; 2001;47:215.
3. Bjornson CL, Johnson DW. Pediatric Prac-
tice: That characteristic cough: When to 
treat croup and what to use. Patient Care, 
2004; NP 27: 64-78.
4. Botelho C, Correia AL, da Silva AM, Macedo 
AG, Silva CO. Environmental factors and 
hospitalization of under five children with 
acute respiratory infection, Int J Pediatr Oto-
rhinolaryngol, Jan 2001; 57 (1):41-3.
5. Cherry JD. The treatment of croup: contin-
ued due to failure of recognition of historic, 
ecologic, etiologic and clinical perspectives. 
J Pediatr, 1979; 94: 352.
6. Cherry JD. Croup (laryngitis, laryngotrache-
itis, spasmodic croup, laryngotracheobron-
chitis, bacterial tracheitis and laryngotra-
cheobronchopneumonitis). Textbook of pe-
diatric infectious diseases, (eds) Feigin RD, 
Cherry JD, Demmler GJ, Kaplan SL. Philla-
delphia: Saunders; 2004;252-65.
7. Chin R., et al. Effectivness of a croup clini-
cal pathway in the managment of children 
with croup presenting to an emergancy de-
partment. J Paediatr Child Health, 2002; 
38: 382-7.
8. Chmielik M, Debska M, Patryka M, Arci-
mowitz m, Chmielik LP, Jakubczyk I, Wa-
chulski B. Body build-Is it factor in acute 
subglottic laryngitis? Int J Pediatr Otorhi-
nolaryngol, 1997; Jun 20; 40(2-3): 147-53.
9. Danielides V, Nousia CS, Patrikakos G, 
Bartzokas A, Lolis CJ, Milionis HJ, Skevas. 
A. Effect of meteorological parameters on 
acute laryngitis in adults. Acta Otolaryn-
gol, 2002; 122: 655-60.
10. Denny FW, Murphy TF, Clyde WA Jr, Col-
lier AM, Handerson FW. Croup: an 11-year 
study in a pediatric practice. Pediatrics, 1983 
Jun; 71(6): 871-6.
11. Fielder CP. Effect of weather conditions on 
acute laryngotracheitis. J Laryngol Otol, 
1989; 103: 187-90.
12. Fielder CP. Effect of weather conditions on 
acute laryngotracheitis. Ann Emerg Med, 
1993; 22(3): 523-9.
13. Hope, Simpson RE. Discussion of the com-
mon cold. Proc R Soc Med, 1958; 51: 267-71.
14. Jaklin RH, Bender SW, Becker F. Environ-
mental factors in croup syndrome. Z Kin-
derheilkunde, 1971; 111: 85-94.
15. Peltola V, Heikkinen T, Ruskanen O. Clini-
cal courses of croup caused by influenza and 
parainfluenza virus. The Pediatric Infectious 
Disease Journal, 2002; 21: 76-8.
16. Ramos Lizana J, Gonzales de Dios J, Lo-
pez Lopez C. Epidemics of laryngitis (8983 
cases of laryngotracheitis and croup). I. Ep-
idemiologic Aspects. An Esp Pediatr, 1990; 
32(3): 193-6.
17. Schweizer E, Weber G, Severien C, Mietents 
C. Effect of various weather parametars on 
the incidence of inpatient treated children 
with stenosis laryngotracheobronchitis 
(psudocroup) Clin Exp Allergy, Nov 2003; 
33(11): 1526-30.
18. Shutty MS, Cundiff J, DeGood DE. Pain com-
plaint and weather: weather sensitivity and 
simptom complaints in chronic pain pa-
tients. Pain, 1992; 49: 199-204.
19. Sprem N, Branica S. Effects of sulfur dioxide 
and smoke on the incidence of laryngotra-
cheitis (croup). Int J Pediatr Otorhinologol, 
1993 Apr;26(3): 245-50.
20. Thomas LP, Friedland LR. The cost-effec-
tivive use of nabulizes recemic epinephrine 
in the treatment of croup. American Jour-
nal of Emergency Medicine, 1998; 16: 87-9.
21. Tibballs J, Shann FA, Landau LI. Placebo 
controlled trial of prednisole in children in-
tubated for croup. Lancet, 1992;340:740-8. 
341MED ARH 2010; 64(6) • ORIGINAL PAPER
Risk Factors for Development of Hip Disorder Among Newborn Babies in Tesanj Region
ORIGINAL PAPER
Risk Factors for Development of Hip Disorder Among 
Newborn Babies in Tesanj Region
Seid Fazlagic 1 Predrag Grubor 2 Suad Fazlagic 3
Department of surgery, General hospital Tesanj, Bosnia and Herzegovina1
Clinic for Traumatology, Clinical center of University of Banja Luka, Bosnia and Herzegovina2
Policlinic “Medicus”, Tesanj, Bosnia and Herzegovina3
INTRODUCTION Development disorder of the hip is a congenital, dy-namic and progressive disease where there is disorder in the development of all elements of hip that is clinically shows as functional disorders. AIM 
To determine clinical and statistical arthrosonographic representation of 
developmental disorders of the hip at newborn babies in Tesanj region, with 
or without risk factors. MATERIAL AND METHODS The subjects are 300 
newborns born in Tesanj region, which are examined in the orthopedic clinics 
in the period from October 1st 2008 to May 1st 2009. RESULTS youngest 
child in the studied sample had an examination in the first nine and the old-
est 42 days, an average of 33 days. In the studied sample representation of 
the firstborn children was 179, and second born children 97, third born 23. 
Only one child was born from the fourth pregnancy. Positive family history 
had 26 children and negative 274. Natural way was born four children, by 
Caesarean section 51 children. One child was born early but naturally. On 
time 244 children were born by normal natural way. Of firstborn children, 
the representation of female children was 80, and the male 99. 6 children 
were born as twins. Associated anomalies were found in two of the exam-
ined children; agenesis of fibula and pes equinovarus. One risk factor had 
113 children, two 27 and three risk factors at one child. The remaining 159 
children had no risk factor or a developmental disorder of the hip. DISCUS-
SION Developmental disorder of the hip is the most common developmental 
anomaly, which occurs in all races and ethnic groups, ranging from 0.4% to 
6%. It is more common in female than male children in the ratio of 1:4 to 
1:10. Mutual disorder appears more than one-sided reports. Sided phenom-
enon affecting more left than right hip. Developmental disorder of the hip is 
often associated with other developmental abnormalities. Early detection of 
initial disturbances in newborn is crucial, because of using of early traumatic 
therapy, which reduces the incidence of operative treatment and secondary 
complications. CONCLUSION Developmental hip disorders in children in 
Tesanj region, defined by hip sonography Graf, were found in 4.33% cases. If 
the borderline cases of type I by Graf included in the category of children with 
possible spontaneous evolution from type I to type II (no prevention mea-
sures), the incidence of RCC would be 10.66%. Almost half of children (139) 
of the investigated sample have a risk factor in the anamnesis. Remarkably 
high percentage of children born caesarean. The greatest correlation of risk 
factors, was determined in children 
with a positive family history, were 
born with abnormalities of the loco 
motor apparatus and natural way of 
born. KEY WORDS Developmental 
disorders of the hip, sonography
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1. INTRODUCTION
Developmental hip dysplasia is a 
congenital, dynamic and progressive 
disease in which there is disorder in the 
development of all elements of the hip 
joint, resulting in complete dislocation 
of the joint parts with all the functional 
disorders. (1) The term “developmental 
disorder of the hip (DDH) encompasses 
all levels in the development of these 
anomalies: dysplastic, subluxated, and 
luxated hip (2).
The first descriptions of RPK gave 
Hippocrates. A significant contribu-
tion to the knowledge of the diagnosis 
is given by Ortolan and Palmen, Lo-
renz, in the treatment of with plaster, 
Hilgenreiner and Pavlik with their ap-
paratus, and in prevention Roser (3). 
The significance of surgical treatment 
of DDH has given in his works Chiari 
1955 introducing a pelvic osteotomy, 
Pemberton in 1959 by etabulum cov-
ering and Salter in 1961with innom-
inate bone osteotomy and later with 
triradiat osteotomy (4). It is known for 
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certain that the DDH occurs in utero, 
and happens more frequent in children 
with positive family history, among the 
firstborn female children, twins, breech 
birth or Caesarean section, children 
who have other congenital anomalies, 
particularly of the locomotor appara-
tus (5,6). Identified are also other risk 
factors such as pelvic disproportion of 
mother and fetus, the lack of amniotic 
fluid (oligohydramnios), heavy and ex-
tended labor ... (5).
Radiographic hip examination is 
valid when the child reaches 3 months 
of life. This is because part of hip car-
tilage is replaced by bone mass and 
ossification core of the femoral head 
forms (7).
Sonography provides an absolutely 
safe intrauterine visualization of the 
hip or in the first days of life of a child. 
In this age most of the hip joints are 
made of cartilage, which provides a 
broad “ultrasonic window and display 
a large portion of the hip joint. In Eu-
rope, hip ultrasonography is used ac-
cording to Graf (3).
For completely correct interpreta-
tion of the sonogram has to be shown 
seven anatomical structures: carti-
lage-bone border, head of the femur, 
the transitional groove, joint capsule, 
labrum acetabula, cartilage acetabula 
roof, bone acetabulum.
Drawing the base line which is tan-
gential to the iliac bone wing and pass-
ing through the intersection and peri-
chondria periosteal or through a place 
where the periosteal becomes perichon-
dria (11). The second line is a line of 
the bony roof. It starts from the lower 
edge of the os ilium, the bottom of the 
acetabulum and passes tangentially 
through the bony acetabula roof angle 
creating alpha. The other line is drawn 
from the cartilage roof starts with bony 
bay windows and passes through the 
center of labrum acetabula making the 
angle beta. The angle beta indicates the 
state of the cartilage roof of the hip joint 
(11,12). According to the values of an-
gles alpha and beta, there are four basic 
types of hips according to Graf (3,12).
2. GOAL
The goals of research are: to de-
termine the clinical and arthrosono-
graphic finding the hip in newborns 
in the hospital Tesanj, 
determine the preva-
lence and clinical and 
statistical significance 
of sonography findings 
in infants with risk fac-
tors and no risk factors, 
to propose recommen-
dations for early detec-
tion of persons with in-
creased risk for DDH.
3. MATERIAL AND METHODS
Subjects are 300 newborn infants in 
Tesanj region, which were examined in 
an orthopedic clinic in the period from 
October 1st 2008 to May 1st 2009. The 
first ultrasound examination was per-
formed in infants who were not older 
than 45 days.
After taking the anamnesis data 
from the parent started clinical ex-
amination of the newborn. Formed is 
a questionnaire in which they entered 
the data used for statistical analysis. In 
addition to basic data such as general 
data, sex and age entered the data on 
the order of pregnancy, type of preg-
nancy (normal, twins). In the section 
on birth, entered the data on the type 
of delivery (normal, premature, by Cae-
sarean section), followed by details on 
the fetus (head first, breech birth) and 
birth weight.
Entered are the data on the asso-
ciated anomalies such as congenital 
pes equinovarus, pes. valgus and other 
anomalies and the occurrence of de-
velopmental anomalies of the hip in 
first degree relatives, and information 
on family history. In a special section 
were possible remarks.
Separate questionnaire was used for 
statistical analysis of the data about the 
DDH risk factors: positive family his-
tory, the firstborn female child, breech 
birth, birth by Caesarean section, twin 
pregnancy, premature birth, congenital 
anomalies of the musculoskeletal sys-
tem, pes equinovarus, pes equinovalgus 
, various forms of dysplasia, and agen-
esis. The part of the questionnaire was 
designed for clinical examination of the 
hips collected are the data on asym-
metry of gluteal, inguinal and femoral 
groove (Bade sign), the result of abduc-
tion test separately for each hip: Orto-
lani luxation and Palmen reposition 
sign. Clinical examination was per-
formed by hip sonography. Used is ul-
trasound machine “Toshiba” with lin-
ear probe of 7.5 MHz. Method used is 
by Reinhardt Graf.
With tests of statistical signifi-
cance determined is inferential statis-
tics–tests of implicit (additional) and 
explicit (main) research hypotheses by 
nonparametric method,–c2 test (Chi-
square test).
4. RESULTS
The youngest child in the sample 
had 9 and the oldest 42 days, an average 
of 33 days. In the baseline there was 179 
(59.67%) first born, and the second born 
in 97 (32.33%), third-born 23 (7.66%) 
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cases. Only one child (0.33%) was born 
from the fourth pregnancy. Positive 
family history in the sample had 26 
(8.67%) children, while with negative 
family history was 274 (91.33%). Breech 
birth was in case of 4 children (1.33%), 
born by Caesarean section were 51 
(17%). (Figure 1) Premature, but natu-
rally born is 1 (0.33%) child. Normal and 
natural way in the term was born 244 
(81.33%) children. From the first-born 
children, in the sample were 80 (26.67%) 
female children and 99 (33.00%) male.
As the twins were born 6 (2%) chil-
dren. Associated anomalies as a risk 
factor for DDH were found in two chil-
dren. In one it was an agenesis of the 
fibula and lateral side of the foot, while 
in the second the congenital pes equin-
ovarus. With only one risk factor for 
DDH was 113 (37.67%) children, with 
two risk factors for DDH 27 (9%) and 
three risk factors for DDH is born only 1 
(0.33%) child. The remaining 159 (53%) 
children had no risk factor.
Testing of hypotheses about the sig-
nificance of differences of research pa-
rameters (characteristics) in relation to 
individual risk factors in the sample is 
presented in Table 1
In the Table (1) NCFT is short: there 
are no conditions for the testing of hy-
potheses. NCFT label indicate the fact 
that at least one cell in the correspond-
ing contingency table have frequencies 
of 5 or lower.
Based on the tables and rules of rea-
soning we conclude that for the stud-
ied sample:
 • There is no correlation between 
individual risk factor and gender 
(p = 0.4675);
 • There is no correlation between 
individual risk factors and the or-
der of birth (p = 0.1599);
 • There are no conditions for test-
ing hypotheses about the relation-
ship of individual risk factors and 
pregnancy;
 • There are no conditions for test-
ing hypotheses about the relation-
ship of individual risk factors and 
types of birth;
 • There are no conditions for test-
ing hypotheses about the relation-
ship of individual risk factors and 
family history;
 • There is no correlation between 
individual risk factors and posi-
tive Bade sign (p = 0.2228);
 • There is no correlation between 
individual risk factors and posi-
tive Abduction test (p = 0.7939);
 • There are no conditions for test-
ing hypotheses about the relation-
ship of individual risk factors and 
positive Ortolani sign;
 • There are no conditions for test-
ing hypotheses about the relation-
ship of individual risk factors and 
positive Palmen sign;
 • There are no conditions for test-
ing hypotheses about the relation-
ship of individual risk factors and 
the angle alpha (right);
 • There are no conditions for test-
ing hypotheses about the relation-
ship of individual risk factors and 
types of hip according to angle al-
pha (right);
 • There are no conditions for test-
ing hypotheses about the relation-
ship of individual risk factors and 
the angle alpha (left);
 • There are no conditions for test-
ing hypotheses about the relation-
ship of individual risk factors and 
types of hip according to angle al-
pha (left);
 • There is no correlation between 
individual risk factors and types of 
hip according to angle beta (right) 
(p = 0.4897);
 • There is no correlation between 
individual risk factors and types of 
hip according to angle beta (left) 
(p = 0.1888);
 • There are no conditions for testing 
hypotheses about the relationship 
of individual risk factors and types 
of hip according to Graf (right);
 • There are no conditions for testing 
hypotheses about the relationship 
of individual risk 
factors and types 
of hip according to 
Graf (left);
 • There are no con-
ditions for testing 
hypotheses about 
the relationship of 
individual risk fac-
tors and medical 
treatment.
Of 113 children with 
one risk factor in the 
sample was mostly female first-born 
children (19.67%), followed by those 
born by caesarean section (10.67%), 
with positive family history (5.33%) 
(Figure 2). The first clinical examina-
tion revealed some of the clinical signs 
of DDH in 59 (19.67%) children in the 
sample and without any clinical signs 
of DDH in 241 (80.33%) child. Asym-
metry of skin furrows (Bade sign), was 
found in 49 (16.33%), abduction test 
positive in 17 (5.67%), and Ortolani Pal-
men sign was not verified. Positive two 
clinical signs (Bade sign and abduction 
test) were in case of 8 (2.67%) children. 
There were three children with positive 
clinical signs of DDH
Sonographic examination revealed 
DDH in 13 (4.33%) children from which 
9 female and 4 male children. In case of 
3 children it was a bilateral, and in 10 
the unilateral DDH, which makes a to-
tal of 16 from which was 8 right and 8 
left DDH. In our sample, 287 children 
had type I by Graf, 12 type II according 
to Graf, one child type III according to 
Graf. From a total of 16 altered hips 15 
were type II and only one type III ac-
cording to Graf. We did not found any 
hip of type IV according to Graf.
Clinical examination of 141 chil-
dren in whom is determined the pres-
ence of risk factors, medical history, 
clinical signs were found DDH in 33 
(23.40%), and of 159 children who have 
not any anamnestic risk factor was 26 
(16.34%) children with clinical signs 
of DDH.
In 26 children who had a positive 
family history 21 had no other risk 
factors for DDH. In the remaining 5 
(31.25%) children were found clinical 
signs of DDH and it was found in 4 cases 
Bade positive sign, and one child with a 
positive Ortolani Palmen sign.
Figure 2. 
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Out of 80 first-born female children 
59 had no other risk factors for DDH. 
From which 21 (30.50%) had clinical 
signs of DDH: 15 positive Bade sign, 5 
abduction positive test and 1 positive 
for both these characters.
From 4 children who were breech 
born none had clinical signs of DDH.
From 51 children that were born 
by caesarean section 32 had no other 
risk factors for DDH. Clinical signs of 
DDH at birth by caesarean section had 
2 (6.25%) children. In one was found 
positive Bade sign, and the abduction 
positive test in other.
For children from twin pregnancies, 
there were no clinical signs of DDH and 
with one child who is born prematurely. 
With congenital anomalies of the loco-
motor apparatus, there were two chil-
dren. Neither of them have clinical 
signs of DDH.
Two risk factors for DDH had 27 
children. In 19 there were no clini-
cal signs of DDH and were found in 8. 
Clinical signs of DDH in 8 children are 
manifested: a positive Bade sign had a 
4, a positive abduction test 2 and a pos-
itive sign for both of these 2 children.
Three risk factors had only 1 child in 
without clinical signs of DDH.
Without risk factors were 159 chil-
dren. Clinical signs of DDH were found 
in 26 (16.35%) and a positive Bade sign 
in 19, abduction positive test in 2 and a 
positive sign of both in 5 children.
Analysis of 141 children with con-
firmed anamnestic, clinical risk fac-
tors, sonographic DDH was found in 
9 (6.38%), and from 159 children with-
out medical history or clinical risk fac-
tors for sonographic DDH was found 
in 4 (2.51%).
In relation to individual risk factors 
was found sonography of hips follow-
ing conditions:
From 16 children with positive fam-
ily history, and without other risk fac-
tors, by sonography DDH was found in 
2 (12.50%).
Out of 59 first born girl child, and 
without other risk factors was found by 
sonography DDH in 4 (6 .77%).
From 32 children born by Caesarean 
section, and without other risk factors, 
only 1 (3.12%) had sonographic signs 
of DDH. One child from a twin preg-
nancy and one that is born premature, 
and without other risk 
factors had sonographic 
healthy hips (type I by 
Graf).
Wit h  congen it a l 
anomalies of the loco-
motor system in the 
sample were 2 children, 
both male. In one it was 
a congenital bilateral pes 
equinovarus, while in 
another the fibula and 
lateral agenesis of the 
right foot. In one was 
found sonographic DDH 
of the right hip.
From the 27 children 
with two clinical risk 
factors for DDH by so-
nography was diagnosed 
in 3 children (11.11%). 
In one child with three 
clinical risk factors there 
was no sonographic di-
agnosis of DDH. Out of 
159 children from the 
tested sample at which 
it is not established in a single clinical 
risk factor, at 4 (2.51%) there was sono-
graphic diagnosis of DDH.
In relation to individual risk factors 
by sonography of the hips was found the 
following conditions:
From 7 children with positive fam-
ily history, and without other risk fac-
tors, DDH was verified by sonography 
in one case.
Out of 13 firstborn female children, 
and without other risk factors did not 
nor by a sonographic diagnosis of DDH,
Of 21 children who were born by 
caesarean section DDH was diagnosed 
by sonography in 2 children. Only one 
child was born from a twin pregnancy 
with sonography diagnosed DDH.
The maximum value of the angle al-
pha that was found on the right hip is 
780, minimum 480, and the mean value 
of 70.440. The maximum value of angle 
alpha on left hip is 780, minimum 430, 
and the mean value of 70.400 degrees. 
(Figure 3)
The maximum value of the beta an-
gle on the right hip was 820, minimum 
390, and the mean value of 46.850 de-
grees. The maximum value of the angle 
beta on the left hip was 830, minimum 
390, and the mean value of 470.
Most often value of angle alpha at 
the first examination of children in 
the sample was on the right hip 750 (41 
times), 720 and 700 (37 times). The left 
hip angle commonly found value of al-
pha is 750 (43 times) 720 (35 times) and 
700 (35 times).
Most frequent value of the angle 
beta in the right hip in the sample was 
450 (30 times), 440 (29 times) and 480 
(25 times). The most common value of 
left hip angle beta was 440 and 450 (29 
times), and 460 (25 times).
Prevention, broadly folded, abduc-
tion exercises, treatment with Pavlik 
stripes and Hilgenrner tracks were in-
volved from the first examination, di-
agnosis. (Figure 4)
Four weeks after the first clini-
cal and sonographic examinations all 
children were reviewed for the second 
time. Clinical examination in neither 
one child from each sample was re-
ported positive abduction test, and Pal-
men-Ortolani sign. All had asymmet-
ric inguinal and femoral grooves, Bade 
positive sign, as at baseline. Any child 
who at the first examination had sono-
graphic type I by Graf, had sonographic 
type I also at the second examination. 
From the 13 children who at baseline 
Figure 4. 
Figure 3. 
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had sonographic type II and type III 
by Graf, 10 patients (76.92%) were diag-
nosed with type I. Three children still 
had type II according to Graf.
At the third examination in the 
sample, by sonography were established 
DDH in two children, one male and one 
female. All children who at baseline had 
sonographic findings of DDH at the 
fourth review were healthy.
Measuring the angles alpha and beta 
in the second, third and fourth review 
is followed by maturation of acetabu-
lum. The average value of angle alpha at 
baseline in healthy children in the sam-
ple was 710, second 730, third 73.50and 
fourth 740, while the average value of 
the angle beta at baseline was 46.50, 
second 440, on third 43.2 0 and fourth 
42.80. (Figure 3)
5. DISCUSSION
Developmental hip dysplasia is the 
most common developmental anomaly 
of the locomotor apparatus. It occurs 
in all races and ethnic groups, ranging 
from 0.4% to 6% (1,2). It is more com-
mon among the Slavic people, Navaho 
Native Americans... There are so called 
luxogenic zones such as the Valley of 
Zeta in Montenegro and Eastern Her-
zegovina, where the incidence of 9% is 
found (2). It is much more common in 
female than in male children and oc-
curs at a ratio of 1:4 to 1:10 in favor of 
female children (12). More frequent is 
bilateral than unilateral. In cases of uni-
lateral occurrence affected is more of-
ten the left hip than right. It is not rare 
that DDH is combined with other de-
velopmental anomalies (2).
Developmental hip dysplasia (DDH) 
is the most common disease of the joint. 
It is manifested as a dislocation in chil-
dren and in adults as coxartrosis (9). 
Early detection of initial disorder in 
newborns and early atraumatic appli-
cation of the therapy reduces the inci-
dence of surgical treatment and second-
ary complications (10).
In our prospective study that was 
conducted in Tesanj from October 1st 
2008 to May 1st 2009 we examined 300 
children. The sample consisted of only 
those children who at the time of ini-
tial examination were not older than 
45 days. The sample includes approx-
imately one-half of children born in 
this region in time when the research 
was done. This data indicates that the 
method of early detection of DDH by 
sonography is not accepted method by 
the doctors who deal with this prob-
lem on Tesanj region. The incidence of 
DDH is different and varies in a range 
from 20-50 or even more per 1000 de-
liveries (2). For the big difference in the 
frequency the result is uneven termi-
nology, the size of the study population, 
ethnic characteristics, and the child age 
during the examination, the experience 
of doctors, examination techniques and 
interpretation of results (5). The lowest 
incidence is in Hon Kong 0.01%, fol-
lowed by Northern Ireland 0.14%, Swe-
den 0.17%, USA by 0.2% to 0.4%, in the 
UK about 1.5% (2.6,8,12). In Croatia, ac-
cording to reports from several places 
DDH screening results show that the 
incidence is around 2%, although there 
are regions where it was 0.2% and even 
higher than 4% (Vrdoljak, Matasovic). 
The incidence of DDH in Serbia in re-
cent years is around 2%. During 2002 
and 2003 at the Department of Gyne-
cology and Obstetrics in Novi Sad and 
the Institute of Orthopedic-Surgery 
“Banjica” clinically is examined 4016 
newborns by ultrasound and found the 
incidence of DDH was 1.95% (12). Re-
sults of the first screening in Bosnia and 
Herzegovina, which was carried out in 
the Tuzla region at the sixties of last 
century, say that the incidence of DDH 
us 4.9%, followed by 6.3% (1,6). Accord-
ing to recent findings, the United King-
dom has the highest incidence of DDH 
in the whole Europe (6).
Data obtained by analysis of the 
sample indicate that the incidence 
of DDH in the Tesanj region is high 
(4.33%) and it is higher than in devel-
oped countries of Europe and neighbor-
ing countries in the region.
Breech birth was in 4 (1.33%) cases 
in the sample. The reports from Zagreb, 
Rijeka, Slavonski Brod in neighboring 
Croatia is that the breech birth is pres-
ent in 2-3% of children (3).
Born by caesarean section in the 
sample are 51 (17%) children. The in-
cidence of caesarean deliveries in the 
sample is as in developed European 
countries but lower than in the USA 
and Canada. According to WHO re-
ports from 2002 and 2004 the inci-
dence of caesarean birth in most de-
veloped countries is 10% to 15%, while 
it is slightly higher in the United States 
20% and Canada 22.5%. These data, and 
data regarding the incidence of breech 
birth vary from region to region, and 
considering that a large number of de-
liveries by Caesarean started as breech 
birth and the birth by caesarean sec-
tion has become a kind of trend, these 
data must be taken with a grain of salt.
The incidence of developmental dys-
plasia of the hip detected by clinical ex-
amination in the literature varies from 
1.66% (Barlow), to 40% (Soc, Brecelj). 
These data do not depend only on the 
assessors, but also by region and time 
in which the research was done, and the 
age of children at the time of the hips 
examination. During sixties Soc and 
Brecelj SOC performed DDH research 
in Donja Zeta and found that the inci-
dence of DDH is more than 40% (1). At 
the same time the data is completely 
contrary to Barlow and sets a very low 
incidence rate of DDH. He surveyed 
children at birth and then followed up 
to age 4 months and came to the con-
clusion that 60% of hips that are unsta-
ble at birth, stabilize in the first week 
and 88% in the next 2 months. The re-
maining 12% had residual instability. 
These data indicate that only a clinical 
examination is insufficient and unreli-
able method of screening of DDH but 
that it should be done within the in-
spection of children’s hips.
Most investigators agree that hered-
ity plays a significant role in the devel-
opment of DDH, and that about 20% 
of children with DDH have a positive 
family history (6,8). In our sample 4 
(30.76%) children with DDH have a pos-
itive family history, which is more than 
the specified data from the literature.
Of 59 first-born female children 
from the tested sample, only 2 (3.38%) 
has a developmental disorder of the 
hips. The incidence of DDH in first-
born female children is even lower than 
in the whole sample, but higher than in 
children without risk factors, where the 
incidence is 2.51%.
Some say that more than 30% of 
children with DDH are firstborn female 
children (3). A number of authors have 
not point out to female first-born chil-
dren, because they believe all the first-
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born child, regardless of sex are at in-
creased risk of DDH due to rigid walls 
of the uterus, and insufficient space for 
the development of the fetus. For female 
children the risk is increased because of 
greater amounts of estrogen that leads 
to looseness of the hip joint capsule (4).
In children with breech birth, twins 
and delivered prematurely within the 
tested sample has been no outbreak 
of DDH. In prematurely born children 
(one in each sample) was established 
DDH. Many authors believe that the 
lower risk of DDH is in these children 
because of better relations between the 
size of the fetus and the uterus. Data 
from this study speak in favor of it.
For breech born children in our 
sample, there was no occurrence of 
DDH, which is not consistent with data 
from the literature where it is stated 
that 20% of children with DDH had 
breech birth.
6. CONCLUSION
The incidence of DDH in children 
in the Tesanj region determined by so-
nography of the hips and using the Graf 
method was found in 4.33% of cases but 
is significantly higher than in developed 
European countries and USA.
If the borderline cases of type I by 
Graf are included in the category of 
children with possible spontaneous 
evolution from type I to type II (with-
out prevention), the incidence of DDH 
would be 10.66% which is almost 2.5 
times more than established.
Incidence of DDH in children with 
risk factors is 2.5 times more frequent 
than in children without risk factors.
Prevalence of risk factors in the 
sample is high. Nearly half of the chil-
dren (141 or 47%) from baseline have at 
least one risk factor for DDH in anam-
nesis. Notably, a higher percentage of 
children are born by caesarean section.
The highest correlation between 
risk factors and DDH in the sample was 
found in children born with anomalies 
of the locomotor apparatus (50%) with 
positive family history (12.50%), and 
children with two risk factors (11.11%).
There was no significant correlation 
between DDH in first-born female chil-
dren and birth by caesarean section, al-
though it is slightly higher than in chil-
dren without risk factors. Twin preg-
nancy, breech birth and preterm birth 
have no significance for the occurrence 
of DDH in our sample.
7th The curve of the value of angles 
alpha and beta indicates that the po-
tential of acetabula bone maturation is 
very good in the first 6 weeks. From 6 
until the late 12th week ossification po-
tential of acetabulum is good, and after 
that period begins to weaken.
Clinical examination is not a reli-
able screening method of DDH. Signif-
icant differences in clinical and sono-
graphic findings point to the possibility 
of diagnostic errors. Healthy children 
can be declared to be ill or sick to be 
healthy, which can have serious conse-
quences. Clinical examination must not 
be omitted, and the first clinical exam-
ination should be carried out already at 
the maternity ward.
Sonography is a reliable method of 
detecting DDH in newborns. Method 
by Graf is practical and applicable. The 
possibility of error in estimating the 
type of hip by Graf is only in border-
line cases. Therefore, the limiting case 
of type I and type II should be treated 
as type II, in order to avoid unwanted 
consequences.
Sonogram hip examination should 
be introduced as mandatory for all new-
borns and should be done in the first 6 
weeks when ossification potential for 
maturation of acetabula is biggest, so 
the results of prevention and treatment 
of developmental dysplasia of the hip 
is the best.
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Purpose: Studies among veterans indicate that veterans with posttrau-matic stress disorder (PTSD) express anger, hostility and aggression as well as alcohol and substance abuse more then veterans without 
PTSD. The aim of this study was to analyze the relationship between anger, 
use of alcohol and symptoms of PTSD in war veterans in Bosnia and Herze-
govina (B&H). Method: Comparing a group of veterans (n=54) with PTSD 
who use alcohol and a group of veterans (n=46) who do not use alcohol, the 
analyzed were dimensions of anger related to PTSD symptoms and alcohol 
usage. Medical records of patients treated at the Department for Psychiatry in 
Tuzla, B&H, Harvard Trauma Questionnaire (HTQ) – version for Bosnia and 
Herzegovina, State-Trait Anger Expression Inventory (STAXI), Structured 
Clinical Diagnostic Interview (SCID-I) were used in this study. The basic 
socio-demographic data were also collected. Results: A significant correla-
tion is found between alcohol usage, and state and trait of anger (P<0.001), 
angry temperament (P = 0.001), anger-in expression (P<0.001), anger-out 
expression (P<0.001), and anger control (P<0.001). PTSD hyperarousal cluster 
symptoms were significantly correlated to state anger, anger-in expression 
(P<0.05), and use of alcohol (P = 0.010). Conclusion: The results indicate 
that there is a significant correlation between PTSD arousal symptom with 
anger dimensions, as well as between anger dimensions and use of alcohol in 
war veterans with PTSD. Key words: Alcohol Use, PTSD Symptoms, Anger
Corresponding author: Avdo Šakušic, Department of Psychiatry, University Clinical Centre of Tuzla, 
Rate Dugonjica bb, 75000, Tuzla, Bosnia and Herzegovina, Telephone number: +38761720242, E-mail: 
tuzlaavdosakusic@yahoo.com
1. INTRODUCTION
Posttraumatic stress disorder is 
frequently co-morbid with other psy-
chiatric disorders (1, 2). Patients with 
PTSD often use alcohol or other psy-
choactive substances in order to cope 
with co-morbid problems such as anx-
iety or depression (3, 4), or as a way of 
reducing distress related to particular 
PTSD symptoms. Some studies point 
to the existence of high prevalence of 
aggression, and a connection of anger 
and aggression with PTSD symptoms 
(5). Symptoms of PTSD intermediate 
in the relation between trauma sever-
ity and the expression of both verbal 
and physical aggression (6). A signifi-
cant number of studies have found a 
connection between PTSD symptoms 
in war veterans and aggressive behav-
ior in partners’ relationship (7, 8). War 
veterans’ social functioning is consider-
ably affected by relation between PTSD 
symptoms and the use of alcohol or psy-
choactive substances (9, 10). The alcohol 
use in war veterans with PTSD is inter-
connected with low quality of life (11). 
Recent study on U.S. soldiers returnees 
from Iraq in which demographic char-
acteristics of the investigated groups 
of soldiers were very similar, point to 
a significantly high level of PTSD, de-
pression and alcohol abuse, as well as to 
a significant presence of stigma linked 
to seeking help in mental health ser-
vices (12,13). The incidence of aggres-
sive and violent behavior in war veter-
ans varies, while studies suggest that it 
is significantly higher in war veterans 
with PTSD. The predominant forms of 
aggressive behavior include auto-ag-
gressive behavior and hetero-aggres-
sive pattern with dominant verbal ag-
gression and impulsive reactions. The 
level of education, low socio-economic 
status, childhood abuse, and prior vio-
lent behavior showed to be of impor-
tance for later occurrence of the aggres-
sive behavior (14). Most studies show a 
high rate of PTSD symptoms, depres-
sion, and use of alcohol in war veterans 
(1, 3, 10), while difficulties related to an-
ger in war veterans were much less an-
alyzed (15). Chemtob et al. (16) report 
on a lack of empirical data on the rela-
tion between combat-related PTSD and 
increase in anger. Persons with PTSD 
symptoms have difficulties in anger 
control (17). Anger might be a very dif-
ficult emotion to deal with, and may 
348 MED ARH 2010; 64(6) • ORIGINAL PAPER 
Relationship Between Anger, Alcoholism and Symptoms of Posttraumatic Stress Disorders in War Veterans 
lead to a number of juridical and inter-
personal problems (15). In DSM-IV TR 
(18) the anger is considered to be a pos-
sible symptom of PTSD. Angry rumina-
tions and verbal expression contribute 
to PTSD symptoms maintenance. Sev-
eral authors have recommended that 
treatment of PTSD should include anger 
management in certain groups of PTSD 
patients (19). The aim of this study is 
to determine the relationship between 
the anger and ways of anger expression, 
as well as the use of alcohol and PTSD 
symptoms in war veterans from Bosnia 
and Herzegovina.
2. SUBJECTS AND METHODS
The subjects enrolled in this study 
were male war veterans of the Army 
of Bosnia and Herzegovina, with the 
average age of 42.84±4.66 years, who 
did not use alcohol before the war and 
were hospitalized at the Department 
for Psychiatry in Tuzla during 2003, 
when diagnosed with combat-related 
PTSD according to DSM-IV criteria 
(18). This research is carried out in the 
period from September 2004 to Febru-
ary 2005. Data were collected from the 
admission protocols and medical re-
cords. Out of 1166 patients treated in 
2003, the 130 (11.2%) were war veter-
ans with PTSD. Their addresses were 
taken from the protocols and the letter 
about objectives of this research with 
a form of voluntary consent was sent 
via post office. The letter included the 
info about time schedule ascertained 
for each veteran as well as the place of 
investigation and travel costs to be cov-
ered. Psychometric tests and clinical as-
sessment is done by clinical psychiatrist 
and psychologist who did not treat these 
patients previously. Out of 130 invited 
veterans, 113 responded among which 
6 did not meet the inclusion criteria (4 
used alcohol before the war, and 2 were 
older then 55). During the study proce-
dure, 7 out of 107 war veterans dropped 
out for various reasons, and the investi-
gated group of veterans with PTSD used 
some of psychotropic drugs in that pe-
riod. All veterans used anxyolytics and 
sedatives, 49 used low dosages of atypi-
cal antipsychotics (Risperidon 1 to 2 mg 
a day), 70 used antidepressants (Par-
oxetin, Setralin, Fluoxetin). Veterans 
who use alcohol were taking psycho-
tropic drugs on their own initiative out 
of recommended protocol, and tempo-
rarily taking anxyolytics with alcohol. 
After discharge 66 veterans were sub-
ject to a regular out-patient psychiat-
ric treatment.
3. MEASURES
The State-Train Anger Expression 
Inventory (STAXI), which provides rel-
atively brief and objectively scored mea-
sures of anger experience, expression 
and anger control, was used for the as-
sessment of anger (20). The STAXI con-
sists of 44 items administered in three 
parts and distributed across five main 
scales. In accordance with the above 
mentioned concept of anger, there ex-
ist three main aspects of the STAXI 
scales: State, Trait, and Anger Expres-
sion. Part 1 consists of 10 items to as-
sess the State Anger. Part 2 contains 10 
items to measure the Trait 
Anger. Trait contains two 
subscales to investigate dif-
ferent dispositions in trait 
anger–temperament and 
reaction. Part 3 consists of 
24 items to measure Anger 
Expression. Anger Expres-
sion is an experimental com-
posite of the three expres-
sion constructs In, Out, and 
Control. All items are rated 
on a four-point scale and 
assigned a score between 1 
and 4. Trait-anger items are 
rated on 4-point scales from 
„almost never“–1 to „almost 
always“–4, and the state-an-
ger items are rated on the in-
tensity of feelings from „not 
at all“–1 to „very much so“–
4. The coefficient of reliabil-
ity for the trait-anger sub-
scale was 0.91, for the state-
anger subscale 0.82, and for 
the anger expression it was 
0.79. The index of anger ex-
pression is being measured, 
which enables measuring the 
total anger expression, levels 
from 0-1.4 being low, 1.5–
2.4 moderate, 2.5–3.4 high 
and 3.5–4.4 extremely high. 
Levels of anger expression 
were determined according 
to percentile range. Values 
of anger expression that fall to percen-
tile 5 to 25 are considered to be low; val-
ues that fall to percentiles 50 to 75 are 
moderate; values to percentiles 75 to 90 
are considered to be high, and values to 
percentiles 95 extremely high.
In order to determine alcohol con-
sumption, the Structured clinical in-
terview for DSM-IV, Axis I disorders 
(SCID-I), and application form for alco-
hol related disorder (21) were used. The 
interview format for the SCID includes 
an initial screen for evidence of any 
lifetime excessive drinking, followed 
by items for specific diagnoses of alco-
hol abuse and addiction. Each item is 
scored 1 – not present, 2 – mildly pres-
ent or unclear or 3 – present. Every in-
terview took about one hour. To evalu-
ate traumatic events and the presence 
of PTSD, as well as the expressiveness of 
PTSD symptoms, a self-rating Harvard 
Characteristics No of war veterans (N=100)
Nationality
Bosniaks 98
Serbs 2
Religion affiliation
Islamic 96
Orthodox 2
Atheist 2
Marital status
Married 82
Divorced 6
Widowed 4
Single 8
Education
No education 10
Elementary 30
Secondary School 56
University degree 4
Employment status
Employed 62
Unemployed 38
Alcoholism in family
Present 40
Not present 60
Traumatic events
Wounding 18
Death of the closest 22
Drawing a wounded and 
killed persons
94
Exposure to a heavy 
shelling
100
Being captured 10
Persecution 14
Witnessing death of other 
soldiers
92
Table 1. Socio-demographic characteristic of Bosnian and 
Herzegovina war veterans (N=100) with Posttraumatic Stress 
Disorders
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Trauma Questionnaire (HTQ), Bosnia 
and Herzegovina Version (22) was used. 
For identified traumatic event, the re-
spondents were asked: “How do you feel 
when you remember that?”, rated on a 
0-5 scale: 0 – No feeling, 1 – a bit up-
set, 2 – somewhat upset, 3 – moderately 
upset, 4 – seriously upset, and 5 – ex-
tremely seriously upset. Another part of 
the questionnaire contained a 16-item 
scale for measuring PTSD symptoms 
and the presence of PTSD. Stress level 
was defined as the frequency of each 
PTSD symptom in the last month, as-
sessed on the 0 – 5 scale by determin-
ing its occurrence: 0 – not at all, 1 – al-
most never, 2 – sometimes, 3 – mod-
erately, 4 – often and 5 – almost ev-
ery day. To collect socio-demographic 
data, a questionnaire designed for this 
research was used; it contained ques-
tions related to general socio-demo-
graphic data and questions about fam-
ily history of alcoholism.
4. DATA ANALYSES
A nonparametric Mann-Whitney 
test was used for the statistic analysis 
of differences between the groups in 
results of answers to questions about 
socio-demographic data (age, employ-
ment, education, marital status, em-
ployment of the partner, alcoholism in 
family). The difference between groups 
in stress levels, intensity of PTSD symp-
toms, number of traumatic events, and 
the score of index’ of the subscale anger 
was analyzed by the factorial ANOVA 
model. The relation between dimen-
sions of anger, use of alcohol, and PTSD 
symptoms was analyzed with the Pear-
son correlations. Collected data were 
statistically analyzed using the Win-
dows Statistical Package for Social Sci-
ences, version 10.0 (SPSS, Chicago, IL, 
USA).
5. RESULTS
Most subjects in this study were 
married, employed, of secondary school 
educational level, with no family his-
tory of alcoholism (Table 1). Average 
number of reported traumatic events 
was 4.8±1.75, where witnessing death 
or wounding of soldier mates prevail 
(Table 1). In total sample of the vet-
eran group the mean of PTSD symp-
toms intensity was 3.37±0.41, the mean 
of stress level was 2.56±0.73, while the 
mean scores of clusters of intrusive 
symptoms was 2.78±0.57, avoidance 
symptoms 2.93±0.47, and arousal symp-
toms 2.46±0.76. According to SCID-
I interview criteria, in the 12-month-
period prior to this study, 54 veterans 
with PTSD used alcohol, and 46 did 
not use alcohol. There was no statis-
tically significant difference related to 
age (43.56±4.94 vs. 42.00±42.84, F = 
1.394, P = 0.244) between war veterans 
with PTSD who used alcohol and those 
who did not use alcohol. Using Mann-
Whitney test, no significant difference 
is found between those two groups re-
lated to marital status (Z = -0.422, P = 
0.673), level of education (Z = -1.199, P 
= 0.230), employment rate (Z = -0.729, 
P = 0.466), and family history on alco-
holism (Z = -1.119, P = 0.263). No signif-
icant difference is found using Factorial 
ANOVA analysis in severity of PTSD 
symptoms (F = 0.268, P = 0.848), the in-
trusive symptoms (F = 1.404, P = 0.254), 
the avoidance symptoms (F = 1.625, P 
= 0.197), hyperarousal symptoms (F = 
2.754, P = 0.053), and the number of 
traumatic events (F = 1.973, P = 0.131). 
Linear regression showed significant 
correlation between alcohol usage and 
the number of traumatic events (r = 
0.334, P = 0.009), intrusive symptoms 
(r = 0.249, P = 0.041), avoidance symp-
toms (r = 0.309, P = 0.014), and hyper-
arousal symptoms (r = 0.384, P = 0.003). 
However, there was no significant rela-
tion between the number of traumatic 
events and intrusive symptoms (r = 
0.039, P = 0.393), avoidance symptoms 
(r = 0.133, P = 0.178), and hyperarousal 
symptoms (P = 0.059, P = 0.342).
Out of total 100 war veterans with 
PTSD, a high and an extremely high 
level of trait anger was found in 18 vet-
erans, a high level of anger-out expres-
sion was found in 24, anger-in expres-
sion a high in 20, and anger control a 
high to extremely high level in 46 war 
veterans (Table 2). Multivariate analy-
Anger Dimensions No of war veterans related to level of anger expression*
Low
(0-1.4)
Moderate
(1.5-2.4)
High
(2.5-3.4)
Extremely
(3.5-4.4)
State anger 23 46 28 -
Trait anger 2 80 16 2
Angry temperament 6 66 28 -
Angry reaction 4 56 38 2
Anger expression - 92 8 -
Anger-in 2 78 20 -
Anger-out 10 66 24 -
Anger controlž 8 42 40 6
* Levels of anger expression were determined according to percentile range; values of anger 
expression that fall to percentile 5 to 25 are considered to be low; values that fall to percentiles 
50 to 75 are moderate; values to percentiles 75 to 90 are considered to be high, and values to 
percentiles 95 extremely high
Table 2. Level of anger expression index measured by the State Trait Anger Expression Inventory (STAXI) 
in Bosnian war veterans with Posttraumatic Stress Disorder (N = 100)
Dimensions of 
anger
War veterans with PTSD (N=100)
Who use alcohol
(n=54) M±SD
Who do not use 
alcohol(n=46)
M±SD
Type III Sum 
of Squere
Mean 
Squere
F P
State anger 2.14±0.61 1.56±0.37 5.33 1.77 6.08 0.001
Trait anger 2.31±0.45 1.86±0.41 3.41 1.13 6.41 0.001
Angry 
temperament
2.29±0.55 1.80±0.45 3.54 1.18 4.44 0.008
Angry reaction 2.36±0.46 2.11±0.57 2.25 0.75 3.03 0.038
Anger expression 2.22±0.11 2.15±0.14 0.13 4.52E-02 2.81 0.050
Anger-in 2.29±0.26 2.00±0.26 1.26 0.42 5.97 0.002
Anger-out 2.32±0.42 1.71±0.30 5.12 1.70 12.53 <0.001
Anger control 2.10±0.67 2.75±0.55 6.72 2.24 6.06 0.001
PTSD- Posttraumatic Stress Disorder, M-mean, SD–standard deviation, F value for factorial ANOVA
Table 3. The mean of anger scores and differences in dimensions of anger measured by the State Trait 
Anger Expression Inventory (STAXI) in Bosnian war veterans with Posttraumatic Stress Disorder who use 
alcohol (n=54) and do not use alcohol (n=46)
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sis used for fixed factors of alcohol us-
age found a significant difference in the 
dimensions of anger between war vet-
erans with PTSD who use alcohol and 
those who not use alcohol (Table 3). In 
relation to cluster symptoms of PTSD 
and dimensions of anger, using linear 
regression it is found a significant cor-
relation between hyperarousal symp-
toms and the state anger (r = 0.285, P 
= 0.022), and angry temperament (r = 
0.270, P = 0.029), anger expression (r 
= 0.342, P = 0.008), and anger-out ex-
pression (r = 0.279, P = 0.025), while be-
tween intrusive symptoms, avoidance 
symptoms and dimensions of anger 
there was no significant correlation. A 
significant correlation is found by lin-
ear regression between the number of 
traumatic events and state anger (r = 
0.267, P = 0.031), angry temperament 
(r = 0.266, P = 0.031), anger-out expres-
sion (r = 0.354, P = 0.006), and anger 
control (r = 0.281, P = 0.024). There was 
no significant correlation between the 
intensity of PTSD symptoms and state 
anger (r = 0.027, P = 0.425), trait anger 
(r = 0.023, P = 0.437), angry tempera-
ment (r = 0.021, P = 0.443), angry reac-
tion (r = 0.009, P = 0.475), anger-in (r = 
0.124, P = 0.195), anger-out (r = 0.142, 
P = 0.163, and anger control (r = 0.105, 
P = 0.235).
6. DISCUSSION
In this study most veterans with 
PTSD have had moderate to extremely 
high level of trait anger, angry reaction, 
and anger-in expression; moderate to 
high level of angry temperament, anger-
out expression, and state anger. Moder-
ate to high index of anger control was 
present in the largest number of veter-
ans, which is opposite to expected re-
sults and results from other studies (16, 
17). A significant correlation between 
the intensity of PTSD symptoms and 
score of anger dimensions is not found 
in this study, while a significant relation 
between symptoms of hyperarousal and 
state anger, angry temperament, anger 
expression and anger-out expression is 
found, which is similar to the results of 
Evans et al. (8). Also, a significant cor-
relation is found between the number 
of traumatic events and state anger, an-
gry temperament, anger-out expres-
sion and anger control. Possible expla-
nation for the results obtained is that 
this study enrolled veterans who were 
taking one or more psychotropic drugs 
during the period of investigation, and 
most of them underwent treatment. It is 
also possible that veterans are afraid of 
their aggressive impulses and may lack 
self-efficacy with regard to anger con-
trol, and therefore, they are more likely 
to “stuff” their anger (23).
With regard to alcohol consump-
tion, 54 veterans from Bosnia and Her-
zegovina enrolled in this study used al-
cohol, and a significant relationship is 
found between PTSD symptoms and 
use of alcohol, which does not differ 
from the results obtained in previous 
studies (4, 10, 12, 24). It is found that 
war veterans with PTSD who used alco-
hol have had significantly higher level of 
the trait anger, the state anger, the an-
gry temperament, and higher expres-
sion of anger-in and anger-out, and a 
weaker control of anger compared to 
veterans suffering from PTSD who did 
not use alcohol. Studies indicate that 
hyperarousal symptoms of PTSD are re-
lated to alcohol usage too (25, 26). The 
studies conducted on war veterans in 
Croatia (24, 27), Bosnia and Herzegov-
ina (28), Iraq and Afghanistan (19), and 
Vietnam war veterans (7, 15) showed 
a high level of aggression in veterans 
with PTSD who have alcohol-related 
disorders. Also, Lasko et al. (29) found 
in Vietnam veterans that those with 
PTSD had a higher aggression score 
compared to veterans without PTSD, 
and that aggression intensity was de-
termined more as a part of PTSD. The 
association of PTSD symptoms with 
aggressive behavior and directing ag-
gression outwardly was also found in 
studies related to violent behavior of 
war veterans against their partners (8, 
15), and interpersonal violence (30). 
However, a relationship between an-
ger, PTSD symptoms and alcohol con-
sumption in veterans is being analyzed 
in only several studies (31). No statisti-
cally significant difference is found in 
socio-demographic variables, number 
of traumatic events, stress level, and 
severity of PTSD symptoms between 
veterans with PTSD who use alcohol 
and those who do not use alcohol. But 
a significant correlation of hyperarousal 
symptoms and state anger, angry tem-
perament, anger expression and anger-
out expression was found. As a symp-
tom of PTSD, hyperarousal appears as 
a predictor of anger and alcoholism. It 
is found by Taft et al. (32) that hyper-
arousal symptoms were directly associ-
ated with aggression and indirectly with 
alcohol related-problems. Also, Sava-
rese et al. (33) report that there is a com-
plex interaction between hyperarousal 
and alcohol consumption in predict-
ing violence. Some explanations for the 
connection of hyperarousal symptoms 
and aggressions may relate to changes 
in the activity of areas of the brain such 
as nucleus accumbens in the dominant 
hemisphere (34).
Based on the results obtained in this 
study, it can be concluded that there is 
a significant relationship between an-
ger, alcohol consumption and PTSD 
symptoms where the cluster of hyper-
arousal symptoms is significantly cor-
related with anger dimensions and use 
of alcohol. It can also be concluded that 
exposure to a larger number of com-
bat-related traumatic events is directly 
connected with alcohol usage and an-
ger dimensions.
There were several methodological 
limitations in this study. Firstly, the fac-
tor related to duration and methods of 
treatment was not included. The study 
is carried out in the group of veterans 
who underwent in-patients treatment 
only with psychotropic drugs, while in-
vestigation took place one to two years 
after the hospitalization. Secondly, this 
study did not include other psychologi-
cal factors such as depression and anx-
iety where the emotion of anger is pres-
ent; and the occurrence of aggressive 
behavior in war veterans with PTSD 
who have a high index of anger and who 
use alcohol is not analyzed. This study 
indicates the need for exploring the an-
ger related to the above mentioned fac-
tors. Also, the results of this study show 
that in the treatment of war veterans 
with PTSD it is necessary to explore the 
emotions of anger as important factor 
to managing therapeutic interventions.
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Application of Botulinum Toxin in Treatment of Spasticity 
and Functional Improvements for Children Suffering from 
Cerebral Palsy
Ajsa Meholjic, Dijana Madjar
Pediatric Clinic, Clinical Centre of Sarajevo University, Patriotske Lige 81, 71000 Sarajevo, Bosnia and Herzegovina
Application of Botulin toxin type A in children with cerebral palsy is represent targeted antispasm treatment for relaxation of spastic mus-cles. Goal: The goal of this study was to determine the significance of 
the application of Botulin toxin in the treatment of spasticity and functional 
progress of children suffering from cerebral palsy. Material and methods: 
At the Department of Developmental diagnosis, habilitation and rehabilita-
tion of children in the Pediatric Clinic, Clinical Center of Sarajevo University 
study included 20 patients aged 4-18 years. Data were obtained by examining 
the patient’s records. Selected patients are diagnosed with cerebral palsy and 
were treated with Botulin toxin. The study was retrospective, and data are 
presented in tables and charts using descriptive statistics. As a measurement 
scale, we used the “gross motor function measurement“–GMFM, based on 
which the children were scored by the “ Gross Motor Function Classification 
System“–the GMFCS. Results: Of 20 children, 11 or 55% were boys and 9 or 
45% of girls. The largest number of children in the sample had 9 ± 4.03 years 
(5 or 25%), with an average age of 9 years (range: 4-18 years). 80% of children 
suffering from cerebral palsy for the first time received botulin toxin at the 
age of 2-6 years, 40% of children had 2 applications of Botulin toxin, and for 
45% of children the time interval between repeated applications was from 
3-6 months. Measuring gross motor function before and after botulin toxin 
application registered significant functional improvement. Conclusion: 
Botulin toxin is beneficial in the treatment of spasticity in children suffer-
ing from cerebral palsy. Key words: spasticity, Botulin toxin, Gross Motor 
Function Classification Systemž
Pediatric Clinic, Clinical Centre of Sarajevo University, Patriotske Lige 81, 71000 Sarajevo, BiH 
1. INTRODUCTION
Cerebral palsy is a set of symptoms 
that arise as a result of abnormal brain 
development or brain damage at an 
early age. These symptoms are motor 
deficits, non-physiological increase or 
decrease and the distribution of mus-
cle tone, sensory and sensitivity distur-
bance, mental deficit, speech distur-
bances, neurovegetative disturbances, 
etc. As a result of damage to the py-
ramidal path develops muscle spastic-
ity (1,2).
To decrease the muscle spasm, as one 
aspect of treatment is the application Bot-
ulin toxin (BT), which is best applied to 
children suffering from cerebral palsy at 
the age of 2-6 years, which have dynamic 
contractures that affect the function of 
the limbs (3)? Clinical signs of improve-
ment are visible within the first two weeks 
after the injection of botulin toxin into 
the muscles. The dose may be repeated 
before the symptoms completely disap-
pear prior injection, but not more fre-
quently than every 2 months (4,5). Con-
traindications for the application are: hy-
persensitivity to some component of the 
product, the generalized disturbance of 
muscle activity (e.g. myasthenia gravis), 
concomitant administration of amino-
glycoside antibiotics, the presence of in-
fection at the site or around the injection 
site, and bleeding disorder (6,7).
The main criterion for inclusion of 
Botulin toxin is localized hypertonic 
muscles and the absence of static contrac-
ture, and indications are: on the feet–dy-
namic equinus, equinovarus, equinoval-
gus, dynamic restriction of movement in 
the knees, adduction position of the hips, 
scissors like position of the legs or the 
hands–permanent position of thumb in 
the palm of the hand, the dominant pal-
mar flexion with ulnar deviation or only 
the dominant palmar flexion (8,9).
2. GOAL
The goal of this study was to deter-
mine the efficacy of the treatment of spas-
ticity in children suffering from cerebral 
palsy by application of botulin toxin in 
spastic muscles of the lower limbs.
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3. MATERIAL AND 
METHODOLOGY
The study included children who were 
diagnosed with cerebral palsy treated at 
the Department of Developmental diag-
nosis, habilitation and rehabilitation of 
children at the Pediatric Clinic of Clini-
cal Center, Sarajevo University who had 
received botulin toxin in spastic muscles 
of the lower extremities. Research data 
were obtained by examining the history 
of the disease of observed groups of pa-
tients. The total number of observed is a 
group of 20 patients. Patients were aged 
4-18 years. The study was retrospective 
and all the data are presented in tables 
and charts using descriptive statistics and 
through the absolute number of cases, 
percentage and arithmetic mean with 
standard deviation.
4. RESULTS
The largest number of children in 
the sample had 9±4.03 years (5 or 25%), 
with an average age of 9 years (range: 
4-18 years). In 10 children (50%) is reg-
istered a spastic tetraparesis. 80% of 
children suffering from cerebral palsy 
has received Botulin toxin for the first 
time at the age of 2-6 years.
The largest number of children 
(40%) had 2 applications of botulin 
toxin into the muscles of the lower 
limbs.
Before application of the Botulin 
toxin 50% of children suffering from 
cerebral palsy was classified as stage 
IV in GMFCS.
After application of Botulin toxin 
noticed is improvement or change to a 
lower level of GMFCS in 50%, of chil-
dren suffering from cerebral palsy.
After application of BT is evident 
that the measurement of gross mus-
cle forces all respondents, except one 
change from high to lower levels of GM-
FCS. The correlation coefficient of GM-
FCS before and after application of Bot-
ulin toxin shows a high statistical sig-
nificance, Rho=-0.981, p<0.01.
5. DISCUSSION
Using Botulin toxin, which leads 
to local haemodenervation, achieved 
is reduction in tome of spastic mus-
cles in children with cerebral palsy. It 
is of great importance for the course of 
treatment because it allows better mo-
bility of joints, prevents contracture, 
facilitates the work of physiotherapists 
in the implementation of the develop-
ment of medical gymnastics and post-
pones or even makes unnecessary the 
corrective surgical procedures.
At the Department of Develop-
mental diagnosis, habilitation and re-
habilitation of children at the Pediat-
ric Clinic of the Clinical Center, Uni-
versity of Sarajevo, the total number 
of children with spastic cerebral palsy 
who received in the period since 2006 
until 2010 botulin were 20, of which 9 
(45%) were girls and 11 (55%) boys. In 20 
children, aged 4-18 years Botulin toxin 
was injected intramuscularly into the 
muscles of the lower limbs, as follows: 
mm. adductores Magni, longi et brevi 
and mm. gastrocnemio.
Analyzing the distribution of CP in 
studied children, we can see that 10 or 
50% had spastic tetraparesis with dom-
inant diaparesis, 7 children or 35% had 
spastic diaparesis, 2 children or 10% 
hemiparesis and 1 child or 5% triparesis 
with dominant spasmodic diaparesis.
16 or 80% of children for the first 
time received botulin toxin at the age of 
2-6 years, and the remaining 4 or 20%, 
at age 7-15 years, mean age 5.75 years. 
Reference literature favors early treat-
ment with botulin toxin before the age 
of 4 years if we want to improve and 
facilitate walking, or a child can be 
treated by the same in any age, for bet-
ter care and spastic pain relief.
Analyzing the application of botulin 
toxin, we found that 6 or 30% of children 
Table 1. The age of children suffering from 
cerebral palsy who had received Botulin toxin
Age (in years) N %
4 2 10.0
5 2 10.0
6 1 5.0
7 3 15.0
8 2 10.0
9 5 25.0
10 1 5.0
15 2 10.0
16 1 5.0
18 1 5.0
Total 20 100.0
Mean 9.00
Standard deviation 4.026
Minimum 4
Maximum 18
Table 2. The gender representation
N %
Male 11 55.0
Female 9 45.0
Total 20 100.0
Table 3 Clinical type of cerebral palsy
Cerebral palsy type N %
Diaparesis spastica 7 35.0
Hemipresis cer. lat. dex. 2 10.0
Tetraparesis spastica pp 
Diaparesis spastica
10 50.0
Triparesis spastica pp 
Diaparesis spastica
1 5.0
Total 20 100.0
Table 4. Age when the child first received Botulin 
toxin
Age N %
2- 6 years 16 80.0
7- 15 years 4 20.0
Total 20 100.0
Mean 5.75
Std. deviation 3.626
Minimum 2
Maximum 15
Number of BT applications N %
1 6 30.0
2 8 40.0
3 3 15.0
4 2 10.0
5 1 5.0
Total 20 100.0
Table 5. Number of Botulin toxin applications
GMFCS before BT 
application
N %
II 4 20.0
III 3 15.0
IV 10 50.0
V 3 15.0
Total 20 100.0
Table 6. Gross Motor Function Classification 
System (GMFCS) before application of Botulin 
toxin
GMFCS after BT 
application
N %
I 4 20.0
II 3 15.0
III 10 50.0
IV 2 10.0
V 1 5.0
Total 20 100.0
Table 7. Gross Motor Function Classification 
System (GMFCS) following application of Botulin 
toxin
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had 1 application, 8 or 40% of children 2 
applications of BT, 3 or 15% of children 3 
applications of BT, 2 or 10% of children 4 
BT applications and one child or 5% had 
5 applications of Botulin toxin. The lit-
erature does not indicate that the maxi-
mum number of applications of BT that 
patient can receive, but is recommended 
for each subsequent application of BT to 
be administered 3 months after the pre-
vious. The dose may be repeated even 
before the symptoms of prior injection 
completely disappear, but not more fre-
quently than every 2 months.
To estimate the severity of cerebral 
palsy used is five degrees classification 
system for gross motor function in cere-
bral palsy (Gross Motor Function Clas-
sification System GMFCS I-V). Before 
the BT application, for the treated chil-
dren was determined a GMFCS level, 
and found that 10 or 50% of children be-
long to stage IV, 4 or 20% of children be-
longing to stage II, 3 or 15% of children 
to stage III and 3 or 15% of children be-
longs to the GMFCS stage V. After the 
application Botulin toxin, children suf-
fering from cerebral palsy were clinically 
re-examined with Gross Motor Function 
Measure-GMFM and re-determined a 
degree of GMFCS. These results indicate 
that 10 or 50% of children now belonged 
to the third stage, 4 or 20% of children 
belonging to stage I, 3 or 15% of children 
belonging to stage II, 2 or 10% in stage 
IV and 1 or 5% of children belonging to 
GMFCS stage V. Noted is the decrease in 
GMFCS level after application of botu-
lin toxin and all the children, except one 
child moved into a lower category. Only 
one child remained in the stage V. Sta-
tistical analysis of the correlation coeffi-
cient of GMFCS before and after applica-
tion of Botulin toxin shows a high statis-
tical significance (Rho=-0.981, p<0.01). 
Lack of response to the application of 
botulin toxin rarely occurs but may oc-
cur as a result of wrong BT injection, 
lower applied doses, achievement of the 
maximum effect only after the second 
or third application, present static con-
tractions or due to the development of 
antibodies.
Camargo and colleagues investi-
gated the safety and efficacy of botulin 
toxin in treating spasticity in 20 chil-
dren with spasmodic diplegia as a form 
of cerebral palsy. All patients received 
injections into the muscles of the lower 
limbs, and 15 patients in the adductors 
of the thighs. The total dose ranges 70-
140 U (99.75 +/- 16.26 U), or 7.45 +/-2.06 
U/ Kg per patient. After the applica-
tions have been recognized significant 
improvements in gait in patients with 
a significant increase in ankle flexibil-
ity. They concluded that botulin toxin 
is safe and effective in the treatment of 
spasticity in children suffering from ce-
rebral paralysis, but that the functional 
changes are temporary (10). Pena-Se-
gura and colleagues investigated the 
effect of botulin toxin in 702 children 
with cerebral palsy with positive results 
in reducing muscle spasms in the limbs 
in 70% of children (11). Based on our re-
search and investigations of numerous 
authors, it is evident that botulin toxin 
significantly reduces muscle spasm in 
children with cerebral palsy.
6. CONCLUSION
Botulin toxin is effective in the con-
servative treatment of spasticity in chil-
dren suffering from cerebral palsy and 
improve the their mobility, provide bet-
ter position the individual parts of the 
body in the supine, sitting or stand-
ing position, allowing the possibility 
of learning new and better pattern of 
movement, extend the time until sur-
gery and reduces pain in spastic muscle.
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GMFCS after application
Total
I II III IV
V 
GMFCS before 
application
II
N 4 0 0 0 0 4
% 100.0 0.0 0.0 0.0 0.0 20,0
III
N 0 3 0 0 0 3
% 0.0 100.0 0.0 0.0 0.0 15,0
IV
N 0 0 10 0 0 10
% 0.0 0.0 100.0 0.0 0.0 50,0
V
N 0 0 0 2 1 3
% 0.0 0.0 0.0 100.0 100.0 15,0
Total
N 4 3 10 2 1 20
% 100,0 100.0 100.0 100.0 100.0 100.0
Table 8. The correlation coefficient of GMFCS before and after Botulin toxin application.  Pearson Rho = 
-0.981, p = 0.0001
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Objective: Congenital diaphragmatic hernia is one of the severe congenital pulmonary anomaly (PA) associated with pulmonary hypoplasia, pulmonary sequestration and severe respiratory distress. 
The aim of this study was to present difference between measurements of 
the size of fetal pulmonary artery and pulmonary branches (PB) in normal 
growth fetuses and comparison with the same in fetuses with congenital dia-
phragmatic hernia (CHD). Measurements were done by echocardiography. 
Methodology: During the period March 2007 to March 2009 measurements 
were performed on a total of 115 normal fetuses, at 20–38 weeks gestation. By 
cross-sectional echocardiography were measured fetal PA and PB diameters. 
Retrospectively were reviewed 6 fetuses with left-sided CHD from 2005 to 
2009. Measurements were done at level of the three vessel view (superior 
vena cava, ascending aorta and main PA). Results: Diameter of main PA 
and both branches were found to correlate with the advanced gestational 
age (r = 0.74, p < 0.01). There was calculated diameter of the left PB to main 
pulmonary artery ratio (LPB/MPA) and right PB to main pulmonary artery 
(RPB/MPA) ratio. These two parameters were almost constant throughout 
gestation. In all fetuses with CDH, LPB was normal or smaller than in nor-
mal fetuses. Both PB in compare with PMA were within the normal range 
in all normal fetuses. Conclusion: Echocardiographic measurement of PB is 
an important method to establish the normal range of diameters of the PA 
branches and it appears to be useful to compare results on normal fetuses 
and fetuses with CDH and pulmonary hypoplasia. Key words: Antenatal 
echocardiography, pulmonary branch, congenital diaphragmatic hernia, lung 
hypoplasia, respiratory distress
Ramush Bejiqi, MD, Pediatrics cardiologist, Head of Intensive Care Unit, Pediatric Clinic, University Clinical 
Centre of Kosova, Prishtina, Kosova. Mobile: 00377 44 120 129, Phone: 00381 38 553 217. E-mail address: 
rbejiqi@hotmail.com
1. INTRODUCTION
Pulmonary hypoplasia (PH) is the 
result of retardation in pulmonary de-
velopment associated after birth with 
high level of early respiratory distress, 
severe respiratory insufficiency, pneu-
mothorax, pulmonary interstitial em-
physema persistent pulmonary hy-
pertension, and high rate of mortal-
ity, ranging from 50 to 90 %. PH may 
be appear bilateral or often, unilateral, 
caused by more different factors. Uni-
lateral congenital diaphragmatic hernia 
(CDH) associated with displacement of 
abdominal viscera in the thoracic cav-
ity, through a defect in the diaphragm, 
results in intestinal obstruction and se-
vere respiratory compromise. It occurs 
often as 1: 2200 live births. The sever-
ity of CDH and respiratory insufficiency 
may be very mild or as severe as to be 
incompatible with life and are related 
to the time and degree of prenatal vis-
ceral herniation. PH is defined as a wet 
lung/body weight ratio of < 0.015 be-
fore 28 weeks gestation or < 0.012 at 28 
weeks or later. The classical diagnosis 
has only been demonstrated by autopsy. 
Advances in antenatal ultrasound tech-
nique, the prenatal diagnosis of CDH 
is possible as early 16 weeks gestation. 
Despite the lethal outcome, there have 
been no reliable prenatal diagnostic 
methods and parameters for indicating 
the severity of pulmonary hypoplasia.
By echocardiography, two-dimen-
sional measurement of main pulmo-
nary artery (MPA) and pulmonary ar-
tery branch (PAB) diameters and Dop-
pler waveform of PA have provided as 
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an effective methods to determine de-
gree of pulmonary hypoplasia. Sokol et 
al. have proposed that fetal branch PA 
diameters correlated strongly with lung 
weights measured at autopsy.
In this presentation we measured 
the normal range of the diameter of the 
main pulmonary artery (MPA), left pul-
monary branch (LPB), right pulmonary 
branch in the normal fetus. This al-
lowed calculation of the LPB/MPA ratio 
and RPB/MPA ratio independent of ges-
tation. These branch PA diameters were 
compared with diameters measured in 
fetuses with CDH and poor prognosis 
caused by pulmonary hypoplasia.
2. METHODS
In a 115 pregnant women, gesta-
tional age 20 – 38 weeks, with single-
ton uncomplicated pregnancies were 
performed measurement of internal di-
ameter of MPA, LPB and RPB, includ-
ing measurements of parameters of fe-
tal growth. Diameters were measured 
from a cross-sectional view at the level 
of the three-vessel view (main pulmo-
nary artery, ascending aorta and vena 
cava superior). We visualized the long 
axis of pulmonary branches when pos-
sible. Measurements were done from 
frozen real-time images, in the absence 
of fetal movement. All measurements 
were done from one obstetrician (H.B) 
and two pediatrics cardiologists (R.B 
and R.R). Measurements were done by 
using an Acuson Aspen Advanced and 
Acuson Sequoia 216, and 
a convex probe 3 and 4 
MHz and pediatric car-
diologic probe 7 MHz. 
Data are presented in 
millimeters (mm).
Retrospectively we 
investigated 6 fetuses 
with CDH, born in dif-
ferent regional hospi-
tals in Kosova, during 
the period March 2005 
and March 2009. Since 
they manifested severe 
respiratory distress, they 
were admitted in Cen-
ter for Neonatology and 
Preterm born children 
in Pristina. One baby 
was delivered by elec-
tive cesarean section and 
other four children were 
delivered by vaginal de-
livery. Despite minimum 
two antenatal ultraso-
nography examination 
none of them were diag-
nosed CDH or any other 
malformation. All babies 
had left CDH. 4 neonates 
(case 1–4) after surgical 
treatment survived, the 
fifth died before surgi-
cal intervention.
3.  RESULTS
In our study both pulmonary 
branches diameter were significantly 
correlated with gestational age (r = 0.74, 
p < 0.01). We calculated diameter of 
MPA, LPB and RPB and calculated ratio 
LPB/MPA and RPB/MPA and we con-
firmed that the data were in correlation 
with gestation (LPB/MPA: 0.48 ± 0.08, 
RPB/MPA: 0.49 ± 0.08). Also we cor-
related data LPB/MPA and RPB/MPA 
with diameters of pulmonary branches 
of 6 patients with CDH. Data are pre-
sented on the diagram (Table.2). There 
was statistically significant correlation 
between LPB/MPA and RPB/MPA ra-
tios and the gestational age. In all ba-
bies with CDH, RPB diameter immedi-
ately preceding delivery was within the 
normal range in the 5 babies surviving 
surgical intervention. In case that died, 
diameter of RPB was under lower limit 
of the norm. LPB diameter was below 
CASE
Maternal a. 
years
Hernia 
side
Herniated viscera
Poly-
hydramnions
Body w. at 
delivery, g
Outcome
1 25 left Intestine - 3.238 Survived
2 25 left Intestine - 2.744 Survived
3 40 left Intestine + 2.904 Survived
4 34 left Intestine, lien - 2.820 Survived
5 29 left Intestine + 2.520 Died
6 24 left Intestine, lien + 3.150 Survived
Table 1. Basic inputs and outcomes of the fetuses with congenital diaphragmatic hernia
CASE
Hernia 
side
Herniated 
viscera
MPA
mm
RPB
mm
LBP
mm
RPB/MPA LBP/MPA
Body w. at 
delivery, g
Outcome
1 left Intestine 9.80 6.80 6.60 0.69 0.67 3.238 Survived
2 left Intestine 8.70 5.80 5.70 0.67 0.66 2.744 Survived
3 left Intestine 9.10 5.90 5.70 0.65 0.63 2.904 Survived
4 left
Intestine + 
lien
9.05 6.10 5.40 0.67 0.60 2.820 Survived
5 left Intestine 9.50 4.80 4.50 0.51 0.47 9.50 Died
6 left
Intestine + 
lien
11.00 7.50 7.40 0.68 0.67 3.150 Survived
Table 2. Achieved measurements in fetuses with congenital diaphragmatic hernia
Figure 1. Two dimensional image cross.sectional view with three vessel 
view in normal fetus; Ao - aorta, MPA - main pulmonary artery, LPA - 
main pulmonary artery; RPA - main pulmonary artery, VCS - vena cava 
superior
Figure 2. Cross-sectional ultrasound image with a three vessel view 
in normal fetus RV - right ventricle, Ao - aorta, MPA - main pulmonary 
artery, LPA - main pulmonary artery; RPA - main pulmonary artery, VCS 
- vena cava superior
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the normal range in all children with 
CDH. Four surviving patients in CDH 
(1 – 5), were bellow the normal range in 
PB/MPA and within the normal range 
in RPB/MPA. In one case, that died was 
within the normal range for both LPB/
MPA and RPB/MPA.
4. DISCUSSION AND 
CONCLUSION
The survival rates of babies with 
severe CDH have increased dramat-
ically, particularly over the past two 
decades as a result of early prenatal ul-
trasonography diagnosis and organi-
zation of these high-risk deliveries to 
tertiary centers so that optimal venti-
latory care and surgical expertise are 
available. Important prognostic pre-
dictors (for survival of congenital dia-
phragmatic hernia) include the degree 
of fetal liver herniation into the chest 
and the presence or absence of other 
anomalies. Prenatal evaluation of con-
genital diaphragmatic hernias consists 
of a Level II ultrasound, an ultrafast fe-
tal MRI, fetal chromosome studies, and 
a fetal echocardiogram. Ultrasonogra-
phy can be a non-invasive method to 
predict prenatal clinical pulmonary hy-
poplasia caused by CDH. Among the 
other basic ultrasonography measure-
ments in fetuses (lung-thoracic trans-
verse area ratio, lung-head ratio, tho-
racic circumference/abdominal cir-
cumference ratio), in diagnosis and 
prognosis of pulmonary hypolasia re-
cent investigations and reports shows 
that diameter of MPA and pulmonary 
branches are related to the pulmonary 
hypoplasia. It is so difficult to measure 
PA at a particular interrogation angle. 
There is also low reproducibility when 
using this method. Fetal PA and PAB 
diameter measurement are a potential 
method for pulmonary hypolasia eval-
uation. In this study we concluded that 
the diameter of the left and right PB and 
the ratio PB and main PA in normal fe-
tuses, were increased linearly with ad-
vancing gestation. In fetuses with CDH 
the LPB diameter was significantly be-
low the normal range during the second 
half of pregnancy, whereas the RPB di-
ameter was around the lower limit of 
normal pregnancy.
In this study the MPA, LPB and RPB 
diameter was measured and the LPB/
MPA and RPB/MPA ratios were cal-
culated. In all normal fetuses these ra-
tios were constant during the gestation. 
MPA diameters, as good as RPB and 
LPB diameters in the babies with CDH 
were smaller than those in normal fe-
tuses but much smaller than those in 
baby who died. The explanation of those 
changes is that the blood flow in the 
LPB decreased due to pressure from the 
herniated viscera and was distributed 
through the ductus arteriosus to RPB, 
in fetuses with CDH. Recent investiga-
tions showed that increasing blood flow 
per unit area would cause injury to the 
pulmonary arterial wall, especially RPB, 
which would lose elasticity and those 
neonate would have persistent pulmo-
nary hypertension after birth.
After 38 weeks gestation in fetuses 
with left CDH, in both sided, the
distal pulmonary arterial wall be-
comes thicker. Also, the weight of the 
right lungs in left CDH is significantly 
smaller than in normal fetuses. This 
indicates that function would be af-
fected by both pulmonary sides, despite 
left CDH at third trimester of preg-
nancy which are in agreement with the 
measurements in our study. Also, the 
branch of PA diameters might become 
smaller in the case of prolonged pre-
term premature rupture of membrane 
or in Potter syndrome, which are lead-
ing to pulmonary hypoplasia.
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Concurrent Chemoradiation for Cervical Cancer: Results of 
Five Randomized Trials
Nermina Kantardzic
Background: Cervical cancer is the second most common cancer among women’s in Bosnia and Herzegovina. Most of these women’s in the time of diagnosis are with advanced disease. In the 1999 NCI issued a 
clinical alert, recommending that chemo radiation should be implemented as 
new treatment for these patients. Aim: To determine a survival, loco regional 
control and toxicity in patients with cervical carcinoma treated in Institute 
o Oncology from 2000-2006. Patients and methods: This is retrospective 
study. Data of five hundred and fourteen patients diagnosed as cervical 
cancer FIGO stage Ib, -IVb and presented in our institute, were analyzed. 
We treated 345 with combined chemo radiotherapy, 162 with radiotherapy 
alone and 7 patients with symptomatic therapy. In the follow up 134 patients 
were lost, so 373 patients were analyzed for survival, loco regional control 
and toxicity. Subgroup of 148 patients with advanced disease and grade of 
tumor unknown and 136 patients with known grade of tumor were compared 
for time to local progression, time to distant metastasis and time to death. 
Results: Median age in this group of patients was 52 (27-85). Of 514 patients 
492 were treated with curative intentions and 15 got palliative treatment. 
All treated patients finished their planed therapy. Follow up was from 6-78 
months, median 28 months. From 373 patients who were analyzed 65 died, 
progressions were observed in 77 patients. Acute toxicity G3/G4 experienced 
109 patients, and late toxicity G3/G4 8 patients. Patients with advanced 
disease and unknown grade of tumor cells had significantly shorter time to 
local progression, distant metastasis and death. Conclusion: The combined 
therapy for cervical cancer is the safe and good tolerated treatment. In the 
group of patients with advanced disease we observed 81% overall survival, 
55.9% disease free survival for median follow up of 28 months. . In the group 
of patients with early disease we observed 90% overall survival, and 78.8% 
disease free survival for median follow up of 28 months. There were no deaths 
caused by treatment. Key words: cervical cancer, chemotherapy, radiotherapy
Corresponding author: 
1. INTRODUCTION
In the United States alone, 11150 
women this year will be diagnosed with 
invasive cervical cancer. That is roughly 
30 females a day, every day, for a year, in 
America alone. About 3,870 women will 
die from cervical cancer in the United 
States during 2008. In the UK, over 
2,700 women are diagnosed with cervi-
cal cancer, and cause around 950 deaths 
each year in the UK. In the whole Eu-
rope around 50000 women will be diag-
nosed with cervical cancer, 25000 will 
die, and more important 175000 liv-
ing with cervical cancer in some stage 
of disease. (1)
Cervical cancer was once one of the 
most common causes of cancer death 
for American women. The cervical can-
cer death rate declined by 74% between 
1955 and 1992. The main reason for 
this change is the increased use of the 
Pap test. This screening procedure can 
find changes in the cervix before can-
cer develops. It can also find early cervi-
cal cancer in its most curable stage. The 
death rate from cervical cancer contin-
ues to decline by nearly 4% a year.
The burden of cervical cancer is par-
ticularly high across the whole of East-
ern Europe. The systematic screening 
for cervical cancer is not jet established 
in the most of Eastern Europe coun-
tries. The dramatic contrast between 
West and East European states merits 
particular attention from the health 
authorities of the countries concerned 
and the EU as a whole. (2)
The prognosis for patients with cer-
vical cancer is markedly affected by the 
extent of disease at the time of diagno-
sis. The current death rate is far higher 
than it should be and reflects that, even 
today, Pap smears are not done on ap-
proximately 33% of eligible women. 
Among the major factors that influ-
ence prognosis are stage, volume and 
grade of tumor, histological type, lym-
phatic spread, and vascular invasion. 
The 5-year relative survival rate for the 
earliest stage of invasive cervical can-
cer is 92%. The overall (all stages com-
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bined) 5-year survival rate for cervical 
cancer is about 72%. (3)
Cervical cancer is still very high in 
incidence among women’s in Bosnia 
and Herzegovina. Around 65% of pa-
tients in the time of diagnosis are with 
advanced disease. All of them who 
reach doctor are treated in Institute of 
Oncology in Sarajevo as the only insti-
tution with radiotherapy department in 
the whole country. (4)
Improvement of survival in patients 
with advanced cervical cancer was ev-
ident from year 2000. New standard 
therapy including concomitant chemo-
therapy and radiotherapy proposed by 
NCI in 1999 was main factor for this 
development. (5)
2. PATIENTS AND METHODS
This is retrospective study. We an-
alyzed records of all patients treated in 
Institute of oncology in Sarajevo from 
the year 2000 to 2006, diagnosed as in-
vasive cervical cancer. There were 514 
patients with histological diagnosis of 
cervical cancer.
Early disease- FIGO stage Ib and IIa 
had 114 patients and 400 were with ad-
vanced stage of disease.
Surgery with adjuvant radiother-
apy had 110 patients, 345 were treated 
with combined chemotherapy and ra-
diotherapy concomitantly, 52 with ra-
diotherapy alone and 7 with symptom-
atic therapy.
Radiation therapy
Radiation therapy was delivered 
with high-energy linear accelerator 
(Philips) from 2000 to 2005 and (Sie-
mens Primus plus) after, using 18 
MV photons at 2Gy/d, 5days/wk with 
no planned breaks. All patients were 
treated with using two–dimensional 
treatment planning (render plan). Bra-
chitherapy was delivered with Selctron- 
Nucletron LDR, and NTP planning or 
Gama Med plus-Varian HDR and ABA-
CUS planning. We used four field box 
techniques with AP+PA fields and two 
lateral fields, no central shielding, to TD 
45-50Gy. Brachytherapy was given on 
Selectron LDR after completing of ex-
ternal radiotherapy with two fractions 
of 15 Gy one week break, or on Gama 
Med plus HDR weekly one fraction of 
5 Gy to TD of 25 to 30 Gy, during and 
after external radiotherapy.
Chemotherapy
Chemotherapy was delivered as 
monochemotherapy weekly, during 
radio therapy, for five or six cycles, or 
polyhchemotherapy platinum based. 
Every week prior to cycle of chemother-
apy we check standard laboratory tests.
Majority of patients got cis-diam-
minedichloroplatinum 40 mg/m², and 
small group got cis-diamminedichloro-
platinum, gemcitabine, or 5 fluoroura-
cil or taxanes.
From the year 2000 to 2006 we ac-
cepted 514 patients with diagnosis of 
cervical cancer. The most of patients 
were between 40 to 60 years, median 
52. The most of patients were with ad-
vanced disease. The most of patients 
had squamous cell carcinoma.
The most of patients had G2 grade 
of tumor cells, but almost 50% of pa-
tients had no G of tumor cells. The most 
of patients had some kind of combined 
treatment (88.5%). The most of patients 
were treated with curative intentions.
The most of patients got standard 
monochemotherapy concomitantly 
with radiotherapy.
3. RESULTS
Follow up was from 6 to 78 months, 
median 28 months. In the first 2 years 
patients were looked at every 4 months, 
to fifth year every 6 months and to 10 
years once a year. We check standard 
laboratory analysis, gynecological exam 
and CT scan every year. We lost 134 pa-
tients in follow up mostly due to geo-
graphic distance and due to health care 
autonomy in different regions of Bosnia 
and Herzegovina. From 514 patients 7 
refused specific oncology therapy, so we 
analyzed 373 patients.
Most of patients had good response 
to treatment. Subgroup of patients with 
known G of tumor cells had better time 
of response in all categories.
Local progression (l.p.) had 19, dis-
tant (d.p.) 31 and both (l.p.+d.p.) 27 pa-
tients. Death occurred in 63 patients, 61 
Age 20-29 30-39 40-49 50-59 60-69 70-79 80-89
Patients 2 61 170 152 85 40 4
Percent 0.3 11.8 33 29.5 16.5 7.7 0.7
Table 1. Patients due to age.
Stage-FIGO Ib IIa IIb IIIa IIIb IVa IVb
Patients 109 5 264 1 124 8 3
Percent % 21.2 0.9 51.3 0.1 24.1 1.5 0.5
Table 2. Stage of disease.
PHD Squamous cell Adenocarcinoma Adenosquamous cell Other
Patients 461 37 9 7
Percent % 89.6 7.2 1.7 1.3
Table 3. Histology of patients
Grade G1 G2 G3 Gx
Patients 44 144 90 236
Percent % 8.5 28 17.5 45.9
Table 4. Distribution of patients due to grade of tumor
Treatment
Surgery and 
radiotherapy
Combined chemo- 
radiotherapy
Radiotherapy 
alone
Symptomatic 
therapy
Patients 110 345 52 7
Percent % 21.4 67.1 10.1 1.3
Table 5. Distribution of patients due to treatment
Radiotherapy Curative Palliative
Patients 492 15
Percent % 95.7 4.3
Table 6 Distribution of patients due to radiotherapy course
Response Complete response Stabile disease Progression
Number 234 62 77
Percent % 62.8 16.6 20.6
Table 7 Distribution of patients due to response
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due to cervical cancer and 2 for other 
reasons, and most of the deaths oc-
curred in the first two years of follow 
up (70%)
Metastases in two organs were 
found in 4 patients and 1 patient with 
metastasis in 3 organs.
Met a st a ses  were 
treated with radiother-
apy in 26 patients and 
chemotherapy in 32 pa-
tients. In 6 patients we 
performed just symp-
tomatic therapy due to 
poor ECOG status.
Toxicity
Acute toxicity mostly 
neutropenia G3/G4 ex-
perienced 109 patients, 
and they had pause in 
treatment for one to two 
weeks.
Late toxicity experi-
enced 14 patients (2.6%)
Necrosis of small 
bowls had 3 patients, 
recto–vaginal or ure-
thra–vaginal fistulas in 
4 patients and pallia-
tive surgeries were per-
formed for all of them.
Seven patients had edema in both 
legs, and symptomatic therapy was 
performed.
4. DISCUSSION
To evaluate results of our Institute 
and to compare with results of similar 
studies in literature is very important 
for us. In this way we can check our 
standard treatments and its efficacy.
With number of total population 
of about 3.5 million, according WHO/
ICO Information centre report for 2007 
number of new cases in Croatia (340), 
Slovenia (207), Serbia (1816) and in Bos-
nia and Herzegovina (500) shows that 
we had fewer patients then can be ex-
pected. In this study we treated about 
20 % of patients annually from the num-
ber we can expect.
This can be connected with poor or-
ganization of the oncology in the coun-
try, poverty of population, no organized 
screening for cervical cancer and still 
present shame of disease.
Peak of disease is between 40 to 60 
years of age which is consistent with 
other countries in the world. Distri-
bution of stage and histology of our 
patients are the same as in the other 
countries.
Presented data of 
grade of tumors cells 
shows us that around 
50% of patient’s grade 
was not known in the 
time of decision of treat-
ment. There are medi-
cal centers in the coun-
try where pathology is 
poor and not adequate to 
fulfill all requirements of modern on-
cology practice. This is one of impor-
tant points witch have to be discussed 
among executives in the planning of 
health care. Pathological diagnosis is 
one of the main prognostic factors in 
gynecological oncology and has to be 
further improved.
The most of our patients were 
treated with combined concomitant 
chemo radiation treatments, and with 
curative intentions, according to stan-
dard in the world.
Results of this study are consistent 
with reported results of other institu-
tions. Survival with no signs of disease 
was 62.7% for follow up of 28 months. 
(6, 7, 8)
Acute and late toxicity were as ex-
pected, and as reported in the most of 
literature. (9, 10, 11)
The most of deaths occurred in the 
first two years after the treatment, and 
none of it was caused by therapy.
5. CONCLUSIONS
 • In our Institute we treated 514 pa-
tients with invasive cervical can-
cer thru years 2000- 2006.
 • Median age of patients was 52 
years.
 • In 45, 9 % patient’s histological 
grade of tumors cells was not 
known.
 • Optimal standard therapy re-
ceived 88, 5 % patients.
 • Median follow up was 28 months.
 • Survival with no signs of disease 
was comparable with other simi-
lar studies in literature for this pe-
riod of time.
 • Time to recurrence, time to me-
tastasis and time to death was bet-
ter in the group of patients with 
known grade of tumor cells.
 • Late toxicity G3/4 was observed 
in 2.6% of patients, for this fol-
low up time.
 • No deaths occurred due to ther-
apy.
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The aim of the study was evaluation of residual deformity after neona-tal septic arthritis of the hip. The patient was operatively treated by intetertrochanteric osteotomy of valgisation of 350 with anterotation 
of 100 and extension 250 at age of nine years because of leg length discrep-
ancy, changes in the femoral neck, coxa vara, plana and breva. It was delay 
in diagnosis and failure to begin treatment promptly in the neonatal period. 
Delay in the diagnosis and the treatment of septic arthritis can result in di-
sastrous complication like in this case report. Key words: Septic arthritis of 
the hip, residual deformity and late treatment, intertrochanteric osteotomy
1. INTRODUCTION
The most serious complication of 
the septic arthritis of the hip in child-
hood and especially in newborns is 
the avascular necrosis of the femoral 
head which can lead to partial or com-
plete destruction of the capital femoral 
epiphysis, the growth plate or both. The 
sequelae of infantile septic arthritis and 
osteomyelitis of the hip are diverse and 
can include1:
 • Necrosis of the articular cartilage 
Premature closure of the triradi-
ate cartilage
 • Premature or asymmetrical clo-
sure of the capital femoral physis
 • Acetabular dysplasia
 • Lower-extremity length discrep-
ancy
 • Osteonecrosis
 • Pseudoarthrosis of the femoral 
neck, and
 • Complete destruction of the fem-
oral head and neck
The aim of the treatment of sequelae 
of neonatal septic arthritis of the hip is 
to preserve good relation between the 
femoral head and acetabulum. We are 
presenting a case of a boy aged twelve 
years, with coxa vara, plana et breve 
treated with corrective osteotomy of 
valgisation with anterotation. The in-
tertrochanteric osteotomy results also 
in local hyperemia, improved venous 
drainage, and remodeling of internal 
architecture.
2. CASE REPORT
On clinical examination, there was 
muscle wasting et the hip and thigh re-
gion. The patient has Duchenne-Tren-
delenburg limp and the Trendelenburg 
sign with flexion, rotational and adduc-
tion contracture of the left hip. Abduc-
tion and adduction was tested with pa-
tient supine. The Thomas test was pos-
itive and flexion deformity was 250, ab-
duction 200, adduction deformity of 250. 
Internal and external rotation was de-
termined with the patient prone. Inter-
nal rotation was limited of 200. Deter-
mination of leg length discrepancy was 
done with patient laying and standing, 
and the shortening was 3.8 cm. Mag-
netic Resonance Imaging (MRI) was 
not done because our hospital lacks the 
equipments. The residual deformity was 
classified with a radiological classifica-
tion system suggested by Choi at al.2. 
Our patient was grouped under Choi’s 
Type IIIA, with severe coxa vara angu-
lar deformity with retroversion but no 
pseudoarthrosis of the femoral neck. A 
boy aged ten years complained of pain-
less limp on the left hip. He had suffered 
septic arthritis of the left hip in the neo-
natal period. Intertrochanteric osteot-
omy was done with lateral approach to 
change the loading of the hip and to 
place the epiphyseal plate at right an-
gle to the resultant of the compressive 
forces. With this intertrochanteric os-
teotomy of valgisation of 350 with an-
terotation of 100 and extension 250 we 
achieved transferring the greater tro-
chanter distally and laterally so it is level 
with the center of the femoral head, re-
storing normal tension to the pelvitro-
chanteric muscles and improving their 
mechanical efficiency. With this proce-
dure we placed the superior end of the 
femur against the lateral aspect of the 
pelvis and also increased the distance 
between the tip of the trochanter and 
the center of the hip rotation, years old 
after op treatment.
3. DISCUSSION
Delay in diagnosis, failure to begin 
treatment promptly, and patient age less 
than 1 year are the most common rea-
son for late complication3,4. Early diag-
nosis and iniatiating immediate treat-
ment is vital for the therapeutic out-
come and long-term good prognosis. 
Septic arthritis of the hip is a common 
and rapidly destructive pyogenic infec-
tion in children and continues to be a 
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challenge despite improved antibiotic 
therapy because of the devastingely 
poor results when treatment fails or 
is begun late5,6. Acute septic arthritis 
represent e surgical emergency which 
demands early and vigorous treatment 
in order to preserve normal joint func-
tion7,8. Septic arthritis of the hip fre-
quently is associated with osteomyeli-
tis of the metaphysis of the proximal fe-
mur, since the capsule in the hip joint 
encompasses the metaphysis. In our 
case intetrochanteric femoral osteot-
omy increased the stability of the hip 
due to correction of the neck-shaft an-
gle. In this type of osteotomy the oper-
ation is extracapsular so the hip joint is 
not directly approached. A good under-
standing of natural history of sequelae 
of septic arthritis of the hip is essen-
tial to plan the best treatment. Our pa-
tient was grouped under Choi’s Type 
IIIA. The intertrochanteric osteotomy 
of valgisation of 350 with anterotation 
of 100 and extension 250 in our case has 
given a satisfactory result, improving 
the lower-extremity length discrepancy 
from 3.8 cm preoperatively to 1, 2 cm. 
and anatomic and functional relations. 
Postoperatively the pelvic drop (Tren-
delenburg gait) was reduce.
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Ecthymagangrenosum (EG)is a rare condition with characteristic clinical appearance of red maculae that progresses to a central area of necrosis surrounded by an erythematous halo. The most frequently it is caused 
byPseudomonas bacteriaemia in neutropenic patient. The authors presents 
a patient with acute myloblastic leukemia M4 type in whom in relapse EG 
caused byPseudomonas aeruginosa was found. The patient was treated with 
antibiotics and surgical debridement.The author wants to point out on clini-
cal significance this condition with high mortality rate. Key words: Ecthyma 
gangrenosum, acute myeloid leukemia
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1. INTRODUCTION
Ecthymagangrenosum (EG) is a rare 
cutaneous disease that is characterized 
with appearance of hemorrhagicbullaes 
that fastly evaluate into gangrenous ul-
cerations and they most commonly oc-
cur inimmunocompromised very of-
ten neutropenic patients. It is oftenly 
caused by bacteriaemia with Pseudo-
monas aeruginosa and it may be a first 
sign of Pseudomonas bacteriemia[1, 2]. 
Apart from P.aeruginosa EG can be 
caused even by other types of these bac-
teria[3, 4] or other bacteria like Staph-
ylococcus aureus, Seratiamarcenses, 
Escherichia colli andother [5-10]. Very 
rarely EG can appear even without bac-
teriaemia and extremely rarely it can 
be a complication of antibiotic therapy. 
This cutaneous disease appears mostly 
in hematologic, especially leukemic pa-
tients andothers who receive immuno-
suppressive drugs [11]. The risk of this 
complication is enlarged in immuno-
compromised or neutropenic patients 
and patients who receive corticoste-
roid therapy [1].
2. CASE REPORT
A 31-year old male presented in Sep-
tember 2006 with fatigue and malaise. 
On physical examination he had pete-
chial bleeding, splenomegaly 170x65 
mm and hepatomegaly 160 mm. Labo-
ratory data showed reduced hemoglo-
bin Hb70 g/l, platelet count 18x109/l, 
on days 1,2,3), WBC 100x109/l (differ-
ential formula myeloblasts 67%, my-
elocytes 3%, monocytes 18%, lympho-
cytes 12%).ESR 120 mm, prothrom-
bin time 105%, partial thromboplastin 
time 21,7 sec, fibrinogen 4,45 g/l. Bio-
chemical analyses of the blood were 
within normal limits. Bone marrow 
aspirate showed hypercellularity. As 
regards the blast cell morphology, the 
type I (<15 acidophilic granules in the 
cytoplasm) and type II (>15 acidophilic 
granules in the cytoplasm) blasts com-
prised 32% of the mononuclear cells, 
some with Auer rods. Some 20% of the 
blasts were of monoblastic morphology. 
The MPO stain was positive in 40% of 
blast cells. The immunophenotype of 
the blasts corresponded to AML-M4 
(HLA DR+, CD34+, CD33+, CD13+, 
CD11b+, CD14+, CD15+, MPO+) and 
glycophorin A-.Cytogenetic analysis 
showed normal karyotype 46XY. Induc-
tion chemotherapy was initiated with 
daunorubicin and cytosine-arabinoside. 
A complete remission was achieved 
and consolidation therapy according 
to MRC AML 10 protocol was admi-
nistered. Four months later, the patient 
developed speech difficultie and relpse 
of acute leukemia with signs of central 
nervous system involvement(cephalea, 
nausea, visual disturbances, synkopa) 
was diagnosed. Physical examination 
showed again hepatosplenomegaly and 
dysphasia. Laboratory date: Hemoglo-
bin was normal 13 g/l, WBC 2,1x109/l, 
platelets 34x109/l (9% of blasts in DLF). 
Bone marrow aspirate showed hyper-
celullarity with 70% of myelomono-
blasts, some of which were myeloper-
oxidase positive. Cytogenetic exami-
nation revealed again a normal male 
karyotype, 46XY. In cerebrospinal fluid 
there was a number myeloblast (109/
mm3). Ophtalmologic examination of 
fundus oculi showed papilla stagnans 
with massive haemorrhages. As it had 
been shown that it was the relapse of 
leukemia in bone marrow and CNS he 
was treated according to Archimbaud 
protocol for relapse with cytosinarabi-
noside 1000mg i.v. in conitinuosly infu-
sion from day 1 to day 3 and days 8 to 
10, novantrone 20 mg from day 1 to 3. 
and etoposide 400 mg i.v. in conitinu-
ous infusion from 8 to 10 days. He was 
treated with intratechal application of 
citosine arabinoside and depo-medrool 
(12 injections). After this he developed 
365MED ARH 2010; 64(6) • CASE REPORT
Ecthyma Gangrenosum In a Patient With Acute Leukemia
aplasia, high temperature in which pe-
riod he was treated with antibiotics and 
G-CSF. His condition improved but in 
ingiunal region appeared deep necro-
ses (Fig. 1.). From the necrotic surfaces 
taken material in cultures Pseudomonas 
aeruginosa was isolated. He was treted 
with imipenem, ciprofloxacin and sur-
gical debridement with signs of local 
improvement. Unfortunately he he is 
still in partial remission with signs of 
CNS leukemia.
3. DISCUSSION
It is known that patients with long 
hospitalization and the ones who re-
ceive antibiotics have more Pseudo-
monas aeruginosa on their skin com-
paring to the healthy persons in gen-
eral population. In the states of dimin-
ished immunity and eventual neutrope-
nia microorganisms enter the body in 
the spots of microerrosions especially 
over intravenous and urinary cathe-
ters, decubital ulcerations and thermic 
damages[1].
EG appears in up to 30% patients 
with septicemia caused by Pseudomo-
nas aeruginosa[12]. Appearance of skin 
lesions often precede high temperature, 
chill and fever, erythematousmaculaes, 
fast evaluate into big bullaes and pus-
tules and after that appears the necro-
sis of epiderm and derm. EG also can 
be accompanied by systemic vasculi-
tis. It is assumed that necrosis of the 
skin is caused with Pseudomonas elas-
tase which destroys elastic lamina of the 
blood vessels which allows for libera-
tionof the bacilli into the subcutaneous 
tissues[11]. The proliferation and mul-
tiplication of the bacte-
ria in the tissue cause 
liberation of exotoxinA 
and proteases leads to 
theulcerative lesions 
which is characterized 
by hemorrhage, encir-
cled by a rim of reac-
tive erythema.Epiderm 
sometimes separates 
from the dermis, der-
mis become indurate, 
gains grey metal colo-
rand become indurat-
edulcurs around which 
the skin is red. Ulcer-
ations are usually sen-
sitive on palpation [1, 4].
The commonest site of involvement 
is the gluteal or perineal region, in ax-
illas, and sometimes on the lips and 
tongue[1, 5]. Gluteal and perineal region 
are involved in more then 50% of pa-
tients[12]. Solitary skin lesion has bet-
ter prognosis then multiple ones.
The diagnosis of EG is easy. It is most 
important to think about this dermato-
logical disease when these symptoms 
appear in immunocompromised or he-
matologic patient, other patients that 
have received cytotoxic drugs that made 
them neutropenic what was the case in 
our patient. The microorganism can be 
proved and diagnosed either by hemo-
culture and/or by culture of the tissue 
taken from the wall of the ulceration or 
ulceration itself [1, 8].
The result of bacteria culture is not 
to be waited for but should immediately 
be started with antibiotic therapy effica-
cious to Pseudomonasaeruginosa as the 
most frequent cause and the ulcerations 
should be surgically treated (surgical 
debridement should be done). Antibi-
otic should be changed after the result 
of antibiogram if the antibiogram shows 
some other microorganism. Very useful 
is the nutrition support of the patient[4].
In the case of failure of antibiotic 
therapy in the literature the authors 
have used the granulocyte colony-stim-
ulating factor (Neupogen). EG should 
be understood as a very serious and 
life-threatening systemic infection. The 
poor prognosis is caused by delay of the 
diagnosis and treatment, which results 
in delay of application adequate antibi-
otic therapy.
Clinicians should be aware of the 
skin manifestations of EG to avoid fatal 
septicemia in neutropenic patients[15]. 
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Introduction: In the present study we report 36 cases of anterior encepha-loceles treated at Clinic of Neurosurgery in the University Clinical Center of Kosova over a 24 year period. Materials and methods: All 36 children 
were included in this retrospective study ( 1986 through 2009). Their ages 
ranged from 1 day to 10 years (mean 13 months); 20 were boys and 16 were 
girls. The commonest type of anomaly seen was nasofrontal 17 patients, 12 
nasoethmoidal , and 7 nasoorbital. The size of the lesion varied from 2.5cm 
to 28 cm. Hypertelorism occurred in 12 patients. Hydrocephalus was present 
in 11 patients and in 8 of them was progressive. Results: 1 patient died on 
10th postoperative day due to fulminant meningitis. Cosmetic results were 
judged from parents as excellent in 16 patients, good in 12 patients, average 
in 6 patients and poor in 2 patients. None of patients were lost to follow-up. 
Discussion:  Histologic examination of the herniated tissue can vary between 
normal brain to fibrous atrophic nonviable tissue (4). No familial cases have 
been reported in the literature , we also have similar experience. In our study 
we have found that the prevalence is higher among patients coming from rural 
parts of our country with pore living conditions, malnutrition and so on . We 
have avoided surgery in very young children until body weight is around 5-6 
kg because of complication from blood lose and hypothermia. Conclusion: 
The aim of treatment is early removal of the meningoencephalocele to allow 
normal growth forces to be re-established. In patients with hypertelorism, 
correction surgery is done in the same session. If hydrocephalus is not treated 
before corrective surgery for encephalocele, the risk of postoperative CSF 
is very high. With one stage surgery excellent results can be achieved. Key 
words: Anterior encephaloceles, craniofacial malforma-
tions, pediatric neurosurgery, sincipital encephalocele.
Corresponding author: prof Arsim Morina,MD, PhD. University Clinical Center of Kosova, Clinic of 
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1. INTRODUCTION
Anterior encephaloceles are con-
genital herniations of cranial con-
tents through a defect in the skull 
(1,2,3,4,5,6,7,8,9,10). Encephaloceles 
commonly are present in the midline 
sagittal axis of the cranium from the 
nasofrontal region to the occiput (11,1
2,13,14,15,16,17,18,19,20). Anterior en-
cephalocele is classified accord-
ing to its location as sincipital and 
basal and according to its content 
in meningoencephalocele and me-
ningocele. Sincipital encephalocele 
are again subdivided into 3 types 
: nasofrontal, nasoethmoidal, and 
nasoorbital (21). The size of the 
lesion may vary from a barely no-
ticeable mass to lesions larger than the 
patient’s head (1). Although now rare in 
Europe and North America, this mal-
formation continuous to be seen fre-
quently in southeast Asia (15,17) and 
its cause are still debated (15,17,22). In 
the present study we report 36 cases 
of anterior encephaloceles treated at 
Clinic of Neurosurgery in the Univer-
sity Clinical Center of Kosova over a 24 
year period.
2. MATERIAL AND METHODS
2.1.  Clinical feature
All 36 children were included in 
this retrospective study (1986 through 
2009). Their ages ranged from 1 day to 
10 years (mean 13 months) ; 20 were 
boys and 16 were girls, with no signifi-
cant difference by gender (X2-test =0.44, 
P>0.05), (Table 1). For testing of the data 
we have used X2-test with significant 
level P<0.05 or P<0.01.
2.2. Radiology 
CT scans were obtained in all cases. 
In 27 of them it was performed 3D re-
construction of the skull. Hydroceph-
alus was present in 11 patients in 7 
of them cerebral index was less than 
2.2cm. 2 patients had corpus callosum 
agenesis.
2.3. Operative procedure
N (%) P-value
Gender
Male 20 (55.6%) P= 0.505
X2-test=0.44Female 16 (44.4%)
Age
Mean ± SD 13 month (± 7 month)
Rank 1 day to 10 years
Table 1. Main characteristic of patients
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One patient was precluded from 
surgery because of severe mental retar-
dation. 35 patients underwent surgical 
reconstruction, 8 patients underwent 
ventriculo peritoneal shunt medium 
pressure before corrective surgery. 5 
cases underwent extracranial repair 
alone. Transcranial approach was done 
in 31 patient. Surgical incisions include 
a bicoronal scalp flap, giving wide expo-
sure of the craniofascial skeleton . Bilat-
eral frontal craniotomy was performed 
were bone was removed as a free graft. 
After the elevation of frontal lobe the 
herniated brain was clearly seen. The 
dura was opened and the cerebral her-
niation inspected. Herniated brain in 
majority of cases consists of gliotic non-
functional neural tissue and was apir-
ated. Bone defect was closed with bone 
graft that was taken from cranium. In 
12 patients osteotomies are performed 
to translocate the orbit medially.
3. RESULTS
The commonest type of anomaly 
seen was nasofrontal 17 patients, 12 
nasoethmoidal, and 7 nasoorbital, with 
no significant difference by localization 
(X2-test =4.167, P>0.05). The size of the 
lesion varied from 2.5cm to 28 cm. In 
9 patients the contents were cystic in 7 
of them when baby cried pulsation was 
felt over the swelling, 27 cases the con-
tents were a mixture of solid and cys-
tic mass with significant difference by 
content (X2-test =9, P<0.01) 
(Table 2). Hypertelorism oc-
curred in 12 patients. Hydro-
cephalus was present in 11 
patients and in 8 of them was 
progressive. In 32 patients 
the skin coverage was com-
plete and in 4 cases thin layer 
of epidermis was covering 
the lesion. In 1 case the le-
sion was extremely large and 
trampled on the nose and 
eyes, causing severe difficulties with 
breathing and vision because of this 
required urgent operative treatment. 
The average paternal age was 28,2 years. 
Consanguinity was reported in 1 family. 
There was no family history of other en-
cephaloceles or any neural tube defect. 
In 3 cases epileptic seizures were pres-
ent. From 36 children 3 of them were 
going to school before the surgery and 
2 of them reported teasing from other 
children. Other congenital anomalies 
like cleft palate, cleft clip, absence of 
nostril, microphtalmia, syndactyly were 
noted in 1 patient each. 34 patients who 
underwent correction survived the op-
eration. Immediate postoperative CSF 
leak through the skin was observed in 
1 patient which required tighter skin 
closure and a tight head bandage. In 
1 patient bone flap osteomyelitis was 
observed she underwent repeated sur-
gery and received antibiotic therapy un-
til the infection heald completely dhe 
cause was: Pseudomonas aeuroginosa. 
1 patient died on 10th postoperative day 
due to fulminant meningitis. In spite of 
anticonvulsant therapy 1 children con-
tinue to seize even after 8 years follow-
ing surgery. Nasolacrimal dysfunction 
usually persisted postoperatively. Cos-
metic results were judged from parents 
as excellent in 16 patients, good in 12 
patients, average in 6 patients and poor 
in 2 patients. None of patients were lost 
to follow-up.
4. DISCCUSION
Anterior encephaloceles are com-
mon in many southeast Asian countries 
such as Burma (19,23), Thailand (14,18), 
Cambodia (11), Malaysia (13),  and In-
donesia (12). In Thailand, it has been 
shown that frontoethmoidal MECs oc-
cur in one of 5000 to 6000 live births 
(14,18). A few authors have described 
these deformities in Australian aborig-
inal people (13), and in some patients in 
African countries (3), and in India and 
Pakistan (9,10). This lesion are rare in 
North America, Japan and Wester Eu-
rope. Till date, the exact etiology is not 
known, although various hypotheses 
have been proposed (5,6). Currently, 
two schools of thought exist regarding 
the origin of these lesions. The first con-
cept involves the point of weakness in 
the facial skeleton. The frontal bone is a 
membranous bone that forms from the 
underlying dura, whereas the ethmoid 
bone developes from endochondral 
bone formation. The function of the 
membranous and endochondral bone 
(foramen cecum is thought to result in 
a week area through which the neural 
elements can hernaite (2,7). A second 
Figure 1. Clinical photograph of an one month 
boy with gigantic meningoencephalocele.
Figure 2. Cranial CT, axial cut of same child.
Figure 4. Two months after surgery.Figure 3. Intraoperative picture from extracranial 
part of surgery.
N (%) P-value
Type of anomaly
Nasofrontal 17 (47.2%)
P=0.124
X2-test = 4.167
Nasoethmoidal 12 (33.3%)
Nasoorbital 7 (19.4%)
Size of lezion 2.5 cm–28 cm
Content
Cystic 9 (25.0%) P= 0.002
X2-test= 9Mixture (solid and cystic) 27 (75.0%)
Table 2. Characteristics of Anterior Encephaloceles
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hypothesis states that a delayed clo-
sure of the neural tube ultimately pre-
vents normal union of the facial bone 
(8). Findings of a trapped meningocele 
and peripheral nerve elements, as well 
as isolated neural tissue remnants along 
the original tract appear to substanti-
ate this second theory. However, the 
fact that most anterior encephaloceles 
are covered with normal skin indicates 
that these defects are not simply a fail-
ure of neuraltion. Thus, the precise eti-
ology of these lesions remains specula-
tive. Histologic examination of the her-
niated tissue can vary between normal 
brain to fibrous atrophic nonviable tis-
sue (4). No familial cases have been re-
ported in the literature, we also have 
similar experience. Suwanwela (16) de-
scribed a pair of identical twins where 
1 twin was not affected, concluding 
that a genetic mechanism was not the 
primary cause. Other theories have in-
cluded a simple vitamin deficiency how-
ever, Kyu and Thu (18), in a large series 
in Burma, revealed that over half of the 
mothers of (16); affected children were 
on vitamins during their pregnancy. In 
our study we have found that the preva-
lence is higher among patients coming 
from rural parts of our country with 
pore living conditions, malnutrition 
and so on . We have avoided surgery in 
very young children until body weight 
is around 5-6 kg because of complica-
tion from blood lose and hypothermia.
5. CONCLUSIONS
In a country such as Kosova, the 
treatment of specific disease processes 
must be adapted to fit current local con-
ditions. The development of low-cost 
procedures is very important. Three-
dimensional CT scan has been a ma-
jor improvement in investigation of de-
fects in craniofacial skeleton. The aim 
of treatment is early removal of the me-
ningoencephalocele to allow normal 
growth forces to be re-established. In 
patients with hypertelorism, correction 
surgery is done in the same session. If 
hydrocephalus is not treated before cor-
rective surgery for encephalocele, the 
risk of postoperative CSF is very high. 
With one stage surgery excellent results 
can be achieved.
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Epiphrenic Diverticulum as a Rare Cause of Dysphagia
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Epiphrenic diverticulum is a rare condition which produces disphagic problems. It occurs in one fifth of the total number of patients with esophageal diverticula. It is often associated with motility disorders 
such as hypertensive lower esophageal sphincter, achalasia and diffuse 
esophageal spasm. Increased intraluminal pressure is responsible for the 
prolapse of mucosa and submucosa through the muscle layer, and the con-
sequently formation bag extensions (diverticula). We presented 55 year old 
female patient who had dysphagia, regurgitation and chest pain caused by 
retrosternal epiphrenic diverticulum who has successfully operated in our 
clinic. We performed open approach (left thoracotomy), and complex surgery: 
diverticulectomy, long esophagomyotomy and antireflux procedure (Belsey 
Mark IV). After 4 years patient is without symptoms of disphagia and in a 
good nuitrition. Key words: Epiphrenic diverticulum, surgical treatment
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1. INTRODUCTION
Epiphrenic diverticula are acquired 
protrusion of mucosa through the mus-
cular wall of the distal esophagus. Most 
of them are associated with underly-
ing esophageal motility disorders. The 
cause of their is motor dysfunction of 
the esophagus (diffuse spasm or acha-
lasia). Elevated intraluminal pressure 
is responsible for the prolapse of mu-
cosa and submucosa through the mus-
cle layer and the consequent formation 
bag extensions (diverticula) (1,2).
The predominant symptoms is the 
dysphagia and regurgitation, and may 
occur retrosternal pain, if it is accom-
panied by spasm of the esophagus. Hal-
itosis (foetor ex ore) due to undigested 
food is expressed in a lesser degree than 
Zenker’s diverticulum. In some patients 
disease is asymptomatic and discovered 
as incidental findings on chest radiog-
raphy. Simptoms is sometimes difficult 
to distinguish from other functional 
esophageal disorders (diffuse esoph-
ageal spasm, achalasia, hiatal hernia 
or reflux esophagitis), and can some-
times mask a picture of esophageal neo-
plasms. Size varies from small ones who 
empted spontaneously and does not 
constitute a big problem, to big ones 
that its size can be to perform compres-
sion on the esophagus and cause dys-
phagia (1,2,3).
Diagnosis is possible to set by con-
trast radiography, endoscopy and 
esophageal manometry.
Asymptomatic patients with a small 
diverticulum and a wide communica-
tions with the lumen of the esophagus, 
empted spontaneously and does not re-
quire any treatment. Progressive dys-
phagia, chest pain, increasing the diver-
ticulum which is not empted spontane-
ously, is indication for surgical therapy. 
Complexity of the surgical procedure 
is that it consists from 3 phases: diver-
ticulectomy long esophagomyotomy 
and transthoracic antireflux procedure 
(modified Belsey Mark IV) (4,5,7,8,9).
2. CASE REPORT
In our clinic since 2002 a total of 
30 patients with benign causes of dys-
phagia had syrgery (functional disor-
ders and diverticula). Only in one case 
the cause of dysphagia was epiphrenic 
diverticulum.
Patient, 55 year old female had dys-
phagia, regurgitation and chest pain 
caused by retrosternalni epiphrenic di-
verticula. Our patient had a diverticu-
lum, which led to the development of 
progressive dysphagia, regurgitation, 
night cough due to retention of undi-
gested food and aspiration. Dysphagia 
developed slowly and led to loss of body 
weight and avoid eating. The diagnosis 
was establish a year ago when the size by 
the X ray examination, radiography and 
Figure 1. 
Figure 2. 
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CT scan was approximately 7 cm, but 
the patient has not adopted for surgical 
treatment. The pains were intensified, 
so that the size of the diverticulum in 
the surgery time was 9 cm in diameter 
(Figure 1). Left thoracotomy approaches 
for the distal thoracic esophagus is ap-
ply who mobilisises and with preser-
vation vagal nerv branches (Figure 2).
After the preparation and presenta-
tion of diverticular sack, the same pre-
parated carefully, making sure not to 
break the parietal pleura, than divertic-
ulum is removed by mechanical sewing 
(TA-60, 4.8 mm stapling device), per-
formed a long infraaortal myotomy on 
the contralateral side of the mouth of 
the diverticulum, and added antireflux 
procedure (modified Belsey Mark IV) 
(Figure 3 and 4).
Early postoperative course was sat-
isfied. Contrast radiography after 6 and 
12 months showed normal findings, and 
the patient has no symptoms, with nor-
mal body weight (Figure 5).
Histopathologic analysis confirmed 
the presence of leyomioma in the diver-
ticular sack.
3. DISCUSSION
Functional obstruction due to mo-
tility disorders resulting intraesopha-
geal increasing pressure, and this is the 
impetus for the development pulsion 
diverticula. Epiphrenic diverticulum 
is generally associated with support-
ing a motor disorder that is considered 
the cause of diverticula (1,2,3). More 
than 30-40% of epiphrenic diverticula 
are asymptomatic. The main symptoms 
are dysphagia, regurgitation or vomit-
ing, chest pain and weight loss. Night 
cough, pneumonia and laryngitis may 
develop secondarily due to aspiration 
of undigested food (4,5).
Diagnosis of diverticula is estab-
lish by chest radiography with barium, 
upper gastrointestinal endoscopy, ma-
nometry and computerized tomog-
raphy (CT scan). However, most epi-
phrenic diverticula were incidentally 
diagnosed. The native chest radiogra-
phy shows the level of shading in the 
middle part of the posterior mediasti-
num. Barium radiography was the pri-
mary modality in the diagnosis epi-
phrenic diverticula. Endoscopy helps 
to exclude other abnormalities of the 
esophagus. Stationary manometric ex-
amination of the esophagus is usually 
indicated regarding diagnostic motility 
disorders that may affect the decision 
on the modality of treatment. Clinical 
manifestations are unpredictable and 
not correlated with the size of the diver-
ticula, but are correlated with primary 
motility disorders (6,7). Dysphagia and 
regurgitation are the dominant symp-
toms, and respiratory symptoms, when 
present, indicate complicated disease. 
CT indicates the differentiation of di-
verticula from mediastinal abscess, tu-
mor or even a hiatus hernia. Epiphrenic 
diverticulum usually appears on CT as 
a structure with thin walls, filled with 
air or air-fluid collection in communi-
cation with the lumen of the esopha-
gus. However, diverticula are associ-
ated with distal esophageal obstruc-
tion may remain in a state of contrac-
tion and may therefore be invisible to 
CT (7.8). Asymptomatic patients should 
be treated conservatively. Symptomatic 
patients should undergo surgical treat-
ment. Surgical options include diver-
ticulectomy, long myotomy and anti-
reflux procedure (according to the re-
sults of manometry) (8). More recently, 
thoracoscopy, minimally invasive pro-
cedure and endoscopic procedures are 
become popular in the treatment of di-
verticular disease, but open approach 
only provides to handle all aspects of 
the disease (9,10).
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Tuberculosis is a leading cause of massive pericardial effusion and tamponade especially in underdeveloped and developing countries. Hypothyroidism is also associated with pericardial effusion with rare 
progression to tamponade. We present a case of pericardial tamponade 
who diagnosed as both tuberculosis and myxedema at admission. Urgent 
pericardiocentesis performed as an initial therapy and four-agents antitu-
berculous and thyroxine replacement therapy started immediately as long 
term management. Coexistance of tuberculosis and myxedema is a rare 
condition and they can cause tamponade formation with synergistic effect. 
Such a additive etiologies of pericardial tamponade have not been reported.
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1. INTRODUCTION
Cardiac tamponade i a life-threat-
ening condition that may occur after 
any cause of pericardial effusions with 
variable incidence. Malignant diseases 
are the most frequent causes of peri-
cardial tamponade. Especially in de-
veloping countries, tuberculosis (tbc) is 
still primary cause of massive pericar-
dial effusion and tamponade (1) . Here, 
we presented a case of pericardial ef-
fusion and tamponade due to tbc and 
myxedema. Tbc and myxedema both 
was contributed to development of ef-
fusion and progression to tamponade. 
Such a case has never reported before 
in the literature.
2. CASE REPORT
A 45-year-old woman was admit-
ted to emergency service with a com-
plaints of shortness of breath, wekness 
and malaise. She defined progressive 
dyspnea for 2 years. There was prom-
inent deteriotion of symptoms within 
last 2 weeks. 2 day before presentation, 
she applicated to another emergency 
service of public hospital. Anemia and 
cardiomegaly on chest x-ray was ob-
tained. She was directed to outpatient 
clinic for further investigation. On ad-
mission, she was looked pale and le-
thargic; tachypnea and tachcardia was 
present. Her blood pressure was 60/40 
mmHg. Heart rate was 130/minute and 
pulses was filiform. There was bilateral 
crackles in the bottom of lungs. Heart 
sounds heard deeply on chest auscul-
tation. There was 2+ bilateral pretib-
ial edema. Hemogram showed a mild 
anemia (hb-9.5 g/dl, hct:27.1 % ) in nor-
mochrome nature. Sedimantation rate 
was 70/ a hour and creatine level vas 0.9 
mg/dl. Electrocardiography showed si-
nusal tachycardia and low QRS voltage. 
İmmediate transthoracic echocardiog-
raphy revealed pericardial effusions 
with tamponade physiology. Effusions 
was surrounding all around the heart 
and its thickness reaching 3.3 posteri-
orly and 2.5 cm from apical segment. 
Fibrinoid structure was observed in 
the discrete part of fluids. There was 
marked compression to the whole heart 
and collapses of both right atrium and 
right ventricle. Ejection fraction of left 
ventricle was normal. Then pericardi-
ocentesis was performed. 850 cc hem-
orrhagic fluid was aspirated. Samples 
from the pericardial fluid were pre-
pared for biochemical, microbiologic, 
and pathologic examinations. After 
pericardiocentesis, signs of respiratory 
distress resolved, arterial blood pres-
sure and heart beats came back to nor-
mal levels. İndomethacin 3*25 mg was 
begun as a first treatment. Biochemical 
analysis of fluid show exudative peri-
cardial effusion. Although there was 
not any proliferation of mycobacterium 
tuberculosis on culture, adenosine de-
aminase (ADA) level found as 59.4 u/l. 
Biochemical analysis of pericardial flu-
ids also show higher levels of choles-
terol (total cholesterol: 189 mg/dl; nor-
mal range:<60 mg/dl) Thyroid function 
test showed deep hypothroidism. Se-
rum free T4was lower than 0.30 ng/dl 
(normal range:0.8-2.0 ng/dl), and TSH 
was 0.693 IU/ml (normal range:0.3-4.5 
IU/ml). On anamnesis, patient also de-
scribed menstrual irregularity for 2 
years. LH and FSH levels also checked 
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for hypophyseal insuffiency. Serum LH 
was 0.562 mIU/ml and FSH was 0.882 
mIU/ml; both was decreased (normal 
ranges for LH:1.1-14.7 and FSH:1.2-9 
mIU/ml). Cranial MRI showed partial 
empty sella with thinning of hypopyh-
sis. Hypothyroidism tought to had de-
veloped secondary to hypophyseal in-
sufficiency. Thyroxine was begun for 
hypothyroidism. 24 hours later, patient 
dicharged from hospital with a treat-
ment of 4 agent-combination antitu-
berculous, tyroxine and indomethacine. 
7-day control echocardiography showed 
minimal pericardial effusion.
3. DISCUSSION
Massive pericardial effusions most 
commonly associated with neoplastic 
diseases, tbc, renal failure and myx-
edema. Up to one-third of patients 
with asymptomatic large pericardial 
effusions develop unexpected cardiac 
tamponate (2) . Tbc induced pericar-
dial effusions mostly seen in developing 
countries and immune-compromised 
patient. Progression to tamponade can 
be seen up to two-third of patient and 
mortality approaches 85 % without 
treatment. Tbc pericarditis and peri-
cardial effusions may be seen in 1-8 % 
of pulmonary tbc cases (3). Exact diag-
nosis of tuberculous pericarditis can be 
made with identification of mycobacte-
rium tuberculosis from the pericardial 
tissue or fluid cultures or histopatho-
logic demonstration of granulomas or 
acid-fast bacilli in the pericardial tissue. 
It is difficult to isolate mycobacterium 
species from pericardial fluid samples 
and only one-third of them are diagnos-
tic. ADA is a white blood cell-mediated 
enzyme and increases of its level in the 
pericardial fluid enhance the diagnos-
tic accuracy. In a prospective study, it 
was reported that ADA levels higher 
than 40 U/l had a sensitivity of 93%, 
and specificity of 97% for the diagnosis 
of tbc (3). If ADA levels are found to be 
higher than 70 u/l, tbc diagnosis can be 
made with 100 % sensitivity and 97 % 
specificity. Therefore, in case of any sus-
picion, pericardial fluid levels of ADA 
must be determined. In our case, fluid 
culture result was negative. Tbc diag-
nosis made according to higher ADA 
level. It was 59.4 u/l which prominently 
higher than cut-off level.
In hypothyroidism, large effusions 
can occur in 5-30 % of patient. But, 
proggression to tamponade occurs 
rarely (4). Fluids accumulates slowly 
and also with treatment effusions de-
creases in a longer time period. Mech-
anism for accumulation of pericardial 
fluids proposed as increased capillary 
permeability and subsequent leakage 
of fluid high in protein into the intersti-
tial space, impaired lymphatic drainage, 
and a greater retention of salt and wa-
ter (5). Cholesterol levels are typically 
higher in the hypothyroidism induced 
pericardial effusion fluids. Higher cho-
lesterol level in the aspirated fluids also 
indicate the role of hypothroidism in 
presented patient.
In our case, hypothyroidism seem 
to be first triggering factor for devel-
opment of pericardial effusion. Patients 
complaint date back to 2 years ago. İt 
indicate that patient had undiagnosed 
hypothyroidism up to 2 years. Such a 
time period is sufficient for slow prog-
gression of massive pericardial effu-
sion. Most probably advancement of tbc 
turned up the clinical picture to tam-
ponade suddenly.
4. CONCLUSION
Myxedema can cause pericardial ef-
fusions up to 30% of patients. Although 
cardiac tamponade is a rare condition, 
with occurance of comorbid diseases, 
such as tbc; tamponade can ocur in a 
rapid manner. Mortality rate is higher 
in such concominant etiology induced 
pericardial tamponade. İmmediate 
pericardiocentesis save up the patient 
life and longer and close follow up of pa-
tient can prevent reoccurance of peri-
carial effusions and tamponade.
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Background: Cholecystoduodenal fistula (CD) is a rare complication of gallstone disease. Laparoscopic stapling techniques have been reported as feasible methods for treating this fistula, however these procedures 
are not always performed successfully. We have reported five cases of CD 
diagnosed intraoperatively, managed successfully by laparoscopic approach. 
Materials and methods During the 3-year period, from 2007 to 2009, 1500 
patients underwent LC for gallstone desease, five of them (3.3%), who pre-
sented with classic symptoms of symptomatic chole-lithiasis, intraoperatively 
CD were found. Data were collected on patients’ age, sex, pre-operative 
diagnoses, operative methods, morbidity and management. Laparoscopic 
surgery was performed using the standard three trocars technique. Results All 
patients were females, 67 years old on average. They had gallstones detected 
by abdo-minal ultrasound, but CD’s were found during operative treatment 
of gallstones. In three cases CD was completely mobilized with a combina-
tion of blunt and sharp dissection and divided using the endoscopic linear 
stapling device. In the other two cases after division of the cystic duct and 
artery the gallbladder was dissected from the liver bed, leaving just the fistu-
lous connection to the duodenum. Then division of the fistula was completed 
using the same stapling device. All five patients had uneventful postoperative 
course. The hospital stay of five patients ranged from 5 do 10 days (median 
6 days). Conclusion CD does not preclude a laparoscopic approach. With 
more experience and improved techniques, most of these cases could be 
performed laparoscopically, with all of the advan-tages of minimally invasive 
surgery. Key words: Cholecystoduodenal fistula, laparoscopic treatment.
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1. INTRODUCTION
Enterobiliary fistulae are a rare 
complication of biliary tract disease. 
Cholecystoduodenal fistulae (CD) are 
most frequently encountered, com-
prising 75-80% of all such fistulae (1). 
In 90% of cases CD is a complication of 
gallstone disease, but it can be related to 
peptic ulcer or neoplasia (2). The symp-
toms of CD are nonspecific, and often 
resemble those due to sympto-matic 
cholelithiasis, unless a gallstone ileus 
is encountered. Laparoscopic stapling 
techniques have been reported as fea-
sible and safe methods for treating this 
fistula (2,3). However, these procedures 
are not always performed successfully. 
We have reported five cases of CD diag-
nosed intraoperatively, managed suc-
cessfully by laparoscopic approach due 
to experienced laparoscopic surgeons.
2. MATERIALS AND METHODS
From January 2007 to December 
2009, 1500 patients underwent LC for 
gallstone desease at the Department 
of surgery, County hospital Slavon-
ski Brod, Croatia. Five (0,1%) of them, 
who presented with classic symptoms 
of symptomatic cholelithiasis, intraop-
eratively CD were found. CD was de-
fined as an abnormal communication 
between gallbladder and duodenum. 
This study retrospectively reviewed the 
medical records of these five patients. 
Data were collected on patients’ age, 
sex, preoperative diagnoses, operative 
methods, morbidity and management.
Surgery was performed under gen-
eral anesthesia using the standard three 
trocars technique.
In one patient ultrasound revealed 
dilated intrahepatic and extrahepatic 
ducts with gallbladder calculi. She also 
had elevated hepatic transaminases. 
She underwent a laparoscopy and a 
chole-cystoduodenal fistula was re-
vealed. The closure of the fistula was 
performed with the use of an endo-
scopic linear stapling device (ELC 35, 
blue firing, ETHICON), but because of 
the unclear anatomy in Calot’s triangle 
and a very dilated common bile duct 
(CBD) it had to be converted to laparot-
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omy. Exploration of CBD showed a large 
stone which was extracted and chole-
cystectomy was performed. The post-
operative course was uneventful and 
a normal T-tube cholangiogram was 
demonstrated on postoperative day 10.
In the other four patients, ultra-
sound revealed contracted gallbladder 
with stones. In each case laboratory 
findings were normal. Laparoscopy re-
vealed a cholecystoduodenal fistula in 
each case. In two cases, cholecystoduo-
denal fistula was completely mobilized 
with a combination of blunt and sharp 
dissection. The fistula was divided us-
ing the endoscopic linear stapling de-
vice (Figure 1). After fistula occlusion 
the cholecystectomy was completed in 
the usual manner.
In the other two cases after division 
of the cystic duct and artery the gall-
bladder was dissected from the liver 
bed, leaving just the fistulous connec-
tion to the duodenum (Figure 2). The di-
vision of the fistula was then completed 
using the same stapling device.
3. RESULTS
All patients were females, 67 years 
old on average. They had gallstones de-
tected by abdo-minal ultrasound, and 
one petient had dilated intrahepatic 
and extrahepatic ducts with gallstones. 
CD was found during operative treat-
ment of gallstones. In three cases CD 
was completely mobilized with a com-
bination of blunt and sharp dissection 
and divided using the endoscopic lin-
ear stapling device. After that, laparo-
scopic cholecystectomy was performed. 
In the other two cases after division of 
the cystic duct and artery the gallblad-
der was dissected from the liver bed, 
leaving just the fistulous connection to 
the duodenum. The division of the fis-
tula was then completed using the same 
stapling device.
None of the patients needed to be 
converted to open cholecystectomy and 
all five patients had uneventful postop-
erative course. The hospital stay of five 
patients ranged from 5 do 10 days (me-
dian 6 days), length of follow up was 6 
months.
4. DISCUSSION
The development of a fi-
sulous tract from gallblad-
der is associated with gall-
stones in 90% of cases (4). 
As seen in this study, pa-
tients with CD are com-
monly presented with signs 
and symptoms of chronic 
cholecystitis. There were no 
specific symptoms which 
suggested CD and each fis-
tula was diagnosed intra-
operatively. Preoperative 
findings such as pneumobi-
lia can be suggestive of in-
ternal biliary fistula (5), but 
we had no this sign. ERCP 
and MRCP are reliable di-
agnostic tools to clearly 
demonstrate the abnormal 
communication (4), but it 
was possible to use only US. 
That is the reason why we 
diagnosed CDs exclusevely 
intra-operatively.
Treatment advocated 
for CD is cholecystectomy 
and closure of fistula com-
munication (4,6). Prompt 
recognition is crucial in 
the treatment of these 
cases along with meticu-
lous prepa-ration of the fis-
tula site. Laparoscopic suturing is time-
consuming and can not secure fistula 
closure (4). For the fistula repair, the 
linear stapling device appears to be an 
useful instrument (1,7). If it is feasible 
to perform the cholecystectomy first, 
then the exposure and repair of the 
fistula is easier and safer. After careful 
dissection, the occlusion of the fistula 
can be performed first, enabling easier 
cholecystectomy.
CD does not preclude a laparoscopic 
approach. With more experience and 
improved techniques, most of these 
cases could be performed laparoscop-
ically, with all of the advan-tages that 
minimally invasive surgery offers.
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Figure 1. The cholecystoduodenal fistula was mobilized and 
divided using the endoscopic linear stapling device.
Figure 2. The fistulous connection of gallbladder with the 
duodenum.
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Pobijedimo infekcije:
  disajnih puteva
  urinarnog trakta
  kože i mekih tkiva
Pravi izbor, zadatak izvršen!
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